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ABSTRACT 
In vitro models represent an important tool in the regenerative medicine research area. Great 
importance is given to utilising a representative system, which closely mimics the in vivo 
environment.  
Developing a model of the neuromuscular junction (NMJ) is a promising step which will allow 
scientists to investigate the physiology and pathophysiology of the interface between skeletal 
muscles (SkM) and peripheral motor neurons (MNs). These cell types can be affected by 
degenerative disease such as amyotrophic lateral sclerosis (ALS), that leads to progressive 
paralysis and for which no treatment is available to this date. A human model of the NMJ could 
be used to study potential therapeutic agents and reduce the use of animals in research.  
The main aim of this project was to “humanise” currently existing models of the NMJ using 
tissue engineered constructs. In the first part of the work, cell lines were used to establish a 
chimeric co-culture. Immunofluorescent staining, gene expression analysis and the evaluation 
of morphological features were used. As a result, the co-culture conditions for C2C12s and 
SH-SY5Ys were optimised, the expression of pre- and post-synaptic proteins was verified and 
agrin was not included in the medium for 3D cultures. Fibrin and collagen constructs allowed 
for the alingnment of C2C12 fibres, and the addition of SH-SY5Ys to the culture did not affect 
matrix remodeling or myotube width. However, information on the cells distribution, training 
on the use of tissue engineered constructs and observations on the alignment of SH-SY5Ys 
were gathered. Subsequently, iPSC-derived MN progenitors were differentiated for 35 days 
and showed typical MN morphology, as well as cholinergic markers expression. The culture 
of SkM on gelatin proved to be more effective for its differentiation, and donor-to-donor 
variability was observed when generating the co-culture with MNs. Despite the expression of 
NMJ markers and the use of 3D constructs, gene expression was depleted when the neurons 
were present in the culture, the distribution of the cells within collagen/Matrigel® gels did not 
allow for an increase in force generation and it was not possible to verify the presence of a 
NMJ.  
The co-culture of human muscle and nerve in a 3D environment is a promising model which 
allows researchers to understand the mechanisms underpinning NMJ development and 
formation. Tissue engineered constructs are suitable systems as they allow for the cells to grow 
and interact in a matrix which mimics the in vivo conditions, while mechanically or electrically 
stimulate the cells. The work carried out for this thesis led to a great amount of future 
IX 
 
developments using a novel co-culture system, which is an improvement compared to exhisting 
animal or embryonic models. This can be further optimised for applications such as drug 
screening, personalised medicine testing, or disease modeling. 
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1 INTRODUCTION 
The experiments described in this thesis represent an attempt to develop a three-dimensional 
model of the neuromuscular junction using human cells. Therefore, this introduction will focus 
on what is currently known regarding skeletal muscle, motor neurons, the interface between 
the two, and tissue engineering approaches to establish a co-culture model. The aim of this 
section is to give the reader an insight into the general structure and physiology of either tissues, 
while providing details which will be useful to understand the experimental design and 
development of each chapter that follows.
1.1 Neurons 
1.1.1 The nervous system  
The nervous system is a complex network of neurons and glia cells which are responsible for 
the transmission of signals throughout the body, via electro-chemical pathways. The structure 
of the nervous system is represented in Figure 1.1. In mammals, it has two main divisions: the 
central nervous system (CNS) conducts and interprets signals and stimuli to the peripheral 
nervous system (PNS). The CNS includes the brain (cerebrum, cerebellum and brain stem), the 
spinal cord, optic, olfactory and autitory systems; the PNS transmits sensory and excitatory 
stimuli to and from the spinal cord. It comprises cranial (from the brain), spinal (from the spinal 
cord) and sensory nerves which interconnect the CNS to the body (Schmidt and Leach, 2003). 
The PNS is divided into somatic and visceral regions. The somatic region includes spinal 
nerves which innervate skin, joints and voluntary muscles. Here lie motor neurons (MNs), 
specialised neurons which command muscle contraction within the body. The soma of MNs 
(i.e. cell body) is located in the CNS (spinal cord), whilst the axons extending from them are 
mostly located in the PNS. The visceral PNS, also called autonomic, is formed by neurons 
which innervate internal organs, glands and blood vessels (Bear et al., 2001). It is subdivided 
into the sympathetic and parasympathetic regions, which are responsible for opposing 
responses. While the sympathetic division is triggered in moments of stress or danger 
commonly known as the ‘fight or flight response’, the parasympathetic system is in charge or 
relaxing the body as a reaction to the sympathetic trigger, known as the ‘rest and digest’ 
response (Alberts et al., 2002; Lodish et al., 2000). 
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From a functional point of view, the nervous system is divided into sensory systems and motor 
systems. Sensory systems are appointed to acquire and process information from the 
surrounding environment, utilising sensory ganglia, nerves and receptors within the body. The 
motor systems include autonomic ganglia and nerves, and MNs, which respond to central 
information and target peripheral structures (smooth, cardiac and skeletal muscles, and glands) 
(Purves et al., 2004).  
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Figure 1.1. Structural organisation of the nervous system. The nervous system is divided into the central nervous system (CNS), which includes 
the brain and spinal cord, and the peripheral nervous system (PNS). This comprises a sensory division which functions as a connection between 
the PNS and the CNS, and a motor division, which runs in the opposite direction. The motor division, is subdivided into autonomic (involuntary 
signals which target smooth muscle, cardiac muscle and glands) and somatic (voluntary signals which target skeletal muscles). The part of the 
autonomic system referred to as sympathetic is responsible for the ‘fight or flight’ response, whereas the parasympathetic is responsible for the 
‘rest and digest’ response. 
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1.1.2 Cellular components of the nervous system and synapses 
The nervous system is mainly composed of two cell types: neurons and glial cells. These differ 
in structure and function across CNS and PNS. Generally, neurons represent the structural and 
functional elements of the nervous system, while glial cells act as support for neurons and 
mediate processes such as development and regeneration (Schmidt and Leach, 2003). 
Neurons (Figure 1.2) are specialised cells capable of conducting electrical signals over long 
distances. This section will elaborate mainly on peripheral neurons as they are relevant to this 
work. Although neurons vary in size and shape depending on their function, their structure is 
consistent: neurons are made of a cell body (soma) and its extensions (dentrites and axons). 
Signal from other cells are picked up by dendrites and transmitted to the soma, whereas 
outgoing signals travel along the axons and are diffused via the axon terminals (Purves et al., 
2004). Axons are surrounded by myelinated Schwann cells, which represent the glial cell 
population. These cells are essential to the survival and function of neurons by secreting trophic 
agents (Bhatheja and Field, 2006; Son and Thompson, 1995), besides being involved in debris 
clearance and cytokine release during axonal regeneration (Schmidt and Leach, 2003). 
Individual axons and myelin sheaths are enclosed in the endoneurium, a complex membrane 
which sustains neurons. Bundles of axons form fascicles around which the perineurium lies as 
a layer of fibroblasts and collagen. Lastly, multiple fascicles are grouped into a large nerve 
cable surrounded by a fibrocollagenous tissue called epineurium (Schmidt and Leach, 2003; 
Winter and Schmidt, 2002). The highly organised and aligned structure of neurons resemble 
the one found in skeletal muscles (SkM), which will be discussed further in section 1.3.  
The signal transmission occurs via an impulse, which is triggered by a change in the membrane 
potential. When neurons are at resting potential, their inner charge equals -70 mV and is 
stabilised by sodium and potassium pumps. If the neuron receives a signal which is powerful 
enough to modify this potential, voltage-gated ion channels open on the surface of the cell and 
allow for a positively-charged ion flow to enter it, thus depolarising the cell (depololarisation). 
Return to the resting potential occurs through hyperpolarisation and the release of positive ions 
(Alberts et al., 2002; Lodish et al., 2015). The presence of myelin around the axons gives rise 
to the so-called saltatory condution: impulses jump faster and more effectively from one node 
of Ranvier to another, as myelin represents a non-conductive layer (Purves et al., 2004).  
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A synapse is the mechanisms through which neurons communicate with other neurons or cell 
types. These signal transmissions can be either chemical or electrical. Chemical synapses 
involve the release of vesicles containing the chemicals by the axon terminals and fuse to the 
post-synaptic membrane to trigger a response. These chemicals are called neurotransmitters, 
and have different effects depending on their class (Alberts et al., 2002; Purves et al., 2004). 
Particularly relevant to this thesis is acetylcholine (ACh), a neurotransmitter released by MNs 
which binds to SkM fibres to trigger muscle contraction. This interaction, referred to as a 
neuromuscular junction (NMJ) will be addressed in detail below (see section 1.1.5). 
 
Figure 1.2. Structure of neurons. The cell body of neurons is called soma. Dendrites are 
responsible for receiving stimuli from other cells to the soma, whereas axons transmit 
information from the soma to other cells. Axons are surrounded by intermittent regions of 
myelin sheaths which insulate and protect them while allowing for a quicker transmission. The 
electrical impulse travels from node to node of Ranvier, thus reaching the axon terminals 
quicker than unmyelinated sheaths. Image from Wikimedia.org. 
1.1.3 Motor neurons  
Peripheral MNs are efferent neurons which develop from the neuroepithelium in the notochord, 
and reside in the somatic portion of the motor division (DeLapeyriere and Henderson, 1997). 
During development, MNs extend axons towards SkM fibres in a process controlled by a 
complex network of chemoattractants and repellents (reviewed by DeLapeyriere and 
Henderson, 1997). Mature MNs are subdivided into three types, α, β and γ.  The most abundant 
ones are α-MNs, the function of which is to innervate extrafusal SkM fibres to trigger 
contraction. The γ subtype innvervate intrafusal fibres and are involved in motor control, while 
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β-MNs innervate both fibre types and have, as yet, a poorly understood role in muscle 
contraction (Kanning et al., 2010). 
1.1.4 Neuromuscular junction development in vivo 
For a NMJ to form, the development of both SkM and MNs must be complete. These cell types 
generate from two different germ lines, MNs from the ectoderm and SkM from the mesoderm. 
Around the 3rd week of gestation, the outer layer of the embryo (i.e. the ectoderm) thickens and 
forms a neural plate which progressively folds to fuse into the neural tube at the end of the 4th 
week. As development progresses, different portions of the tube will give rise to different areas 
of the nervous system. The patterning process determines the dorso-ventral and rostro-caudal 
axes, and early MNs originate to then mature and synapse with SkM fibres. These fibres are 
fully formed at the end of the 12th week of gestation, and evidence of NMJ formation was 
observed within that time (Molina et al., 2010).  In the mesoderm, MyoD and Myf5 expression 
triggers the generation of myogenic precursors which then mature into myoblasts thanks to an 
increase in Myogenin and Mrf4. Further expression of Mrf4, MyoD and MyoG allows for the 
fusion of myoblasts into multinucleated cells called myotubes. This process is explained in 
detail in section 1.3.1.  
Understanding how either cell type originates is crucial when establishing a co-culture, and 
particularly important during the generation of MNs from pluripotent stem cells. Such 
information can give clues on which factors can be used for the differentiation, as well as on 
which cell type can be added to the culture first, if not at the same time.  
1.1.5 Neuromuscular junction formation 
The motor unit is the elementary component of motor control, which includes α-MNs, their 
axons and the muscle fibre they innervate (Figure 1.3) (Heckman and Enoka, 2004). The 
mechanism through which a MN innervates a SkM fibre and triggers contraction is called 
neuromuscular junction (NMJ) formation.  
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Figure 1.3. Motor unit structure. Lower MNs cell bodies reside in the grey matter of the spinal 
cord. Their axons project out of the spinal cord and travel towards SkM’s to form the motor 
unit. The axon terminals which interact with the SkM fibres generate muscle contraction via 
the formation of a process known as NMJ. Image from physiopolis.wordpress.com.  
A schematic representation of NMJ formation and and its constituent elements is shown in 
Figure 1.5. Essentially, the NMJ controls a very brief release of vesicles containing the 
neutransmitter ACh, which travels through the synaptic cleft (the space between the axon 
terminal and the muscle fibre) and binds to ACh receptors (AChR’s) on the post-synaptic 
membrane (Colquhoun and Sakmann, 1998; Witzemann, 2006). At their resting potential, 
neurons maintain a membrane potential of -70 mV. If the summation of the inputs coming from 
other neurons is greater than the threshold potential, this triggers the generation of an action 
potential which travels down the axon, reaches the axon terminals and induces release of ACh 
(Figure 1.4).  
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Figure 1.4. Action potential in neurons. Neurons maintain a resting potential of -70 mV thanks 
to the sodium-potassium pump. When a stimulus is received, depolarisation starts, and at the 
threshold of -55 mV, the sodium channels open and allow ions to flood inside the cell. This 
process continues until potassium channels open at +40 mV. This triggers repolarisation and 
exit of potassium ions . After a refractory period in which sodium gates remain closed, the cell 
returns to its resting potential. Image from Wikimedia.org.  
The binding of ACh to the surface of the muscle causes the release of Ca2+ from the 
sarcoplasmic reticulum. Meanwhile, the Na+ channels located on the post-synaptic membrane 
open and Na+ ions enter the muscle fibres, thus creating the end plate potential which spreads 
through the muscle fibres and causes contraction (Hall and Guyton, 2016). This process 
continues for as long as ACh is available in the synaptic space. Two events block further 
excitation of the ACh receptors: first, some of the ACh diffuses away from the synaptic space. 
Second, the enzyme acethylcholinesterase (AChE) splits ACh into an acetate ion and choline, 
which can be reabsorbed into the neural terminal to be re-used when more ACh is needed (Hall 
and Guyton, 2016). The mechanism of muscle contraction will be further discussed in section 
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1.3.1  (Bear et al., 2001; Guyton and Hall, 2005). The NMJ process has been investigated for 
several years, and the role of other cell types and proteins was found to be crucial. During 
muscle formation, the pre-patterning process leads to clustering of AChR’s in the central 
regions of the myofibres (Witzemann, 2006). The AChR’s are stabilised by rapsyn (Wu et al., 
2010), agrin and the activation of a muscle-specific kinase (MuSK) even before innervation 
(Burden et al., 2013; Legay and Mei, 2017). In fact, the presence of MuSK drives the axonal 
extension towards the muscle (DeChiara et al., 1996) because studies in mice lacking MuSK 
showed loss of AChR’s and aberrant neuronal growth (Hesser et al., 2006). The activation of 
MuSK occurs via phosphorylation induced by R-spondin 2 (Rspo2), an activator of the Wnt 
signalling which is produced by MNs and binds to receptors on the muscle membrane called 
Lgr5 (Nakashima et al., 2016). Once bonded, this mediates AChR clustering, which is then 
stabilised by the structural protein rapsyn, similarly to the mechanism of action of agrin. Agrin 
is a proteoglycan expressed both by neurons and muscles, although neuronal agrin is known to 
be much more powerful than its muscle counterpart in inducing accumulation of AChR’s at the 
synaptic sites (Witzemann, 2006). Agrin binds to the receptor Lrp4 and also mediates the 
activation of MuSK (Weatherbee et al., 2006). An inducible Lrp4 mutant mouse model was 
generated to investigate the NMJ maintenance (Barik et al., 2014). Prolonged absence of Lrp4 
causes muscle weakness, body weight loss, reduced AChR intensity and fragmented AChR 
clusters, suggesting that Lrp4 is essential for NMJ maintenance in adults (Barik et al., 2014). 
However, Lrp4 can bind to MuSK independently from agrin (Kim et al., 2008; Zhang et al., 
2011). In fact it was found that even in the absence of innervation, MuSK was activated, 
perhaps due to the muscle agrin counterpart (Schaeffer et al., 2001).  
Extensive studies carried out in the past 50 years have generated fundamental knowledge on 
the formation of the NMJ, a crucial mechanisms for survival and locomotion which involves 
different cell types and molecules. However, research on the pathophysiology of this interface 
is still limited by the requirement of a human source of MNs which can be used to generate a 
model of the NMJ in vitro. 
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Figure 1.5. NMJ formation. The enzyme ChAT (choline acetyltransferase) is responsible for 
the generation of ACh (acetylcholine) by binding Ch (choline) to Aa (acetic acid). ACh is 
internalised in synaptic vesicles which are exocytated by the nerve terminal into the synaptic 
cleft. Here, ACh travels to AChR’s (acetylcholine receptors) on the surface of the muscle fibre. 
These receptors are stabilised by rapsyn and MuSK, which are activated when neuronal agrin 
binds to its receptor on the post-synaptic membrane (Lrp4). Further activation of MuSK comes 
from the bound of Rspo2 (R-spondin 2) to the transmembrane receptor Lgr5. The excess ACh 
is split into Ch and Aa by AChE (acetylcholinetransferase).  
1.1.6 Pathophysiology of the neuromuscular junction 
Malfunctioning of the NMJ apparatus results in serious consequences for patients. Toxins (i.e. 
black widow spider venom, botulinum toxin or cobratoxin) can bind to AChR’s, blocking them 
and causing paralysis which can quickly lead to death. The NMJ can also be affected by a 
pathological disorder. Myasthenia gravis (MG) is an autoimmune disease in which the patient’s 
immune system attacks acetylcholine receptors, resulting in progressive muscle weakness and 
difficulty in completing every day actions (Miralles, 2016). More common than MG are 
amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA). ALS occurs 
predominately in males over the age of 60, with a frequency of 2 individuals out of 
100,000/year in the United Kingdom (UK). This disorder hits neurons in the cortex, 
corticospinal tract, brain stem and spinal cord. At the moment there are no clear evidences of 
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the factors which lead to the development of the disease. Only a mutation in the SOD1 gene 
on chromosome 13 has been shown to be related to it (Wijesekera and Leigh, 2009). SMA 
targets the MNs of the spinal cord, leading to progressive loss of function of the muscles which 
are innervated by the neurons. The disease hits 1 out of 10,000 children and causes death by 
the second year of life in the most severe cases. The patients who reach adult age live quite 
normally, but experience motor impairment. SMA is caused by the disruption of the gene 
SMN1 (survival motor neuron 1),  which causes degeneration of α-MNs (Ebert et al., 2009). 
For neither of these diseases is there, to date, a cure. (Vitte et al., 2009). Therefore, all current 
treatments aim to improve the patients symptoms and slow down the progression of the 
degeneration. Studying the NMJ in a representative in vitro model is crucial to both understand 
the mechanisms underpinning the pathophysiology of such conditions, and to test novel 
therapeutics and explore personalised medicine for those who undergo treatment. 
1.1.7 Neurons in culture 
Cell lines which express neuronal properties are useful tools for studying the nervous system 
and interactions between neurons and other tissues (i.e. SkM). The use of cell lines ensures 
reproducibility and availability at a much lower cost and ethical implications than when 
utilising primary cells. This paragraph briefly describes the most widely used neuronal lines. 
The neuronal cell line PC12 was first isolated from a tumor in the adrenal medulla of a rat in 
1976. The cells were treated with neuronal growth factor (NGF) to generate dopamine- and 
noradrenalin-releasing neurons, thus proving to be suitable for studies on the sympathetic 
division of the PNS (Greene and Tischler, 1976). The presence of ACh was also reported in 
small vesicles inside PC12’s (Howard and Melega, 1981; Schubert et al., 1980), and the 
treatment with Luteolin, an active compound found in Rosmarinus officinalis, induced PC12 
differentiation and cholinergic activities (El Omri et al., 2012). A PC12 co-culture with the 
murine myoblast line C2C12 reported higher muscle maturity, differentiation and expression 
of neuromuscular markers (Ostrovidov et al., 2017), thus showing the suitability of this cell 
line for various neuronal studies. However, PC12s are an animal cell line, and as such, not the 
primary choice when designing a human in vitro model.  
Studies have also been conducted using another cell line, NSC-34 (Maier et al., 2013; Matusica 
et al., 2008). This line is mouse-derived, and it is undifferentiated. Therefore, specific protocols 
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for differentiation into MNs are necessary and unpractical. It has recently suggested that NSC-
34 cells cannot be considered a valid model for studies related to MNs (Hounoum et al., 2016).  
A human neuronal alternative to PC12 cells is the neuronal line NT2, which was derived from 
a human embryonic teratocarcinoma (Andrews et al., 1984). These cells possess typical 
markers of dopaminergic neurons (Zigova et al., 1999), and the release of dopamine was later 
confirmed (Iacovitti et al., 2001). The versatility of these cells lies in their pluripotency, thus 
showing their potential to differentiate into different neuronal types. Previous work generated 
a mixed population including glial cells to sustain the differentiated glutamatergic neurons 
(Langlois and Duval, 1997). Others obtained a subpopulation of glutamatergic cells and a major 
portion of neurons which appeared cholinergic (Podrygajlo et al., 2009). The potential to derive 
both a neuronal population (NT2N) and a glial population (particularly astrocytes, NT2A), 
allowed for the generation of a co-culture where several aspects were analysed: morphology, 
electrical activity, response to the neurotransmitter glutamate and to Tetrodotoxin (a neurotoxin) 
were investigated and revealed a co-dependance between NT2N and NT2A. This confirmed 
the versatily of this cell line, as well as reiterate the supportive role of a glial population in 
neuronal cultures (Hill et al., 2012). All in all, NT2’s represent an adaptable neuronal 
population which can be utilised for several studies.  
1.1.8 SH-SY5Y human neuroblastoma cell line 
Another versatile source of human neurons is the neutoblastoma line SH-SY5Y, a 
neuroblastoma line. Neuroblastoma is the most common malignant tumor affecting neuronal 
crest-derived cells (Joshi et al., 2006). This cell line was first derived by a bone marrow biopsy 
of the tumor (SK-N-SH) in 1973 (Biedler et al., 1973). SK-N-SH cells were characterised by 
the presence of three different cell types: neuronal (N), Schwannian (S) and intermediary (I). 
However, SH-SY5Ys are a homogenous population of N-type cells (Hong-rong et al., 2010). 
SH-SY5Ys can be used as neuronal model because they grow continuously in an 
undifferentiated state, presenting a neuronal-like morphology and expressing immature 
neuronal markers such as nestin (Smith et al., 2013). Given the availability of SH-SY5Ys and 
their extensive use in our laboratory, co-culture studies were performed in this work, 
particularly to determine the culture conditions and the interaction between human neurons and 
murine skeletal muscle. Certainly, these cells present limitations too, but as a primary human 
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source of MNs is not obtainable, SH-SY5Ys were proven to be sufficient for preliminary 
studies in this thesis. 
1.1.8.1 Differentiation of SH-SY5Ys: an ‘eclectic’ line 
SH-SY5Y cells are a versatile cell line which can be used to generate dopaminergic, adrenergic 
or cholinergic neurons. Different factors can be used to guide the SH-SY5Y cells towards such 
phenotypes. The most commonly used are retinoic acid (RA) and phorbol esters (Smith et al., 
2013).  RA is a derivate of vitamin A which is used to guide the cells to exit the cell cycle, 
therefore stopping them from proliferating and inducing differentiation (Joshi et al., 2006). It 
plays an essential role in neurite outgrowth and development of the nervous system (Clagett-
dame et al., 2006); it was also linked to peripheral nerve regeneration, therefore representing a 
key element of neuronal physiology (Mey and McCaffery, 2004). Furthermore, RA is involved 
in the development and functional maintenance of vital organs in adults (Zhu et al., 2009). 
RA’s mechanism of action involves the binding of this compound to two families of nuclear 
receptors: the RA receptors (RAR’s) and the retinoid X receptors (RXR’s) (Joshi et al., 2006). 
The so-formed heterodimers then bind to RA responsive elements (RARE) and activate 
transcription via the Wnt signaling pathway (Hong-rong et al., 2010). 
In the majority of reported works, RA was used at a concentration of 10 μM, but different 
protocols were also proposed (Adem et al., 1987). RA can lead to a cholinergic phenotype, 
which can be verified by the expression of markers such as choline acetyl esterase (ChAT) and 
vesicular monoamine transporter (VMAT) (Ichikawa et al., 1997). Some studies, however, 
suggest that when RA was used in combination with other factors like phorbol esters 
(Presgraves et al., 2004) or cholesterol (Sarkanen et al., 2007), the expression of dopaminergic 
receptors (D2R and D3R) and the dopamine transporter DAT increased. These markers were 
positive also in the undifferentiated SH-SY5Y cells, but the dopaminergic characteristics 
significantly increased upon differentiation. Phorbol esters like 12-O-tetradecanoyl-phorbol-
13-acetate (TPA) enhanced the cellular noradrenaline content (Påhlman et al., 1984), therefore 
inducing an adrenergic phenotype (Murphy et al., 1991; Scott et al., 1986). In fact, one study 
analysed the differences between differentiated SH-SY5Ys in the presence of RA or TPA alone, 
and the combination of both. The treatment with RA and TPA increased the number of 
differentiated cells which also had longer neurites than the ones treated with RA or TPA only. 
The same applied to the inhibition of cell proliferation. The neuron-specific enolase (NSE) 
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activity was similar among the three conditions. RA caused a 4-fold increase in noradrenalin 
concentration, whereas TPA caused a 200-fold increase. When treated with RA and TPA, the 
levels of noradrenalin where comparable to the untreated control (Påhlman et al., 1984). 
Following this work, the same research group investigated the effect of RA and TPA on 
muscarinic receptors on the membrane of SH-SY5Ys. Moreover, the treatment with both RA 
and TPA caused an increase in AChE and choline acetyltransferase (ChAT) activity. Overall, 
the use of RA caused a major cholinergic phenotype than TPA. 
In contrast with the majority of studies which indicate that RA causes SH-SY5Y cells to 
differentiate into cholinergic cells, one study showed that the administration of 1 μm RA 
produced an increase in dopaminergic markers (Korecka et al., 2013). The expression of 50 
genes which are involved in development and differentiation was investigated after treatment 
with RA. These were more expressed in the treated samples, confirming the role of RA in the 
differentiation process. TFAP2B, Isl-1, SIX3 and ATF5 are negative regulators of neuronal 
differentiation and were downregulated upon treatment with RA. The group did not observe 
significant differences in the expression of transcription factors typical of the early stage of 
development of dopaminergic neurons. However, the cells expressed the enzymes which are 
crucial during synthesis and degradation of dopamine, a characteristic which is typical of 
mature dopaminergic neurons. Despite these results, there was no significant difference 
between the levels of these markers before or after RA treatment, indicating perhaps that the 
cells already possessed dopaminergic features and that RA did not affect them. The same 
applies to the expression of cholinergic neurotransmitters. It is clear, then, that SH-SY5Y cells 
present an heterogeneous phenotype which is not always affected by the presence of RA in a 
significant manner (Korecka et al., 2013).   
Although it can be generally said that the population of undifferentiated SH-SY5Ys is made of 
N-type cells (Hong-rong et al., 2010), a previous study (Encinas et al., 2000) showed that 
differentiated cells presented characteristics of S-type cells after 8-10 days in RA. RA was used 
in combination with brain-derived neutrophic factor (BDNF), which had an anti-apoptotic 
effect. Therefore, 3-5 days appeared to be the best interval to keep the cells in RA. For the work 
presented in this instance, 5 days in differentiating medium were considered. To date, SH-
SY5Y cells represent a valid cell line to study neurons with different phenotypes. A summary 
of the approaches which have been used to differentiate SH-SY5Y cells, the investigated 
markers and the resulting phenotypes can be found in Table 1.1.
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Table 1.1. Summary of the techniques reported in the literature to induce differentiation of SH-SY5Y cells.  
Abbreviations: RA = retinoic acid; TPA = 12-0-tetradecanoylphorbol-13-acetate; NSE = neuron-specific enolase; AChE = 
acetylcholinesterase; ChAT = choline acetyltransferase; MPP = 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinium ion; DAT = dopamine 
transporter; TH = tyrosine hydroxylase; DRD2 = dopamine receptor D2; DRD3 = dopamine receptor D2; VMAT = vesicular monoamine 
transporter; dBcAMP = Dibutyryl-cyclic adenosine monophosphate;SypI = synaptophysin I; AM1-43 = activity-dependent fluorescent nerve 
terminal probe; FGF-8 = fibroblast growth factor 8; Nkx2.2 = homeobox protein Nkx2.2; Nkx6.1 = homeobox protein Nkx6.1; SHH = sonic 
hedgehog; Sox2 = sex-determining region Y; TGF-β = Transforming growth factor beta; Wnt-1 = protooncogene protein; COMT = Catechol-
O-methyltransferase; DDC =  dopamine decarboxylase; GCH1 = Guanosine triphosphate cyclohydrolase; MAO-A = Monoamine oxidase A; 
MAO-B = Monoamine oxidase B; PTS = 6-pyruvoyltetrahydropterin synthase; VMAT2 =  = vesicular monoamine transporter 2; DMEM HG 
= Dulbecco’s Modified Eagle’s Medium high glucose; BDNF = brain-derived neutrophic factor; 6-OHDA = oxidopamine. 
Reference Methods Markers Phenotype 
(Påhlman et al., 
1984) 
10 μM RA; 16 nM TPA; RA + TPA. 
All for 10 days. 
Number of differentiated cells; proliferation rate; 
NSE activity; noradrenalin concentration. 
Cholinergic. 
 
(Adem et al., 
1987) 
0.1 μM RA; 16 nM TPA. Characterisation of muscarinic receptors; AChE 
and ChAT activity. 
Cholinergic. 
(Presgraves et 
al., 2004) 
10 μM RA for 6 days; 80 nM TPA for 6 
days; RA for 3 days and then TPA for 3 
days. 
Sensitivity to the neurotoxin MPP+ and DAT. 
Expression of TH, DRD2 and DRD3 and VMAT. 
The cells treated with RA 
only presented 
characteristics typical of 
cholinergic neurons.  
A dopaminergic portion 
was observed after 
treatment with RA/TPA 
or TPA only. 
(Sarkanen et al., 
2007) 
20 nmol/L TPA; 50 μmol/L dBcAMP; 5 
μmol/L RA; 10 μg/mL cholesterol; 5 
μmol/L RA+ 5 μg/mL cholesterol. All 
for 14 days. 
Neurite length; SypI and AM1-43 co-localisation. Dopaminergic. 
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(Korecka et al., 
2013)  
1 μM RA for 8 days. Early stage dopaminergic markers (FGF-8, 
Nkx2.2, Nkx6.1, SHH, Sox2, TGF-β, Wnt-1). 
Dopamine synthesis and turnover markers 
(COMT, DDC, GCH1, MAO-A, MAO-B, PTS, 
VMAT2, DAT, TH).  
Dopaminergic neuron markers and 
neurotransmitter receptors.  
Dopaminergic 
characteristics, not 
significantly different 
from the non-treated 
samples. 
(Forster et al., 
2016) 
First, DMEM HG, l-glutamine and 10 
μM RA. Then, Neurobasal medium, l-
glutamine, N2 supplement and BDNF. 
Markers of undifferentiated and differentiated 
state. Analysis of the plasma membrane potential. 
Response to 6-OHDA. 
No dopaminergic 
phenotype was observed. 
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1.2 Pluripotent stem cells  
Stem cells are cells capable of self-renewal and differentiation into specific cell types (Hanna 
et al., 2010). There are different levels of potency, depending on how many cell types can 
orginate from a stem cell. Totipotent stem cells are solely those in the blastocyst at the 3rd day 
of gestation, which can give rise to the entire organism and to extra-embryonic cells (i.e. the 
placenta). Pluripotent cells can generate the entire body and include both embryonic (ESCs) 
and induced pluripotent stem cells (iPSCs). Multipotent stem cells, such as hematopoietic stem 
cells, can differentiate into a limited amount of cell types. Finally, unipotent stem cells are only 
capable of generating one cell type, as satellite cells do in SkM (Singh et al., 2016). 
Pluripotent cells can differentiate into the three germ layers: mesoderm, ectoderm and 
endoderm (Binder et al., 2009). Just over a decade ago pluripotent cells from human adult cells 
were generated (Takahashi and Yamanaka, 2006). Both these and ESCs were utilised to 
generate human neurons (Shi et al., 2012), but the use of  iPSCs has the promising advantage 
of not requiring embryos, together with the possibility to derive specific cell types from a 
patient.   
During the maturation of MNs in vitro, pluripotent cells acquire cell polarity and migrate to 
form rosettes (Elkabetz et al., 2008; Yonemura et al., 1993), which eventually give rise to MNs 
(Delli Carri et al., 2013). This process depends on the activation of Sonic Hedgehog (SHH) 
and Notch pathways, following which the neuronal rosettes become positive for 
neuroectodermal markers such as Pax6 and Sox1 (Elkabetz et al., 2008). Therefore, the rosettes 
can differentiate into the three cell lineages of the nervous system: neurons, oligodendrocytes 
and astrocytes (Elkabetz et al., 2008). Although there are no specific markers for mature MNs, 
one that can be used is nestin (a neuroprogenitor indicator) (Zhang et al., 2001) and others 
which are typical for neural plate and tube formation in the neuroectoderm, such as Pax6 and 
Sox1 (Pevny et al., 1998). In order to confirm the presence of mature MNs in culture, the 
following markers are often used; HB9 (Arber et al., 1999), ChAT, Islet 1 (Ericson et al., 1992), 
Islet 2 (Tanabe et al., 1998), and Olig2 (Shirasaki and Pfaff, 2002).   
1.3 Muscle 
Muscle is a soft tissue which can be of three types: cardiac, smooth or skeletal. Cardiac muscle 
(or myocardium) constitutes the heart and has involuntary contractile properties. Smooth 
18 
 
muscles are also involuntary muscles which are found in certain organs like the skin, stomach, 
intestines, uterus and urinary bladder, as well as in the walls of arteries and veins (Gray, 1960). 
This section will focus on the development and physiology of skeletal muscle (SkM) as it is 
relevant to the work carried out in this thesis. 
1.3.1 Skeletal muscle gross structure and development  
SkM is a striated, contractile tissue which is connected to bones via tendons. It covers a range 
of functions including maintaining posture, voluntary movement, breathing and is responsible 
for the generation of heat which contributes to keeping body temperature stable. By interacting 
with MNs and other components of the musculoskeletal system, it contracts and allows 
locomotion (Lumley et al., 1980). The gross structure of SkM is shown in Figure 1.6. Muscles 
are covered by a layer of connective tissue called epimysium. They are made of several, highly 
aligned substructures called fascicles, covered by the endomysium. Each fascicle is made of 
organised and elongated fibres. Muscle fibres are characterised by even smaller structures 
called myofibrils (Sciote and Morris, 2000).  
SkM cells secrete a series of components which support the tissue from a structural and 
mechanical point of view. These components constitute the SkM extracellular matrix (ECM). 
The main component of this ECM is collagen; the outer layer of the muscle primarily formed 
by collagen type I. The other two layers (epymisium and endomysium) are made of collagen 
type I and III (Gillies and Lieber, 2012). In the ECM there is also a  large portion of 
proteoglycans (i.e. decorin) and glycoproteins (Kjær, 2004). The complex architecture of the 
ECM and its interaction with nearby tissues such as tendons or neurons is a crucial aspect of 
SkM structure. Tissue engineering can help create a more complex environment in which SkM 
cells grow, differentiate and interact with other cell types.   
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Figure 1.6. Skeletal muscle structure. The whole muscle is surrounded by the epismysium. The 
perimysium surrounds bundles of fibres. The endomysium is the internal membrane which 
covers the multinucleated fibres. Image from Wikimedia.org.  
SkM derives from the embryonic lineage of mesoderm: stem cells in this germ line give rise to 
immature muscle cells called myoblasts. During the commitment to the myogenic lineage, 
specific transcription factors are expressed in these muscle progenitors. These are called 
myogenic regulatory factors (MRFs) and they alternately appear and disappear in the 
differentiation process (Figure 1.7).  
 
Figure 1.7. MRF in SkM maturation and differentiation. During the maturation process, there 
is activation of Myf5, MyoD and Mrf4. Mrf4 remains active also during the differentiation step, 
together with MyoG. The morphology of the cells also varies. Myogenic precursors appear 
round-shaped and they elongate during development. At the mature stage of myotubes, they 
fuse to fibre-like, multinucleated structures.  
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The best characterised MRFs are MyoD, Myf-5, Mrf4 and myogenin (MyoG), as well as the 
paired box (Pax) transcription factors Pax 3 and Pax 7 (Buckingham and Relaix, 2007; Burattini 
et al., 2004; Rudnicki et al., 1993). Initially, myogenic precursors express Pax 3 which is 
downregulated during maturation to myoblasts, which form thanks to the activation of Myf5, 
MyoD and Mrf4 by the SHH and Wnt pathways (Cossu and Borello, 1999). Mrf4, MyoD and 
MyoG then promote the differentiation of myoblasts into myotubes, which form a continuous 
layer of aligned cells (Olson and Klein, 1994). Further growth of the SkM tissue is facilitated 
by Pax 3 and Pax 7 positive cells which are mainly Myf5 and MyoD positive and therefore 
myogenic. These cells fuse with existing fibres and create bigger structures (Buckingham and 
Relaix, 2007). Towards the end of fetal development, a subpopulation of Pax 3 and Pax 7 
positive cells form the mammalian postnatal satellite population. Satellite cells are the stem 
cell population of SkM, although they express SkM markers which suggest commitment ot the 
myogenic lineage even prior to their activation (Beauchamp et al., 2000; Irintchev et al., 1994). 
Satellite cells lie between the sarcolemma and the basal lamina of SkM fibres and they are 
activated upon SkM injury, where repair is required (Charge and Rudnicki, 2004). A small 
population of satellite cells remains undifferentiated in order to replenish the fibre’s satellite 
pool, thus enabling future response to traumatic events (Ten Broek et al., 2010). 
1.3.2 Skeletal muscle microstructure and physiology  
When several myoblasts fuse together, they share their cytoplasm and become a whole 
multinucleated cell called a myotube. Myotubes run parallel to the line of muscle action and 
range in length from 1 mm to several cm (Sciote and Morris, 2000). Myotubes do not proliferate, 
but produce muscle contractile proteins and elements of the ECM which allow interaction with 
MNs and the generation of a functional NMJ (Blau et al., 1985). Within myotubes, elements 
such as nuclei, mitochondria and other organelles are pushed to the periphery to allow 
myofibrils to occupy most of the intracellular space (Sciote and Morris, 2000). These are 
cylindrical structures made up of long chains of repeated contractile units, the sarcomeres 
(Alberts et al., 2002). Sarcomeres are responsible for the striated appearance of SkM, due to 
the presence of alternated thick and thin filaments made of the most abundant proteins within 
the muscle: actin (thin filament) and myosin (thick filament). These proteins interact in the core 
of the muscle to initiate contraction (Bell et al., 1980). Sarcomeres are linked end to end 
through the attachment of the myofibril, and the junction points are called Z lines. Attached to 
the Z lines are strains of actin and myosin. The muscle isotropic bands consist of actin filaments 
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which spirally run along a protein called tropomyosin. This works together with troponin to 
block the binding sites for actin, on the myosin filaments. Thus, when the muscle is relaxed, 
the sites for the actin to bind to myosin are occupied (Franzini-Armstrong and Peachy, 1981; 
Huxley, 1953). The actin filaments are bound at their plus end to a Z disc, while the capped 
minus ends extend into the anisotropic band where they interlock with myosin filaments 
(Alberts et al., 2002). The process of contraction is shown in Figure 1.8. Actin is made of a 
double chain which can bind to myosin during contraction. Thin and thick filaments slide 
towards each other, in the presence of adenosine triphosphate (ATP), which is hydrolised to 
adenosine diphosphate (ADP) and an inorganic phosphate (Pi), and Ca
2+. ATP is used as source 
of energy to lift the actin heads towards the myosin. Intracellular Ca2+ increases due to the 
arrival of an action potential from MNs which causes depolarisation of the post synaptic cell 
(Alberts et al., 2002). The influx of Ca2+ in the cell triggers the removal of troponin and 
tropomyosin from the binding sites for actin, thus allowing the myosin heads to bind to the 
thick filaments. After actin binds to myosin, it slides the myosin, therefore reducing the length 
of the sarcomere. When this process occurs in several muscle fibres simultaneously, the 
contraction of a whole muscle or groups of muscles allows movement of the skeleton (Lieber, 
2009). Relaxation occurs again when cytosolic Ca2+ is sequestered and the actin-tropomyosin 
structure returns to its original conformation, blocking the myosin heads from binding to the 
actin filaments (Gomes et al., 2002). A third key protein in the sarcomere is titin, also known 
as connectin. Titin holds together the basic structure of the sarcomere and helps maintain its 
shape, while transmitting force from the contractile proteins to the Z lines (Heckman and Enoka, 
2004). Even though titin is not directly involved in the contraction process, it provides stiffness 
to the muscle fibre when the sarcomere is elongated past its resting length (Heckman and Enoka, 
2004). 
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Figure 1.8. Schematic representation of the muscle fibre and its micro components. 
Contraction occurs when thick myosin filaments interact with thin actin filaments. Actin 
filaments are capped at their minus end by Tropomodulin and interact with CapZ at their plus 
end to bind the filament to the Z disc. Titin is a highly elastic protein which connects the myosin 
filaments to the Z disc and changes length to allow contraction and relaxation of the sarcomere. 
B) Interaction of actin and myosin enables sarcomeric shortening. Synchronised shortening of 
thousands of sarcomeres lying end to end in each myofibril facilitates rapid contraction of the 
SkM tissue. Image from Wikimedia.org. 
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What gives SkM its contractile properties are different isoforms of myosin proteins within their 
myofibrils (Sciote and Morris, 2000). Myosin is a large molecule made of 2 myosin heavy 
chains (MyHC) and 2 pairs of non-identical myosin light chains (MyLC) (Allison Weiss et al., 
1999). MyHC’s cover different roles within the muscle, from structural support during 
contraction, to the enzymatic hydrolysis of ATP (Pette and Staron, 2000). In particular, 
different MyHC isoforms determine the nature of the excitation-contraction coupling during 
sarcomere shortening and the force-velocity characteristics of the muscle fibres, which were 
characterised (Barany, 1967; Sciote and Morris, 2000). The major SkM MyHC isoforms and 
their relative fibre types in mouse and human are reported below in Table 1.2. A total of nine 
fibre types were identified in SkM: type I, α, extra-ocular, neonatal, embryonic, IIa, IIb, IIx 
and IIm. The expression of the different isoforms during development and in the adult muscle 
are conserved across mouse and human (Weiss et al., 1999), but a few differences were 
identified. For example, MyHC2 encodes for type IIa fibres which are expressed in the fetal 
stage in human, but later in the early postnatal phase in mouse (Schiaffino et al., 2015).  
Table 1.2. MyHC isoforms in mouse and human during development and in adult SkM. 
Gene Fibre type Development Adul muscle 
MyHC3 Embryonic Embryonic and foetal Specialised muscles only 
MyHC8 Neonatal Embryonic and foetal Specialised muscles only 
MyHC7 Type I, slow Embryonic and foetal Type I fibres and ventricles 
MyHC2 Type IIa, fast 
Foetal (human) 
Early postnatal (mouse) 
Type IIa 
MyHC1 Type IIx, faster Embryonic Fast muscle 
 
1.3.3 Skeletal muscle force generation 
Muscles contract upon a number of events which follow neuronal signalling, via a process 
called excitation contraction coupling. When MNs release ACh, towards a muscle fibre, the 
neurotransmitter crosses the synaptic cleft and reaches its receptors on the post-synaptic 
membrane (Lieber, 2009). The action potential which causes depolarisation and eventually 
triggers contraction must be transmitted from the pre-synaptic membrane (MNs) to the muscle 
fibre. It is the depolarisation of the sarcolemma in muscle cells which allows the propagation 
of the action potential. When this reaches the sarcoplasmic reticulum, dihydropyridine 
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receptors sense this change in voltage and release Ca2+, which can then bind to troponin, 
allowing myosin to bind to actin and generate force which causes contraction of the fibres 
(MacIntosh et al., 2006; Schiaffino and Reggiani, 2011). Once the stimulus ceases, Ca2+ is 
pumped from the sarcoplasm back into the sarcoplasmic reticulum so that troponin can go back 
to its inhibitory role on the actin molecule (MacIntosh et al., 2006).  
As shown in Figure 1.9, the activation of SkM through this mechanism lasts about 5 
milliseconds (ms), whereas the relaxation step in which Ca2+ returns to the sarcoplasmic 
reticulum takes up to 100 ms (Lieber, 2009). The coupling of this type of contraction/relaxation 
is known as unfused tetanus. If, however, MNs fire repetitive stimuli to the muscle, there is not 
enough time for the Ca2+ to return to its resting location, thus triggering a second contraction 
and an increase in the amount of force produced (Lieber, 2009). This causes the so-called fused 
tetanus. Finally, when the stimulus occurs at low frequency, single twitches are observed.  
 
Figure 1.9. The force-frequency relationship in SkM. Low frequency stimuli generate single 
twitches (brown and green lines). When the frequency of stimulation from MNs is higher, 
summation occurs leading to unfused (red line) and subsequently fused tetanus (blue line), 
which results in increased force.  
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1.3.4 Skeletal muscle in culture 
The culture of SkM in vitro presents less challenges if compared to MNs cultures. This is 
simply due to the much larger availability of primary SkM tissue, which can be obtained 
without permanently damaging the tissue. On the other hand, the removal of great portions of 
nerves could cause an irreparable injury which would not differentiate and would require auto- 
or allografts. Thus, cultures of primary human and rat SkM were established several decades 
ago using various methods for cell extraction (Bischoff, 1974; Yasin et al., 1977).  
1.3.4.1 C2C12 murine myoblast cell line 
The murine cell line C2C12 was firstly isolated for its ability to rapidly differentiate and 
produce mature myotybes. These myotubes contract and express SkM proteins (Blau et al., 
1985). C2C12 were derived from satellite cells. Therefore, their characteristics correspond to 
the ones of a progenitor lineage (Burattini et al., 2004). 
The use of C2C12 as a SkM model was widely reported (Burattini et al., 2004; Manabe et al., 
2012; Sharples et al., 2012). Several studies also showed that this line is suitable for modelling 
the NMJ. A summary of these works can be found in Table 1.3. 
The extensive use of C2C12 cells as model for the SkM shows effective differentiation and 
NMJ formation when cultured with MNs. However, being an animal-derived cell type, it 
presents limitations for human-related studies such as disease modelling or drug screening. 
Models of the NMJ which are based on human cells are therefore a promising alternative (Guo 
et al., 2011). 
1.3.4.2 Human skeletal muscle 
The use of primary hSkM is reported in the literature (Brady et al., 2008; Mouly et al., 2005), 
whereby a small portion of muscle is removed from the vastus lateralis (quadricep) and minced 
into pieces in the presence of muscle growth medium (MGM). Over the following days, a 
population of cells migrates from the tissue sample onto the culture dish. These cells are as mix 
of muscle precursor cells, which retain the potential to form multinucleated myotubes, and non-
myogenic cells which will not differentiate (i.e. fibroblasts and pericytes)  (Asakura et al., 2001; 
Machida et al., 2004). Ideally, the population of myogenic cells should be predominant, but not 
necessarily the sole component, as other cell types sustain muscle growth and differentiation. 
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Alternatively to the mince approach, enzymes such as trypsin and collagenase can be used to 
digest the connective tissue and release the cells (A. S. T. Smith et al., 2012). Whichever the 
method, the culture of primary hSkM remains the same and the donor-to-donor variability plays 
an important role in the amount of myogenic cells that can be obtained, thus varying the 
outcome of experimental work carried out with such cells.  
When plated on glass or tissue culture plastic, primary muscle adheres to a stiff surface which 
differs from the native environment it is derived from. In fact, maturation of these cells was 
shown to be poor as much as on very soft substrates, whereas mimicking the in vivo stiffness 
of the tissue using hydrogels could ensure higher maturation (Engler et al., 2004). The timing 
of primary cultures is also variable and each experiment has to take this under consideration.  
Despite the challenges that are intrinsic to using primary cells, moving from cell lines to these 
alternatives is a promising step towards personalised screening tests and disease studies. In 
addition, this approach helps reducing, refining and replacing animals and animal-derived cells 
in research (https://www.nc3rs.org.uk/the-3rs).  
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Table 1.3. Summary of the applications of C2C12 cells as model for the NMJ. 
Abbreviations: MNs = motor neurons; BTX = α-bungarotoxin, AChR = acetylcholine receptor; iPSC 
= induced pluripotent stem cell; ESC = embryonic stem cell; ChAT = choline acetyltransferase. 
Reference Methods Results 
(Tong et al., 
2014) 
Mouse embryonic MNs were co-
cultured with C2C12 in a 
microfluidic device which allows 
neurites extension. 
MNs extended axons towards the 
myotubes after 7-10 days in culture. 
Staining with BTX identified 
AChR’s, Myosin II was used for 
C2C12 and β-III Tubulin for MNs.  
(Hu et al., 
2010) 
Human iPSC-derived MNs were 
co-cultured with C2C12 in 
monolayer. 
After 2 weeks in culture, the neurites 
bound to the myotubes, which 
contracted. Staining with BTX and 
confocal analysis confirmed the 
presence of a synapsis.  
(Li et al., 
2005) 
C2C12 were plated on top of 
human ESC-derived MNs. Also, 
ventral progenitor cells were plated 
on top of the myotubes.  
The BTX staining was positive after 4 
days in culture and more evident after 
2 weeks. The myotubes were 
innervated by ChAT+ fibres. After 3 
weeks, C2C12 cultured alone did not 
show contraction, which was instead 
present in the co-culture. 
(Son et al., 
2011) 
Mouse and human fibroblasts-
derived MNs were purified by flow 
cytometry and cultured with C2C12 
cells for 7-14 days. 
The MNs projected axons towards the 
myotubes, which twitched in the co-
culture, but not when cultured 
separately from the neurons. After 
adding a contraction inhibitor to the 
culture, the frequency of myotubes 
contraction declined.  
(Martin et 
al., 2015) 
Primary mouse-derived MNs were 
cultured with C2C12s to determine 
whether the presence of the neurons 
would affect the myotubes 
morphology and contractile force 
generation in tissue engineering 
constructs.  
The MNs did not affect the 
differentiation of the muscle 
precursors, but enhanced the 
cytoskeleton organisation of C2C12 
cells, which plays a key role in the 
improved force generation within the 
constructs.  
(Hester et 
al., 2011) 
Human iPSC-derived MNs were 
co-cultured with C2C12  
Complete myotube maturation was 
confirmed by the positivity to the 
marker α-actinin. Staining with BTX 
also showed interaction between the 
two cell types. 
(Du et al., 
2015) 
Human iPSC-derived MNs were 
co-cultured with mature C2C12 for 
7 days. 
BTX+ receptors were overlapped with 
ChAT+ neurites, suggesting the 
formation of NMJs.  
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1.4 3D tissue engineering constructs 
Tissue engineering is the branch of science which focusses on generating materials and or 
tissues which can be integrated in vivo or used to study physiology and pathophysiology in 
vitro. This field is vast and incorporates several types of biocompatible materials (metals, 
polymers, ceramics, hydrogels) which can be used as scaffolds to sustain cell growth before 
and after implantation. This section will introduce two particular types of tissue engineering 
constructs which are used for SkM cultures and are suitable for studies on the NMJ. 
1.4.1 Fibrin gels 
Fibrin is the product of polymerisation of fibrinogen by thrombin, and it represents the main 
constituent of a blood clot (Mosesson, 2005). Fibrin gels have a similar stiffness to muscle 
tissue and provide a matrix onto which tissue engineered SkM can be formed, as previously 
reported (Bian and Bursac, 2009; Boonen et al., 2010; Huang et al., 2005; Khodabukus and 
Baar, 2009). Within similar collagen-based constructs, myotubes develop and mature whilst 
aligning to the pins which hold the gel on a sylgard coated dish (Strohman et al., 1990). 
Similarly, this was repeated using laminin, strongly suggesting that myoblasts embebbed in a 
matrix anchored to two fixed points allows myotube formation and resembles the in vivo 
muscle architecture (Dennis and Kosnik, 2000).  
A schematic representation of the constructs is shown in Figure 1.10.  
 
Figure 1.10. Schematic representation of the culture of myoblasts in fibrin gels. The gel (grey) 
contracts over time, until it aligns to the pins. The cells expand until day 4, when they are 
exposed to differentiation medium. During the last 10 days in culture, myoblasts fuse into 
multinucleated fibres which follow the alignment of the gel to the pins.  
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Fibrin gels have also been used for rat primary SkM/MN co-cultures, showing the ability of 
neurites to extend through the matrix, reach myotubes and form a functional NMJ (Martin et 
al., 2015).  This is particularly relevant to this work, as the co-culture of muscle and neurons 
in a matrix which allows cell-cell interaction is fundamental. In addition, these constructs can 
be used for functional studies, described in details below (1.4.3). 
1.4.2 Collagen gels 
Collagens are components of extracellular matrices, and comprise up to 10% of muscle dry 
mass (Gillies and Lieber, 2012). Together with other proteins such as laminin, fibronectin and 
tenascin (Lewis et al., 2001), collagens provide a supporting matrix to which the muscle 
connects to exploit its physiological function (Smith et al., 2010). Collagen type IV is 
particularly abundant in the basal lamina, whereas type I, III and V are most abundant in the 
epi-, peri- and endomysium of connective tissues (Kjaer, 2004). Therefore, collagen-based 
constructs represent a suitable matrix for the culture of myoblasts in vitro. These hydrogels 
were first described in 1979 (Vandenburgh and Kaufman, 1979) and subsequently have been  
proven to improve SkM maturation (Vandenburgh et al., 1988). Similarly to fibrin constructs, 
the principle behind the alignment of the myotubes lies in the directional cues given by the 
fixed points (Eastwood et al., 1998, 1994). In addition, collagen gels can undergo mechanical 
stimulation to simulate exercise and record SkM response (Passey et al., 2011).  
A schematic representation of the constructs is shown in Figure 1.11.   
 
Figure 1.11. Schematic representation of the culture of myoblasts in collagen gels. The gel 
(grey) is cast into the 3D-printed chamber and contracts over time, until it aligns to the posts. 
The cells expand until day 4, when they are exposed to differentiation medium. During the last 
10 days in culture, myoblasts fuse into multinucleated fibres which follow the alignment of the 
gel to the posts.  
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1.4.3 The use of 3D constructs for functional studies 
In order to engineer a functional tissue in vitro, it is key to generate a biomimetic 
microenvironment in which the cells find a tissue specific ECM, together with the biochemical 
and mechanical stimuli that encourage maturation and functionality (Khodabukus et al., 2018). 
The fibrin and collagen gels described above are able to provide this matrix for SkM to grow 
and differentiate, as well as to be investigated from a functional perspective. As shown in 
section 1.3.3, depending on the stimulus generated by MNs, SkM contracts in different ways 
and generates more or less force. The quantification of this force can be achieved by performing 
functional studies, which are important in tissue engineering to determine whether the cells or 
tissues retain their capabilities to function and interact with other cell types in vitro, as they do 
in vivo. Force generation in SkM is the main functional aspect that can be investigated, and 
being able to do this using the fibrin and collagen constructs described above is an advantage. 
For example, collagen/Matrigel® gels were used to generate an artificial SkM model and 
electrically stimulate it to investigate the effect of insulin growth factor 1 (IGF-1) on the 
contractile force of C2C12 (Sato et al., 2011). This study showed that IGF-1 was able to induce 
hypertrophy and higher force generation if compared to untreated C2C12. Similarly, another 
compound, Leucine, was added to C2C12 cultures to determine its effect on muscle maturity 
and functionality when cultured in fibrin gels. It was observed that the supplement increased 
contractile force, thus showing the suitability of fibrin constructs for functional studies (Martin 
et al., 2017). More importantly, these gels can not only be used for SkM studies, but also to 
generate a functional interaction between SkM and MNs (i.e. NMJ). This was recently achieved 
using primary rat cells, and the fibrin constructs proved to be appropriate when determining 
that the presence of MNs enhanced SkM contractility (Martin et al., 2015). The previous use 
of these constructs for force generation measurements shows their potential as tissue 
engineering platforms for the study of SkM/MNs functionality. 
1.5 Conclusions and considerations 
Given the background provided in this first chapter, the reader should have gathered knowledge 
on the key aspects of MNs, SkM and the neuromuscular junction. This will help understanding 
the aims and rationale behind the experiments conducted in this work. Information on NMJ 
development and formation are key to generate SkM/MN co-cultures, both using cell lines and 
primary cells. Components of the motor unit such as agrin can be added to the culture to 
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facilitate NMJ formation, and SkM markers expression can be investigated following the 
information provided on SkM development, maturation and differentiation. Using a tissue 
engineering approach for the generation of this model is essential, and information on the 
composition of collagen and fibrin constructs, together with their applications for muscle-nerve 
co-cultures, together with applications for functional studies, justify their use for this work. 
Finally, background on the culture of each cell type, available lines and stem cells is important 
to understand why C2C12s, SH-SY5Ys, primary human SkM and iPSC-derived MNs were 
utilised in this work. Further literature and background specific to each results chapter will be 
provided at the beginning of each of them.  
Regarding the applications for this model, different ones can be identified. The general aim for 
this work was to generate a biologically-relevant muscle-nerve co-culture, and to do this in 3D 
constructs which are suitable for different kinds of studies. Therefore, additional optimisation 
and modifications may be carried out in the future to adapt the model to the intended application. 
In order to study the effect of a treatment on specific patients’ cells, the differentiation of iPSCs 
into either SkM or MNs would be improved to allow for a more efficient model. For drug 
testing, cost may be reduced by using less growth factors (e.g. eliminating Matrigel®) and 
making the process for the gels preparation automated and reproducible. However, if the aim 
for this model is to study how the NMJ forms and neuromuscular diseases arise, it will need to 
closely mimic the in vivo muscle-nerve interface (e.g. by adding more cell types to the model, 
or adjust the muscle:nerve cells ration). 
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2 GENERAL METHODS 
2.1 2D cell culture methods 
For the fulfilment of this work, different cell types, including cell lines and primary human 
cells were used. C2C12 murine skeletal muscle myoblasts and SH-SY5Y human 
neuroblastoma were used as cell lines. For the culture of primary human cells, skeletal muscle-
derived myoblasts (hSkM) and induced pluripotent stem cell-derived motor neuron Progenitors 
(MNPs) were utilised. 
2.1.1 Cell culture: C2C12 
The murine SkM myoblast line C2C12 (ATCC, USA) was cultured in T75 ⁄ T175 flasks in a 
humidified 5% CO2 atmosphere at 37° C in muscle growth medium (MGM), composed of: 79% 
Dulbecco’s Modified Eagle Medium (DMEM, Merk, UK), 20% Foetal Bovine Serum (FBS, 
PAN Biotech UK Laboratories, UK), and 1% penicillin-streptomycin (P/S, PenStrep: 100 
units/mL penicillin and 100 µg/mL streptomycin, Thermo Fisher Scientific, UK). The 
incubators used for the culture were Thermo Scientific HERAcell 240i, and the cell culture 
cabinets utilised were ThermoScientific HERAsafe. The cells were expanded to 75% 
confluence before passaging (see section 2.1.5) and to 100% confluence for experimental work. 
To induce myotubes formation, the cells were washed 3x in sterile phosphate buffered saline 
(PBS, Thermo Fisher Scientific BioReagents™ Phosphate Buffered Saline Tablet, dissolved in 
dH2O) solution and the medium was switched to muscle differentiation medium (MDM) 
composed of 97% DMEM, 2% Horse Serum, (HS, Merk, UK) and 1% P/S. For optimal 
differentiation, the cells were used between passage 6 and 10. 
2.1.2 Cell culture: SH-SY5Y  
The human neuroblastoma cell line SH-SY5Y (ATCC, USA) was cultured in T75 ⁄ T175 flasks 
in a humidified 5% CO2 atmosphere at 37° C in neuronal growth medium (NGM) composed 
of: 89% Glutamax (DMEM 1X + Glutamax™ - Gibco, UK), 10% heat inactivated FBS (NFBS, 
Merk, UK), and 1% P/S. The incubators used for the culture were Thermo Scientific HERAcell 
240i, and the cell culture cabinets utilised were ThermoScientific HERAsafe. The cells were 
grown until they reached 60% confluence. To induce neurite extension, the serum 
concentration in the medium was decreased to 2% and 1 μM Retinoic Acid, (≥98% (HPLC), 
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powder all-trans RA, Merk, UK) was added to the neuronal differentiation medium (NDM). 
For optimatl differentiation, the cells were used between passage 6 and 10.  
2.1.3 Cell resuscitations: C2C12, SH-SY5Y and hSkM  
When cells were needed from the liquid nitrogen storage, a cell culture flask was prepared by 
pipetting approx. 10 mL MGM or NGM into it. Then, the cells were removed from the liquid 
nitrogen and placed in a water bath (37° C) until the cell suspension was thawed. The cell 
suspension was then placed into the flask and incubated overnight at 37° C, 5% CO2. The 
following day, the MGM or NGM was removed, the flask was washed 2x with sterile PBS and 
fresh MGM or NGM was pipetted into the flask.   
2.1.4 Cell culture: hSkM cells 
Primary hSkM cells were obtained by explant biopsy at Loughborough University. The 
samples were obtained from healthy males, between the ages of 18–55 reporting no recent 
injuries or intake of anti-inflammatory pharmaceuticals. Tissue was obtained via the Bergstrom 
biopsy procedure, with any visible connective tissue being removed (Bergstrom, 1975). Tissue 
samples were removed from the storage MGM solution and washed 3 times in a buffer solution 
(PBS, 1% P/S & 1% Amphotericin, Merk, UK). Once washed, tissue chunks were placed into 
a petri dish, suspended in 1 mL of MGM and mechanically minced using 2 scalpel blades until 
broken down into small sized pieces. Tissue was then seeded into 0.2% gelatin (Merk, UK) 
coated T25 flasks (approximately 4 pieces/flask) and suspended in 0.5 mL of MGM to ensure 
tissue was planted on the culture surface and not floating. Flasks were then placed in standard 
tissue culture incubators (Sanyo O2/CO2 incubator MCO-18AIC) for 7-10 days to allow cellular 
migration to occur with more MGM added to prevent flasks drying out. Migration of hSkM 
cells was monitored with the migrated cellular population passaged at 60% confluence to 
prevent spontaneous differentiation at low passage. Cells were dissociated with accutase 
(Corning®) before re-plating. The cells were then cultured through 3 passages to confirm 
myogenic capacity and increase cell quantity for experimental purposes. All SkM cells were 
used between passages 3 and 6 as previously published by our group (Martin et al., 2013). For 
experimental work, the cells were plated in gelatin-coated wellplates. To coat the culture 
vessels, a solution of gelatin was prepared (1:10 in sterile PBS). The solution was then used to 
cover the culture vessels at RT for 30 minutes. When the cells were seeded, the gelatin solution 
was removed and replaced by prewarmed warm, MGM. Differentiation medium was composed 
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of DMEM, 2% HS and 1% P/S. All cell culture work was done in a Airstream ESCO Class II 
Biological Safety Cabinet. 
Information on the donors used for this work are reported below in Table 2.4.  
 
Table 2.4. Donors information for work using primary SkM cells. 
Donor code Gender Age 
Hu020 M 22 
Hu027 M 24 
Hu028 M 25 
Hu035 F Unknown 
 
2.1.5 Cell passage and count: C2C12 and SH-SY5Y 
Prior experimentation, GM was removed from C2C12 and SH-SY5Y cells and the flask was 
washed 3x in PBS. A volume of 5 mL of trypsin/ethylenediaminetetraacetic acid (EDTA) was 
added to each flask and incubated for 5 minutes at 37° C, 5% CO2. After checking that cells 
had detached from the tissue culture plastic, trypsin was neutralized with an equal amount of 
GM. For C2C12, the total volume was collected and transferred to a 15 mL centrifuge tube, 
which was then centrifuged at 600 xg for 5 minutes at room temperature (Thermo Fisher 
Scientific Heraeus Megafuge 11R). For SH-SY5Y, cells were centrifuged at 600 xg, for 5 
minutes at room temperature. The supernatant was removed and the cells were re-suspended 
in 1 mL of GM for counting. After mixing the cell suspension thoroughly, 10 µL of suspension 
were added to 90 µL of Trypan Blue and mixed. Then, 10 µL was added to a hemocytometer 
(Neubauer, 0.0025 mm2).  
2.1.6 Cryopreservation: C2C12, SH-SY5Y and hSkM 
In order to cryopreserve C2C12, SH-SY5Y and hSkM cells, these were trypsinised and counted 
as described in section 2.1.5. A solution made of 90% MGM with 1x106 cells, and 10% 
dimethyl sulfoxide (DMSO, Thermo Fisher Scientific BioReagents®) was prepared and 
immediately pipetted into a cryogenic vial (Corning®, UK). The vials were then placed into a 
freezing container (Mr Frosty™, Thermo Fisher Scientific) and placed at -80° C overnight. The 
day after, the cryovials were transferred into a liquid nitrogen storage dewar for long term 
preservation.  
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2.1.7 Cell culture and resuscitation of induced pluripotent stem cell-derived motor 
neurons progenitors 
Human induced pluripotent stem cell-derived motor neuron progenitors (MNPs, Axol 
Bioscience, UK) from a healthy 74 years old male donor, were received in dry ice and kept in 
liquid nitrogen until needed. All cell culture work was done in a Airstream ESCO Class II 
Biological Safety Cabinet.  
All protocols for thawing, expanding, passaging and differentiating MNPs were provided by 
the manufacturer and a copy can be found in the Supplementary section of this thesis.  Updated 
protocols will be available at: 
 https://www.axolbio.com/shop/product/human-ipsc-derived-motor-neuron-progenitors-5172. 
The day before thawing the MNPs, the culture vessels (T25 flasks) were prepared by coating 
them with SureBond™ (see section 1.8.1).  
On the day of thawing the MNPs, motor neuron recovery medium (MN RM, Axol Bioscience) 
was prepared by adding Y-27632 (Selleck Chemicals) to a final concentration of 10 µM, and 
Retinoic Acid (≥98% (HPLC), powder all-trans RA, Merk, UK) to a final concentration of 0.1 
µM. All medium and culture vessels were pre-warmed at 37°C prior to use. A volume of 4 mL 
of RM (+Y-27632 and RA) was added to a 15 mL sterile Falcon™ tube. To thaw the cells, the 
vial was submerged in a water bath set at 37°C. Once the vial was 2/3 thawed, the cell 
suspension was added dropwise to the 15 mL tube containing RM (+Y-27632 and RA). The 
cryogenic vial was washed with 1 mL of the same medium. The cells were then centrifuged at 
200 xg for 5 minutes at RT (Thermo Fisher Scientific Heraeus Megafuge 11R). The supernatant 
was discarded and the cells were counted as described in section 2.1.5. The coating solution 
which has previously been added to the wells (see section 2.1.7.1) was then removed from the 
wells and the cells were re-suspended in the appropriate volume of medium to obtain a seeding 
density ranging from 100,000-150,000 cells/cm2.  
The cells were incubated at 37° C, 5% CO2 for 24 hours, and then the medium was changed to 
RM supplemented with 0.1 µM RA. Every 2 days, the medium was replaced with fresh, pre-
warmed RM supplemented with 0.1 µM RA. The cells were ready to passage between day 5 
and 7. 
2.1.7.1 SureBond™ coating 
SureBond™ (Axol Bioscience) was used to coat culture vessels upon resuscitation of iPSC-
derived MNPs. Briefly, aliquots of SureBond™ coating solution were thawed over night at 
4°C. The following day, the SureBond™ stock solution (50x) was diluted in Dulbecco’s PBS 
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(1x) (DPBS, without calcium or magnesium, Thermo Fisher Scientific, UK). Specifically, one 
vial of SureBond™ (120 µL) was diluted in 6 mL of DPBS. The surface of the culture vessels 
was then coated with SureBond™ 1x working solution at a volume of 200 µL/cm2 overnight 
at 37° C, 5% CO2. 
2.1.7.2 SureBond™+ReadySet coating 
A combination of SureBond™+ReadySet (Axol Bioscience) was used to coat culture vessels 
for experimentation. The SureBond™ solution was thawed overnight at 4°C the day before 
coating. The culture vessels were pre-coated with ReadySet at a volume of 250 µL/cm2, and 
incubated at 37° C, 5% CO2 for 45 minutes. Then, the plates were washed 4x using an equal 
volume of sterile dH2O. The SureBond™ solution was prepared as described in section 2.1.7.1 
and the culture vessels were incubated with it for 1 hour at 37° C and 5% CO2. 
2.1.7.3 Cell passage: MNPs 
When the culture was 70% confluent, the cells were ready to undergo passaging. The day 
before passaging, an aliquot of Unlock™ (Axol Bioscience) and Motor Neuron Maintenance 
Medium (MM, Axol Bioscience) were thawed at 4°C. On the day of passaging MNPs, the 
culture vessels were pre-coated with SureBond™+ReadySet (Axol Bioscience) as follows: 
SureBond™ was thawed overnight at 4°C the day before coating (2 days before passaging the 
cells). The culture vessels were then coated with ReadySet at a volume of 250 µL/cm2. The 
vessels were incubated at 37°C, 5% CO2 for 45 minutes. Then, the plate was washed thoroughly 
4x using an equal volume of sterile dH2O. Meanwhile, a 1x SureBond™ working solution was 
prepared as described in section 2.1.7.1. The surface of the culture vessels was then coated with 
SureBond™ at a volume of 200 µL/cm2 for 1 hour at 37°C and 5% CO2.  
To detach the cells from the culture vessel, the medium was removed and the vessels were 
washed once with DPBS at a volume of 2 mL/10 cm2. The DPBS was then removed and the 
cells were incubated with Unlock™ at RT (1 mL/10 cm2). The cells were then incubated for 5 
minutes at 37°C, 5% CO2. Once the cells were detached, a 4x volume of pre-warmed RM was 
added to the culture vessel and the cells were centrifuged at 200 xg for 5 minutes (Thermo 
Fisher Scientific Heraeus Megafuge 11R). Subsequently, the supernatant was discarded and 
the cells were re-suspended in 1 mL fresh RM to perform a cell count as described in section 
2.1.5. 
Finally, the coating solution was removed from the culture vessels and the cells were seeded at 
a density of 150,000-200,000 cells/cm2. The day after plating, the medium was replaced with 
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MM supplemented with 0.5 µM RA, 5 ng/mL brain-derived neutrophic factor (BDNF, 
Peprotech, UK) and ciliary neutrophic factor (CNTF, Peptrotech). MM was changed every 2 
days.  
2.2 3D cell culture methods 
Collagen and fibrin-based gels were used as 3D tissue engineering constructs for the 
completion of this work. The purpose of using these systems is that cells grow in a 3D 
enviroment in vivo, and thus, mimic a 3D structure in vitro could aid to obtain a more reliable 
response in terms of functionality. In addition, the use of these gels in particular make the cells 
align, which is especially  important for SkM cells, as the fusion of myoblasts into myotubes 
ensures that the cells acquire an in vivo-like architecture.  
2.2.1 Gel scans and gel width measurement 
All constructs were images using a computer scanner (Epson Perfection V330 Photo). The 
images were processed using the software Fiji (Java 1.6.0_24, available to download at 
https://imagej.net/Fiji/Downloads) to measure the width of the gels. 
2.2.2 Fibrin gel constructs 
The cells were trypsinised and counted as described in section 2.1.5. Fibrin gels were prepared 
as previously described (Martin et al., 2013). Two 6 mm silk sutures were pinned into Sylgard 
184-coated (Dow-Corning, UK) 35-mm plates 12 mm apart using 0.15 mm minutien pins 
(Entomoravia, Slavkov u Brna, Czech Republic). Plates were sterilized by washing with 70% 
ethanol and left to dry for 3 hours, followed by 1 hour exposure to the ultraviolet lamps of the 
cell culture cabinet (ThermoScientific HERAsafe). Each plate then received 500 mL of GM 
containing 10 units/mL thrombin (Merk, UK) and 80 mg/mL aprotinin (Merk, UK) which was 
spread evenly over the surface of the plate ensuring the sutures were fully covered. 200 μL of 
20 mg/mL stock fibrinogen (Merk, UK) solution was then added to the plate, agitated gently 
to ensure even distribution and then left to incubate for 10 minutes at room temperature before 
being incubated at 37°C, 5% CO2 for 1 hour. Once the gel had set, 1x10
5 C2C12 cells were 
evenly plated on top of the gel surface in 2 mL of MGM containing 0.25 mg/mL 6-
aminocaproic acid (Merk, UK) to prevent fibrin degradation. Culture medium was replaced 
every other day for the duration of experimentation. Once the cells within the gels became 
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confluent (typically 4 days of culture), the medium was switched to MDM containing 0.25 
mg/mL 6-aminocaproic acid.  
For co-culture fibrin gels, the procedure remains unchanged. However, after 4 days of MGM, 
the neurons (SH-SY5Y) were passaged as described in sections 2.1.5. MGM was removed 
from the culture vessels and the gels were washed 3x in sterile PBS. Then, a total of 100,000 
cells/gel in 50 µL NGM were seeded on the fibrin layer. The cell suspension was left to adhere 
at 37°C, 5% CO2 for 30 minutes, and then NDM was added until the end of the culture period 
(14 days).  
2.2.3 Collagen gel constructs 
Collagen gel constructs were prepared using different protocols. Optimisation and scaling 
down of the process were performed in the laboratory to achieve smaller gels, requiring less 
cells and consumables, and ultimately making the system more representative of the 
physiological architecture of the tissue. Matrigel® (Corning™ Matrigel™ Membrane Matrix) 
 was added to 50 µL gel mixture to facilitate the migration of neurites through the matrix. Two 
different types of 3D printed inserts were used to perform the 3D cell culture (Figure 2.1). 
The 50 µL constructs were assembled in 2-parts with a removable barrier. The external 
geometries of the part were designed to fit into a standard 6 or 12 well culture plate. All 3D 
modelling was performed using computer aided design (CAD) Siemens NX software (version 
8.5) with completed .stl files verified using Materialise MiniMagics. FDM printing utilised a 
commercially available Ultimaker 2+ system (Ultimaker, Netherlands). For FDM, 
completed .stl files were processed using the in-house Cura Software for Ultimaker 2+ (version 
3.2). FDM parts were printed using PLA and were extruded onto the standard glass build plate, 
at previously published settings (Rimington et al., 2017). LS parts were printed using an EOS 
Formiga P100TM (EOS GmbH, Germany) from PA-12. The powder used was a mixture of 
recycled and virgin powder (20% recycled, 80% virgin); well within manufacturer 
recommendations. Samples were removed from the build chamber and cleaned using a soft 
abrasive brush to remove un-sintered powder. All samples were sterilised via UV for ≥ 1 h, 
prior to being adhered to culture well plates using an in-house bio-adhesive which has been 
found to be completely compatible (Rimington et al., 2017). Once adhered, samples were 
rinsed with 70 % IMS and left for the remaining solvent to evaporate prior to use.  
The designs of the 500 µL mold mold are available at 
https://figshare.com/articles/500uL_Mould_FDM/6969851; the designs for the 50 µL mold 
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and inserts are available at https://figshare.com/articles/50uL_Mould_FDM/6969710 and 
https://figshare.com/articles/50uL_FDM_removable_insert/6969707.  
 
 
Figure 2.1. 3D printed inserts for collagen gels preparation. A) 500 µL insert. B) 2-part 50 µL 
insert (Rimington et al., 2018b, 2018a).  
2.2.3.1 Collagen only constructs 
Prior to collagen/myoblast construct setup, muscle cells (both C2C12 and primary SkM) were 
passaged as described in section 2.1.5. The collagen gels protocol was adapted from previous 
work ( A. S. T. Smith et al., 2012). Although different volume gels were used for this work 
(500 µL and 50 µL), the preparation remained the same. For 500 µL gels, 20% of the total 
volume minimal essential media (MEM; Gibco) was added to 85% type 1 rat-tail collagen 
(First Link, UK; dissolved in 0.1 M acetic acid, protein at 2.035 mg/mL). NaOH was used to 
neutralise the solution for polymerisation until the mixture fully changed colour from yellow 
to bright pink. Following neutralisation, the cells suspended in 5% volume of MGM and then 
added to the collagen solution, at a final concentration of 4x106/mL. The tube was swirled to 
ensure homogeneous distribution of the components and then the collagen solution was 
pipetted into 3D printed moulds described in section 2.2.3.  
The resulting construct was allowed to polymerise for 30 minutes at 37°C, 5% CO2. Once set, 
the compliant construct was physically detached from the chamber and floated in 6 mL MGM 
for the 2 mL gels, 5 mL MGM for the 500 µL gels and 2 mL for the 50 µL gels. Following 4 
days of culture in MGM, the constructs were transferred to DM to promote myoblast 
differentiation. A further 10 days of culture allowed for the maturation of the constructs and 
the differentiation of myoblasts into multinucleated myotubes. 
For co-culture gels, the procedure remains unchanged. However, after 4 days of MGM, the 
neurons (SH-SY5Y and MNPs) were passaged as described in sections 2.1.5 and 2.1.7.3, 
respectively. MGM was removed from the culture vessels and the gels were washed 3x in 
sterile PBS. Then, a total of 1x106 SH-SY5Y cells/gel were seeded on the 2 mL collagen gels, 
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in 200 µL NGM; 250,000 cells/gel were seeded on the 500 µL collagen gels, in 100 µL NGM; 
100,000 cells/gel were seeded on the 50 µL collagen gels, in 50 µL NGM. The cell suspension 
was left to adhere at 37°C, 5% CO2 for 30 minutes, and then NGM was added for 24h. The 
following day, the medium was changed to NDM until the end of the culture period (14 days).  
2.2.3.2 Collagen & Matrigel® constructs 
While working with Matrigel®, the solution and the centrifuge tubes were kept on ice at all 
times. The collagen/Matrigel® mixture was only used for 50 µL gels. The preparation was 
based on the protocol described above (section 2.2.3.1). However, the collagen concentration 
in the gel was reduced from 85% to 60%, and 20% Matrigel® (Corning™ Matrigel™ 
Membrane Matrix) was added to the gel mixture.  
2.3 Methods for biological analysis  
The morphological and quantitative analysis for this work was performed mainly using 
immunofluorescent staining procedures. The outputs of this were morphological analysis and 
measurement of cell features such as myotube width and neurite length. Furthermore, the gene 
expression analysis was used to reveal muscle maturity in the presence of absence of neurons 
and other factors such as agrin.   
2.3.1 Immunofluorescent staining 
For the completion of this work, immunofluorescent staining was used to verify the expression 
of both morphological and cell-cell interaction specific markers. Particularly, Rhodamine 
Phalloidin was used to stain the actin filaments in C2C12 and SH-SY5Y cells. Anti-β-III 
Tubulin was used to stain neuronal microtubules (SH-SY5Y and MNPs). Choline 
acetyltransferase (ChAT) and Islet 1 were used as MN markers in MNPs. The neurotoxin α-
bungarotoxin (BTX) bound to acetylcholine receptors (AChR’s) on muscle fibres (both C2C12 
and primary SkM).  
Each staining protocol required fixation and permeabilisation first; the protocols for these steps 
slightly differ for cells cultured in 2D or 3D. For indirect methods, a blocking stage was 
performed before the incubation with the primary antibody (β-III Tubulin, ChAT and Islet 1). 
2.3.1.1 Fixation of cells in 2D 
The immunostaining of both C2C12 and SH-SY5Y cells was performed after fixation. Briefly, 
GM or DM was removed from the chamber and the cells were washed 3x in PBS. Then, a 
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solution of 3.7% paraformaldehyde in PBS was incubated onto the glass coverslips for 15 
minutes. After removal of the fixative, the coverslips were washed 3x and left in PBS for short 
term storage at 4°C. 
2.3.1.2 Fixation of cells in 3D 
The immunostaining of collagen and fibrin gels was performed upon fixation. Briefly, GM or 
DM was removed from the chamber and the cells were washed 3x in PBS. Then, half of the 
total volume used for the washes was added to the chambers, and the remaining 50% was added 
dropwise to the chamber (a cold solution of methanol:acetone (v/v 1:1)). The gels were left at 
RT for 30 minutes, after which the volume was removed from the chamber and substituted by 
a total amount of methanol:acetone (v/v 1:1) for further 30 minutes. At the end of the fixing 
period, the fixative was removed and the wells were washed 3x with sterile PBS. For short term 
storage, the gels were left in PBS at 4°C. 
2.3.1.3 Permeabilisation of cells 
Before performing immunostaining, the cells were washed 3x with 1x tris-buffered saline (TBS, 
pH 8.5). Then, the cells were incubated in a 0.2% (v/v) Triton X-100 (Thermo Fisher Scientific) 
solution in 1x TBS for 30 minutes. This was done equally for cells culture in 2D and 3D. 
2.3.1.4 Rhodamine phalloidin 
For Rhodamine phallodidin staining (Life Technologies), the coverslips were washed 3x in 1x 
TBS and incubated with a 1x TBS solution containing 1:200 (v/v) Rhodamine-Phalloidin 
antibody and incubated for 2 hours. Then, the coverslips were incubated with 1 μL/mL 4',6-
diamidino-2-phenylindole, DAPI (Thermo Fisher Scientific) to stain the nuclei for 10 minutes. 
Finally, the cells were washed 3x in 1x TBS and mounted onto glass slides using mounting 
medium (Fluoromount™ Acqueous Mounting Medium, Merk, UK). The coverslips were left 
to dry overnight and protected from light, before imaging. To stain 3D tissue engineering 
constructs, the antibody was incubated for 3 hours instead of 2.  
2.3.1.5 β-III Tubulin 
For the β-III Tubulin staining, the initial blocking solution was prepared using 5% goat serum 
(GS, Merk, UK), 0.2% Triton in 1x TBS and the coverslips were incubated for 30 minutes. 
Then, the coverslips were washed 3x and incubated for 1 hour in the I antibody (monoclonal 
anti-β-III Tubulin, Scientific Laboratory Supplies Ltd (SLS, Merk, UK) solution at a 
concentration of 1:200 and 2% GS. Then, the coverslips were washed 3x and incubated with 
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the secondary antibody solution containing 1:200 II antibody (AlexaFluor 488® goat anti-
mouse, IgG, SLS, Merk, UK), 2% GS and 1 μL/mL for 1 hour. After the incubation, the cells 
were incubated for 10 minutes with a 1x TBS and 1:1000 (v/v) DAPI solution. Finally, the 
coverslips were washed 3x in 1x TBS and mounted onto glass slides using mounting medium. 
The coverslips were left to dry overnight and protected from light, before imaging. 
2.3.1.6 Choline Acetyltransferase 
The immunofluorescent staining for Choline Acetyltransferase (ChAT) was performed upon 
fixation (section 2.3.1.1) and then as follows: firstly, the cells were permeabilised in a solution 
of 1x TBS (pH 8.5) and 0.2% (v/v) Triton X-100 (Thermo Fisher Scientific) for 30 minutes. 
Then, the blocking step was done using a solution of 5% GS for 30 minutes. The cells were 
washed in TBS 1x, 3x for 5 minutes and then incubated for 1 hour with a solution of primary 
anti-ChAT antibody (abcam, UK) 1:100 (v/v), with 5% GS in 1x TBS. Then, after 3x washes 
(5 minutes each) in TBS 1x, the cells were incubated with the secondary antibody solution: 
goat anti-rabbit IgG H&L, conjugated with Alexa Fluor® 488 (abcam, UK), with 5% GS for 1 
hour. After washing the cells 3x with TBS 1x, they were counterstained with a solution of TBS 
1x and DAPI 1:1000 (v/v) for 10 minutes. At the end of the staining protocol, the cells were 
washed again 3x with TBS 1x and then mounted onto glass slides using Fluoromount™. The 
coverslips were left to dry overnight and protected from light, before imaging. 
2.3.1.7 Islet 1 
The Islet 1 staining (abcam, UK) staining was performed in one step, as the primary antibody 
was conjugated with the Alexa Fluor® 568 fluorophore. Upon fixation and permeabilisation 
(sections 2.3.1.1 and 2.3.1.3, respectively), the cells were incubated in a solution with 1x TBS 
and 1:1000 (v/v) Islet 1 for 2 hours. At the end of the incubation, the cells were washed 3x with 
1x TBS before incubating with 1x TBS and DAPI 1:1000 (v/v) for 10 minutes. At the end of 
the incubation, the cells were washed with 1x TBS, 3x for 5 minutes and the coverslips were 
mounted onto glass slides using Fluoromount™. The coverslips were left to dry overnight, 
protected from light, before imaging. 
2.3.1.8 α-Bungarotoxin  
The α-Bungarotoxin (BTX, Merk, UK) staining was performed in order to determine the 
presence of acetylcholine receptors (AChR’s) at different stages of differentiation of C2C12 
cells (after 3, 5 and 7 days in DM).  
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Upon fixation of C2C12 cells (section 2.3.1.1), the wells were washed 3x with non-sterile 1x 
TBS and a solution of 1x TBS and 0.2% (v/v) Triton X-100 was added for 30 minutes.  After 
washing the cells with 1x TBS, 3x for 5 minutes, a solution of 1x TBS and 1:1000 (v/v) Texas 
Red® conjugated BTX was added for 3 hours. At the end of the incubation, the cells were 
washed 3x with 1x TBS before incubating with 1x TBS and DAPI 1:1000 (v/v) for 10 minutes. 
At the end of the incubation, the cells were washed with 1x TBS, 3x for 5 minutes and the 
coverslips were mounted onto glass slides using Fluoromount™. The coverslips were left to 
dry overnight, protected from light, before imaging. 
2.3.1.9 Synaptic vesicle 2  
The C2C12/SH-SY5Y co-culture in monolayer was stained with α-BTX and synaptic vesicle 
2 (SV-2, DSHB) in order to identify the co-localisation of vesicles containing the 
neurotransmitter acetylcholine (in SH-SY5Y cells) and clusters of acetylcholine receptors 
AChR’s in C2C12 cells.  
The co-culture was fixed (section 2.3.1.1) and the wells were washed 3x with non-sterile 1x 
TBS. A solution of 1x TBS and 0.2% (v/v) Triton X-100 was added for 30 minutes. Then, the 
cells were blocked by adding 1x TBS, 5% GS, and 0.2% (v/v) Triton X-100 for 1 hour. After 
washing the cells with 1x TBS, 3x for 5 minutes, the solution containing the primary antibody 
for SV-2 was prepared as follows: 1x TBS, 2% GS, 1:10 (v/v) SV-2 primary antibody. The 
primary antibody was incubated at RT for 3 hours. The cells were washed with 1x TBS, 3x for 
5 minutes before adding 1x TBS, 2% GS, 1:100 AlexaFluor 488® goat anti-mouse IgG, 1:1000 
(v/v) Texas Red® conjugated α-BTX for 3 hours. At the end of the incubation, the cells were 
washed with 1x TBS, 3x for 5 minutes and a solution of 1x TBS with DAPI (1:1000 v/v) was 
added for 10 minutes. Finally, the cells were washed with 1x TBS, 3x for 5 minutes and the 
coverslips were mounted onto glass slides using Fluoromount™. The coverslips were left to 
dry overnight, protected from light, before imaging. 
Image acquisition was performed using a fluorescent microscope Leica DM2500 and the 
software LAS X. For coverslips imaging, 5 frames per coverslips were taken. Further image 
analysis is described in section 2.3.2.  
2.3.2 Quantitative measurement of myotube width and neurite length  
The morphological analysis was performed using  the software Fiji (Java 1.6.0_24, available 
to download at https://imagej.net/Fiji/Downloads). A total of 10 myotubes and 10 neurites were 
measured in each image. The myotube width and neurite length from one image was averaged, 
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and then the value obtained was averaged with the remaining frames (5 frames per coverslip, 
3 coverslips per well). The measured cells were picked randomly in the frames, but only 
myotubes with 3 or more nuclei were considered for myotube width measurement, and the 
middle of the myotube was taken for the measurement itself. Whenever possible, neurite length 
was measured from nucleus to the end of the neurite. 
2.3.3 RNA extraction 
In order to extract the RNA from cells cultured in monolayer, culture medium was removed 
from the culture wells and the cells were washed 3x with sterile PBS. Then, 1 mL TRI 
Reagent® (Trizol, Merk, UK) per 10 cm2 of culture surface were added to each well. Using an 
upside-down 1 mL pipette tip, the culture surface was scraped in all directions to ensure 
detachment of the cells from tissue culture plastic and production of a lysate. This was then 
transferred to RNAse-free tubes and stored at -80°C until needed. 
On the day of the extraction, the samples were thawed at RT and let to set. Then, chloroform 
was added to the tubes (200 µL/mL Trizol used). The samples were shaken vigorously for 15 
seconds and allowed to stand at RT for 15 minutes. The mixtures were then centrifuged at 
12,000 xg for 15 minutes at 2-8°C (Thermo Fisher Scientific Heraeus Megafuge 11R). This 
step allows the formation of three phases; the upper phase, containing the RNA, was transferred 
to fresh RNAse-free tubes, to which 2-propanol (Merk, UK) was added (500 µL/mL Trizol 
used). The samples were mixed by invertion and left to stand at RT for 10 minutes, then 
centrifuged at 12,000 xg for 10 minutes at 2-8°C. Subsequently, the supernatant was removed 
and the pellet was washed by adding 75% ethanol (1 mL/mL Trizol used). The samples were 
vortexed before being centrifuged at 7,500 xg for 5 minutes at 2-8°C. Finally, the ethanol was 
removed and the samples were left to dry for 5-10 minutes. To store the RNA samples, 50 µL 
of Storage Solution (Ambion, UK) were added to each sample and these were stored at -80°C 
unless immediately used for RNA quantification or RT-qPCR. 
2.3.4 RNA quantification  
The RNA quantification (260 nm) and purity (260/280 nm ratio) were determined 
spectrophotometrically using a NanoDrop 2000 (Thermo Scientific, UK). Only RNA samples 
which resulted in a 260/280 ratio between 1.8 and 2 were used. Briefly, 1 µL Storage Solution 
(Ambion, UK) was loaded into the machine as blank. Then, the samples were analysed using 
1 µL per sample. 
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2.3.5 RT-qPCR  
The genes analysed via RT-qPCR for mouse and human cells are reported in Table 2.5 and 
Table 2.6, respectively. 
Before setting up the PCR plate, the bench and pipettes were wiped using RNaseZap™ 
(Thermo Fisher Scientific). Reactions were prepared in triplicates in 384 well plates (Applied 
Biosystems, UK) using filtered pipette tips (Starlab, UK) The reactions consisted of 5 ng of 
RNA in 5 μL, and 5 μL of master mix consisting of 4.7 μL SYBR® Green, 0.1 μL of both 
forward and reverse primer and 0.1 μL of quantifast reverse transcriptase kit (Qiagen, UK). 
The reaction was carried out as follows: 50°C for 10 minutes and 95°C for 5 minutes, followed 
by 40 cycles of 95°C for 10 seconds and 60°C for 30 seconds. 
 
2.3.6 RT-qPCR data analysis 
Relative quantification of gene expression has been analysed in this thesis by the 2-ΔΔCT method 
as previously described (Schmittgen and Livak, 2008). All methods and reagents were used  
based on previous RT-qPCR conducted in our laboratory. This analysis requires the use of a 
housekeeping gene (always expressed) to which the data is normalised. RPII was used as a 
reference gene, both for mouse and human samples. All primers were customised and supplied 
by Merk, UK. These were optimised in our laboratory, using the standard curve methods. 
Briefly, serial dilutions of RNA were run to generate a linear curve from which the primer 
efficiency was calculated. Only primers with an efficiency between 90-110% were used. 
The amplification of RT-qPCR was assessed by using QuantiFast® SYBR® Green one step  
kit (Qiagen, UK) on ViiA™ 7 RUO Software. 
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Table 2.5. Target genes and primer sequences utilised for RT-qPCR of mouse cells (C2C12). 
Target mRNA  Primer sequence 5’-3’ NCBI  reference sequence 
RPII 
F 
R 
GGTCAGAAGGGAACTTGTGGTAT 
GCATCATTAAATGGAGTAGCGTC 
NM_153798.2 
MyoD 
F 
R 
CATTCCAACCCACAGAAC 
GGCGATAGAAGCTCCATA 
NM_010866.2 
MyoG 
F 
R 
CCAACTGAGATTGTCTGTC 
GGTGTTAGCCTTATGTGAAT 
NM_031189.2 
MyHC1 
F 
R 
CGCTTTGGTAAGTTCATCAG 
TAGATCCGGCTTCTTGTTAG 
NM_030679.1 
MyHC2 
F 
R 
CCTATCTGCTAGAGAAGTCC 
CTTCTTGTTGGATGTGATCTG 
NM_001039545.2 
MyHC3 
F 
R 
CATATCAGAGTGAGGAGGAC 
CTTGTAGGACTTGACTTTCAC 
NM_002470.3 
MyHC7 
F 
R 
GCAGAGTCAGTGAAGGGCAT 
CTTGGAGCTGGGTAGCACAA 
 
NM_080728.2 
MyHC8 
F 
R 
TGGATGATCTATACCTACTCAG 
TTGTCAGAGATGGAGAAGATG 
 
NM_177369.3 
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Table 2.6. Target genes and primer sequences utilised for RT-qPCR of human cells (hu020, hu027, hu028_1 and hu028_2). 
Target mRNA  Primer sequence 5’-3’ NCBI  reference sequence 
RPII 
F 
R 
AAGGCTTGGTTAGACAACAG 
TATCGTGGCGGTTCTTCA 
NM_000938.1 
MyHC1 
F 
R 
CGCTTTGGTAAGTTCATCAG 
TAGATCCGGCTTCTTGTTAG 
NM_005963.3 
MyHC7 
F 
R 
GCTTTGCCACATCTTGAT 
AATTGCTTTATTCTGCTTCCT 
NM_000257.3 
MyHC8 
F 
R 
ATTTCCACCAAGAACCCA 
AAAGGATTCTGCCTCTGG 
NM_002472.2 
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2.4 Statistical analysis 
GraphPad Prism 6.0 software was used for statistical data analysis. Specific statistical analyses 
performed in this thesis have been highlighted in the methods section of each chapter, as each 
experiment had specific analytical requirements. 
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3 C2C12 & SH-SY5Y: OPTIMISING A CHIMERIC MUSCLE-
NERVE CO-CULTURE IN 2D 
3.1 Introduction 
In order to develop an in vitro model of the NMJ, preliminary studies using cell lines were 
performed. This first step ensured that the co-culture conditions were optimised before using 
human primary cells and the 3D tissue engineering models. Establishing suitable co-culture 
conditions presents several challenges. Integrating heterotypic cells within the same system 
requires optimisation of the culture conditions to allow both cell types to survive, differentiate 
and coexist (Grey, 2011). Other aspects are the seeding density and the timing of the cultures, 
which must be carefully planned to ensure that both cell types reach optimal confluence when 
needed. For the realisation of this co-culture, cell lines were chosen primarily because of their 
higher availability and lower cost, compared to primary cells. This is particularly relevant when 
considering the neuronal population, as human primary motor neurons (MNs) can only be 
obtained using stem cells, whereas primary muscle is easily extracted with a biopsy. In addition, 
establishing a chimeric co-culture (murine muscle and human neurons) represents a 
progression from the previously established mouse models (Morimoto et al., 2013). 
The culture of different cell types in in vitro models is essential, as it provides researchers with 
a system that mimics the in vivo environment, allowing study of natural interactions occurring 
between cells and improves monocultures success (Goers et al., 2014). Although some of the 
mechanisms underpinning NMJ formation are still unclear, the formation of nerve-muscle 
contacts was characterised and extensively reviewed (Witzemann, 2006), explaining the role 
of the proteins involved in the NMJ formation process and sustaining the pre-patterning theory. 
Co-cultures mimic functional interactions between cell types (Grey, 2011; Smith et al., 2016). 
In particular, culturing MNs with skeletal muscle (SkM) showed enhancement of muscle 
contractility and maturity (Larkin et al., 2005; Martin et al., 2015).  
Optimising a system whereby murine SkM and human neurons are cultured together represents 
a step forward if compared to animal cultures, and a platform for further studies with primary 
human cells. Besides the advantages of using cell lines, which are more reproducible, cheaper 
50 
 
and less time-consuming to use, this chimeric model will develop understanding of the 
physiological interaction between the cell types.   
3.1.1 The effect of retinoic acid on C2C12 and SH-SY5Y cells. 
The aim of this work was to combine human SkM cells and MNs. During the first stage, cell 
lines were used to generate a chimeric system (mouse/human). The human neuronal cell line 
(SH-SY5Y) was used in combination with murine myoblasts (C2C12). SH-SY5Y cells require 
retinoic acid (RA) to differentiate. RA is a major component of vitamin A and plays a key role 
in biological processes like cell growth, apoptosis, migration and differentiation. Every cell 
type requires specific growth and differentiation conditions, which may involve different media 
formulations, oxygen levels, supplementations etc. (Goers et al., 2014). Therefore, it is 
essential to establish the culture conditions when co-culturing heterotypic cells such as C2C12 
and SH-SY5Y. The phenotype of RA-treated SH-SY5Y cells is the subject of controversy in 
the literature (Hong-rong et al., 2010). Being a versatile cell line, it can be used to generate 
dopaminergic, adrenergic or cholinergic neurons. Protocols in the literature differ, although 
generally, RA was found to promote a cholinergic phenotype in SH-SY5Y (Adem et al., 1987; 
Forster et al., 2016; Påhlman et al., 1995).  
While the role of RA in neurological development is essential (Rhinn and Dolle, 2012), its 
effect on SkM cells showed variable results in the literature. The influence of RA on SkM cells 
was studied in different species including quail (Maden et al., 2000), zebrafish (Hamade et al., 
2006), chicken (Reijntjes et al., 2010) and rat (Arnold et al., 1992). In murine myoblasts, RA 
promoted MyoD expression and myoblast differentiation (Albagli-Curiel et al., 1993; Halevy 
and Lerman, 1993). The concentrations used to induce differentiation were as low as 0.0001 to 
0.01 µM  (Halevy and Lerman, 1993), suggesting that RA may be beneficial to myotube 
formation, if kept at low concentrations. Also, RA promoted C2C12 myotube formation and 
expression of myogenic markers upon treatment with concentrations ranging from 0.25 to 4 
µM (Zhu et al., 2010). However, another study showed that concentrations between 0.1 and 10 
µM induced a reduction in MyoD, Myogenin (MyoG) and myosin light chain MyLC1/3 
expression, suggesting inhibition of the differentiation process (Xiao et al., 1995a). Recently, 
reduced myotube width was reported when C2C12 myoblasts were treated with 10 µM RA if 
compared to no RA at all, suggesting that the presence of RA induced muscle atrophy (Pardo-
Figueres, 2017). 
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Another study (Yun et al., 2008) showed that RA is involved in cytoskeleton remodeling which 
allows the cells to change morphology and migrate. The process through which this occurs, 
involves the activation of a specific protein which is involved in the regulation of glucose 
uptake in SkM cells: AMP-activated protein kinase (AMPK). The authors also believed that 
RA did not affect C2C12 viability, but no results were shown to confirm this statement. This 
represents a limitation because qualitative and quantitative experiments would support such a 
declaration. In fact, it is not clear what exactly was not affected by RA (adhesion, proliferation, 
metabolic activity, differentiation).  
 In human myoblasts, the treatment with RA impaired SkM differentiation, but the inactivation 
of endogenous RA receptors enhanced myoblasts differentiation, showing that RA enhanced 
the expression of myogenic specification genes while inhibiting the expression of early and 
late muscle differentiation markers (El Haddad et al., 2017).  
In conclusion, the variability in the literature reinforces the need to test the effect of RA on 
C2C12 and in co-cultures with SH-SY5Y cells, to ensure survival and differentiation of both 
cell types. 
3.1.2 The use of agrin to increase muscle-nerve interactions 
Agrin is a protein involved in the formation of the NMJ (Witzemann, 2006), found to play a 
role in synaptogenesis in the brain (Daniels, 2012). There are two main subtypes of agrin: 
neuronal agrin is responsible for the anchoring to the SkM fibres, stabilising AChR clustering 
and controlling axonal growth (Bian and Bursac, 2012; Hoch, 1999; Witzemann, 2006); muscle 
agrin is involved in synaptogenesis (Burgess et al., 1999). Lack of neuronal agrin in vivo can 
result in impaired synaptic development of the NMJ (Burgess et al., 1999). The use of agrin in 
muscle-nerve co-cultures aims to increase AChR’s clustering and enhance interactions between 
the two cell types (Marangi et al., 2001; McMahan et al., 1992; Smith, 2012; Wallace, 1989), 
thus aiding NMJ formation. 
3.2 Aims & objectives of the chapter 
Co-culturing different cell types requires optimisation of the culture conditions (e.g. 
differentiation medium composition, amount of time the cells require to either fuse into 
multinucleated myotubes or extend neurites, seeding procedures…). In addition, the presence 
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of neurons (SH-SY5Y) in a SkM culture (C2C12) was hypothesised to enhance muscle 
maturity in terms of increased myotube size and expression of mature SkM markers. The reason 
for enhancing SkM maturity was to obtain an in vitro model which was functional, and this can 
only be obtained if the muscle is mature. Hence, the aim of this chapter was to test different 
differentiation medium compositions to allow both myotube formation and neurite extension, 
as well as to determine whether the presence of a neuronal population in the culture could cause 
larger C2C12 myotubes to form, suggesting a higher degree of maturation. Finally, the role of 
agrin in the co-culture was investigated to determine its effect on AChR’s clustering and 
muscle markers expression. The results obtained in this chapter represent a helpful step to 
determine the conditions for the 3D co-cultures performed afterwards and to understand the 
potential of SH-SY5Y as an in vitro neuronal model and to increase C2C12 maturity.  
The aims for this chapter were: 
 Identifying the differentiation medium composition for C2C12/SH-SY5Y cells co-
culture; 
 Verifying the expression of pre- and post-synaptic proteins on C2C12s and SH-SY5Ys; 
 Adding agrin to the culture to increase NMJ contacts and C2C12 cells’ markers 
expression. 
The objectives for this chapter were: 
 To test three concentrations of RA and measure myotube width and neurite length as 
measurements of cell differentiation; 
 To observe cell morphology, distribution and pre/post-synaptic markers expression 
using immunofluorescent staining; 
 To test the addition of agrin to the culture and observe AChR expression on C2C12s, 
and gene expression of MyoD, MyoG, MyHC1, MyHC2, MyHC3, MyHC7 and 
MyHC8. 
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3.3 Materials & Methods  
C2C12 murine myoblasts and SH-SY5Y neuroblastoma cells were routinely cultured, passaged 
and plated as described in section 2.1. The immunofluorescent stainings for morphological and 
synaptical markers were performed as described in Error! Reference source not found. and 
adjusted for the co-culture as explained in sections 3.3.3 and 3.3.4. Quantitative analysis of the 
images was done according to section 3.3.5 and gene expression analysis was investigated via 
RT-qPCR as reported in 2.3.5. 
3.3.1 Co-culture medium optimisation: different RA concentrations  
This experiment was conducted to establish the optimal differentiation medium. The aim was 
to determine which concentration of RA allowed for both myotube formation and neurite 
extension. Firstly, C2C12 and SH-SY5Y were monocultured in optimal conditions based on 
previous protocols (Pardo-Figueres, 2017; Turner et al., 2018) (Table 3.1). The cells were also 
monocultured in different compositions of differentiation medium (NDM), and three 
concentrations of RA: 1, 5 and 10 μM (Table 3.2).   
 
Table 3.1. Composition of gold standard media used to expand and differentiate C2C12 and 
SH-SY5Y.
 GM DM 
C2C12 DMEM + 20% FBS + 1% P/S DMEM + 2% HS + 1% P/S 
SH-SY5Y Glutamax + 10% NFBS + 1% P/S Glutamax + 10% NFBS + 10 µM RA + 1% P/S 
 
 
Table 3.2. Composition of different media used with different concentrations of RA for the 
co-culture of C2C12 and SH-SY5Y. 
RA concentration NDM 
1 µM Glutamax + 2% NFBS + 1 µM RA + 1% P/S 
5 µM Glutamax + 2% NFBS + 5 µM RA + 1% P/S 
10 µM (control) Glutamax + 2% NFBS + 10 µM RA + 1% P/S 
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The experiment was setup as follows: C2C12 were seeded in muscle GM (MGM) at the density 
of 10,000/cm2 until they reached 100% confluency. Then, they were differentiated for 5 days 
in muscle DM (MDM). SH-SY5Y controls were seeded at the same density and differentiated 
when they reached 60% confluency. For the co-cultures, C2C12 were seeded in MGM at day 
0 at the same density as in the monocultures and expanded until they reached 100% confluency. 
Then, an equal density of SH-SY5Y cells was seeded on top of the myoblast layer in neuronal 
GM (NGM) (Glutamax, 10% NFBS, 1% P/S) for 24h. The following day, neuronal DM (NDM) 
was removed and the co-culture was washed 3x with sterile PBS before adding to NDM 
(Glutamax, 2% NFBS, 1% P/S and 1, 5 or 10 µM RA). The culture was carried on for further 
5 days. At the end of the experiment, the cells were fixed and immunostained  for 
morphological markers as described in sections 2.3.1.4 and 2.3.1.5. SH-SY5Y were also seeded 
on a layer of  myoblasts (undifferentiated C2C12) which were subconfluent to prevent fusion 
into myotubes. 
 
3.3.2 Addition of agrin to mono and co-culture  
To induce AChR’s clustering on C2C12 myotubes, agrin (Recombinant Rat Agrin Protein 100 
µg, R&D Systems, USA) was added to the culture at the point of differentiation in NDM, at a 
concentration of 200 ng/mL as previously described (Martin et al., 2015). C2C12 monocultures 
were used as control, then agrin was added to C2C12 monocultures (C2C12 +agrin); in 
C2C12/SH-SY5Y co-cultures, NDM was kept standard (co-culture -agrin) or supplemented 
with agrin (co-culture +agrin). The samples are defined in the table below (Table 3.3) for 
clarity. The differentiation was carried out for a 5 days. 
Table 3.3. Samples details for the addition of agrin to C2C12 monocultures and co-
cultures with SH-SY5Y cells. 
Sample name Growth Differentiation 
Control MGM MDM 
C2C12 +agrin MGM MDM +agrin (200 ng/mL) 
Co-culture -agrin MGM (+24h NGM) NDM 
Co-culture +agrin  MGM (+24h NGM) NDM +agrin (200 ng/mL) 
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3.3.3 Co-culture morphological staining: phalloidin & β-III Tubulin 
Morphological immunostaining was performed according to 2.3.1.4 and 2.3.1.5. For the 
staining of co-cultures, a combination of such previously described methods was used. 
3.3.4 Co-culture interaction staining: BTX & SV-2  
Similarly to the morphological staining described in section 3.3.3, a combination of BTX and 
SV-2 immunostaining was based on individual protocols described in 2.3.1.8 and 2.3.1.9.  
3.3.5 Quantitative analysis: measurement of myotube width and neurite length  
The morphological analysis was performed using the software Fiji (Java 1.6.0_24, available to 
download at https://imagej.net/Fiji/Downloads). The quantitative analysis was done using the 
cumulative frequency method. The myotube width and neurite length from one image was 
averaged, and then the value obtained was averaged with the remaining frames (5 frames per 
coverslip, 3 coverslips per well). The measured cells were picked randomly in the frames. Only 
myotubes with 3 or more nuclei were considered for myotube width measurement. Whenever 
possible, neurite length was measured from the soma to the end of the neurite. 
3.3.6 Statistical analysis 
The statistical differences between the values in this chapter were analysed using the software 
GraphPad 6.0. The Shapiro-Wilkinson test was used to determine if the populations were 
normally distributed, and the homogeinity of the data was also tested.  
Multiple comparison two-way ANOVA was used to determine differences between myotube 
width and neurite length the values of the cells in monoculture and co-culture, as well as to 
compare the experimental conditions to the control, considered as the cells cultured in gold 
standard conditions. Differences were considered significant at p ≤ 0.05 (*), p ≤ 0.01 (**) and 
p ≤ 0.001 (***). The level of significance was adjusted according to the Bonferroni’s correction. 
Gene expression were analysed using a 1 by 3 ANOVA with parametric results, and Kruskall 
Willis test for non-parametric results. All results are presented as average ± standard deviation 
(SD). 
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3.4 Results 
3.4.1 Co-culture medium optimisation: the effect of the RA concentration on C2C12 
and SH-SY5Y morphology 
In order to effectively co-culture C2C12 and SH-SY5Y cells, the co-culture medium required 
optimisation, particularly regarding the RA concentration, which was necessary for neurite 
extension and thus neuronal differentiation. C2C12 and SH-SY5Y were treated with different 
NDM compositions (Table 3.2). As controls, C2C12 and SH-SY5Y were monocultured and 
differentiated in gold standard conditions (Table 3.1) and showed myotube formation and 
neurite extension (Figure 3.1). Similarly, differentiation was observed when C2C12 and SH-
SY5Y were monocultured in different NDM compositions (Table 3.2).  
 
Figure 3.1. Representative images of C2C12 and SH-SY5Y monocultures in optimal 
conditions. C2C12 myoblasts (A) were immunostained with rhodamine phalloidin to show 
actin filaments (red) and DAPI for the nuclei (blue). SH-SY5Y (B) were immunostained with 
β-III Tubulin (green) and nuclei were counterstained with DAPI (blue). Scale bars: 50 µm.  
As controls, C2C12 and SH-SY5Y were monocultured and differentiated in gold standard 
conditions (Table 3.1) and showed myotube formation and neurite extension (Figure 3.1). 
Similarly, differentiation was observed when C2C12 and SH-SY5Y were monocultured in 
different NDM compositions (Table 3.2).  
In the co-culture conditions, SH-SY5Y were co-cultured both with fully differentiated C2C12 
(myotubes) and undifferentiated C2C12 (myoblasts) (Figure 3.3). Both in the monoculture and 
in the co-culture, C2C12 myotubes appeared smaller as the concentration of RA increased. SH-
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SY5Y extended neurites at all culture conditions and RA concentrations. When SH-SY5Y were 
monocultured, the neurites did not extend in specific directions (Figure 3.1B, Figure 3.2) as 
opposed to the co-cultures (Figure 3.3), where they formed bundles which aligned to the 
direction of the myotubes. The values of myotube width and neurite length resulting from these 
co-cultures are reported in Table 3.4 and represented in Figure 3.4 and Figure 3.5. 
 
The myotube width did not show any statistical differences when compared to the optimal 
control. A general trend was observed when culturing the cells in the presence of RA, showing 
that increasing the concentration of RA led to a decrease in myotube width, and that the co-
culture had larger myotubes at 1 and 10 µM RA, if compared to the monoculture. The myotube 
width values when the cells were monocultured in 1 µM RA were the closest to the optimal 
control (2% HS) (Figure 3.4). The longest neurites were observed when SH-SY5Y were 
monocultured and co-cultured with myotubes at 1 µM RA. Generally, the cells projected longer 
neurites when co-cultured with myotubes, if compared to co-cultures with myoblasts and 
monocultures. In particular, a significant difference in neurite length was observed between the 
monoculture at 1 µM and the monoculture at 10 µM RA; the co-culture with myoblasts and 
with myotubes at 1 µM RA; the co-culture with myotubes at 1 µM RA and the monoculture at 
10 µM RA; finally, the co-culture with myotubes at 1 µM RA and the co-culture with myoblasts 
at 10 µM RA (Figure 3.5). 
Table 3.4. Myotube width (µm) and neurite length (µm) of C2C12 and SH-SY5Y.  
The difference between average values was analysed using ANOVA and the Bonferroni 
correction. Results are show as average ± SD and were considered significant when p ≤ 0.05. 
 C2C12 SH-SY5Y 
 Monoculture Co-culture Monoculture 
Co-culture 
(myoblasts) 
Co-culture 
(myotubes) 
1 µM RA 14.95 ± 4.59 17.26 ± 5.73 124.97 ± 12.83 69.48 ± 14.86 138.56 ± 40.98 
5 µM RA 14.91 ± 5.08 13.92 ± 2.80 89.42 ± 13.98 81.4 ± 12.81 106.68 ± 33.70 
10 µM RA 12.67 ± 3.93 12.94 ± 3.60 56.81. ± 10.40 70.95 ± 9.55 101.30 ± 33.71 
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Figure 3.2. Monocultures differentiated with different concentrations of RA. The cells were 
fixed and immunostained with morphological markers: actin filaments were stained with 
rhodamine phalloidin (red), SH-SY5Y cytoskeleton was stained with β-III Tubulin (green) and 
nuclei were counterstained with DAPI (blue). Scale bars: 50 µm.  
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Figure 3.3. C2C12 and SH-SY5Y co-cultures differentiated with different concentrations of 
RA. The cells were fixed and immunostained with morphological markers: actin filaments were 
stained with rhodamine phalloidin (red), SH-SY5Y cytoskeleton was stained with β-III Tubulin 
(green) and nuclei were counterstained with DAPI (blue). Scale bars: 50 µm.  
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Figure 3.4. C2C12 myotube width (µm) when the cells are monocultured and co-cultured with 
SH-SY5Y in optimal conditions (control) and at different concentrations of RA. No significant 
differences were found across all samples. No significant differences between the average 
values were assessed using ANOVA statistical analysis. Results are shown as average ± SD, 
n=12. 
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Figure 3.5. SH-SY5Y neurite length (µm) when the cells are monocultured and co-cultured 
with myoblasts and myotubes at different concentrations of RA. Asterisks indicate significant 
differences between samples: * = p ≤ 0.05, ** = p ≤ 0.01. Significant differences between the 
average values were assessed using ANOVA and the Bonferroni post-hoc test. Results are 
shown as average ± SD, n=12.  
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3.4.2 C2C12 and SH-SY5Y interactions: co-localisation of acetylcholine receptors and 
synaptic vesicle 2 
After establishing the composition of the NDM used for C2C12/SH-SY5Y co-cultures, the 
presence of AChR’s on C2C12 myotubes and SV-2 positive vesicles on SH-SY5Y was 
investigated. This analysis allows the identification of pre- and post-synaptic markers which 
are physiologically interacting to form a NMJ in vivo, thus giving us an insight on the markers 
which are directly involved in NMJ formation. First, the presence of AChR’s on differentiated 
C2C12 was verified by using α-Bungarotoxin (BTX) as an immunostaining marker. The cells 
showed clusters of AChR’s after 3, 5 and 7 days in MDM (Figure 3.6).  
 
Figure 3.6. AChR’s are expressed on C2C12 differentiated for 3 (3D), 5 (5D) or 7 (7D) days 
in MDM. The cells were fixed and immunostained: texas red-conjugated α-Bungarotoxin (BTX, 
red) was used for AChR clusters and nuclei were counterstained with DAPI (blue). Scale bars: 
50 µm. 
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The morphology of the myotubes was not stained, so the less intensively stained red areas were 
considered as background of the BTX immunostaining. A high magnification image (Figure 
3.7), shows the receptors after 5 days in MDM with the arrows highlighting them. Subsequently, 
the co-culture was immunostained with BTX and anti-SV-2. SH-SY5Y were positively stained 
by SV-2 when co-cultured with C2C12 and C2C12 retained their positivity to BTX staining in 
the co-culture (Figure 3.9). SH-SY5Y projected SV-2-positive neurites towards C2C12 
myofibres (Figure 3.8). In sporadic areas there was overlap between BTX and SV-2-positive 
areas, which may indicate co-localisation of the two markers, and therefore muscle-nerve 
interaction. These co-localisation spots appeared yellow and can be seen in Figure 3.9. 
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Figure 3.7. Detail of AChR’s on the surface of C2C12 myotubes after 5 days of differentiation. 
The cells were fixed and immunostained: texas red-conjugated α-Bungarotoxin (BTX, red) was 
used for AChR clusters and nuclei were counterstained with DAPI (blue). The arrows highlight 
AChR clusters. Scale bar: 25 µm.  
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Figure 3.8. C2C12 and SH-SY5Y express pre- and post-synaptic structures in monolayer co-
cultures. The cells were fixed and immunostained with pre- and post-synaptic markers: texas 
red-conjugated α-Bungarotoxin (BTX, red) was used for AChR clusters, synaptic vesicle 2 
(SV-2) was used for ACh-releasing vesicles in SH-SY5Y cells (green) and nuclei were 
counterstained with DAPI (blue). Scale bar: 50 µm.  
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Figure 3.9. C2C12 and SH-SY5Y cells interact and AChR’s and SV-2 colocalise. The cells were fixed and immunostained for pre- and post-
synaptic markers: texas red-conjugated α-Bungarotoxin (BTX, red) was used for AChR clusters (B), synaptic vesicle 2 (SV-2) was used for ACh-
releasing vesicles in SH-SY5Y cells (green, C) and nuclei were counterstained with DAPI (blue, A). The arrows in the merged picture (D) highlight 
the co-localisation of the two markers, which appeared yellow. Scale bars: 50 µm.
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3.4.3 The addition of agrin did not affect myotube width and muscle maturity 
Agrin was added to NDM to both C2C12 in monoculture and in co-culture with SH-SY5Y. 
The rationale behind adding this compound to the differentiation stage was to increase AChR’s 
clustering and enhance interactions between pre- and post-synaptic proteins (Smith, 2012). As 
outputs, the myotube width was measured, and the expression of 8 genes was tested to 
investigate muscle maturity across all conditions. The genes of interested were MyoD, MyoG 
and Myosin Heavy Chain (MyHC) 1, 2, 3, 4, 7 and 8. These were considered as they represent 
different stages of development (from embryonic to post-natal) and types of muscle fibres, thus 
providing important information on the maturity of the muscle. 
In terms of morphology, agrin did not appear to influence neither C2C12 in monoculture or 
C2C12 and SH-SY5Y in co-culture (Figure 3.10). The cells differentiated in all conditions, 
forming myotubes which did not differ in terms of myotube width (Figure 3.11), although a 
slight increase in myotube width was observed when C2C12 were co-cultured with SH-SY5Y, 
instead of monocultured in control conditions.  
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Figure 3.10. Morphological immunostaining of C2C12 monocultures and co-cultures with SH-
SY5Y, in the presence or absence of agrin. The cells were fixed and immunostained for 
morphological markers: actin filaments were stained with rhodamine phalloidin (red), SH-
SY5Y cytoskeleton was stained with β-III Tubulin (green) and nuclei were counterstained with 
DAPI (blue). Scale bars: 100 µm.  
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Figure 3.11. Myotube width of C2C12 in monoculture and co-culture, with or without agrin. 
The width of the myotubes was measured in control conditions (control, C2C12 monoculture 
without agrin), C2C12 monoculture with agrin, C2C12/SH-SY5Y co-culture without agrin and 
C2C12/SH-SY5Y co-culture with agrin. Student’s t-Test did not reveal statistical difference 
across mean values. Results are shown as average ± SD, n=6.  
 
The immunostaining for AChR’s was performed on C2C12 monocultures and an increase in 
the number of clusters was observed (Figure 3.12), but not quantified. The interaction 
immunostaining was performed to identify differences in the presence or absence of agrin, in 
the co-culture. Although AChR’s were marked by BTX, the SV-2 immunostaining appeared 
aspecific, as it bound to the myotubes too, which appeared yellow/green instead or black/red. 
No interaction was recorded, but proximity of neurites and AChR’s was observed. 
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Figure 3.12. Interaction staining C2C12 myotubes in monoculture in the absence or presence 
of agrin, and in co-culture with SH-SY5Y in the presence or absence of agrin. The cells fixed 
and immunostained to highlight pre- and post-synaptic markers: AChR’s were identified on 
C2C12 using texas red-conjugated α-Bungarotoxin (BTX, red), synaptic vesicle 2 on SH-
SY5Y (SV-2) were stained in green, and nuclei were counterstained with DAPI (blue). Scale 
bars: 25 µm.
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Gene expression analysis of MyoD (Figure 3.13), MyoG (Figure 3.14), MyHC3 (Figure 3.14), 
MyHC8 (Figure 3.15), MyHC7 (Figure 3.16), MyHC1 (Figure 3.18)  and MyHC2 (Figure 
3.19)  was investigated. Significant differences were found in MyoG expression between the 
monoculture +agrin and the co-culture +agrin (p=0.037), in MyHC3 between the monoculture 
+agrin and the co-culture+agrin (p=0.006). Differences were also observed in MyHC8 
expression, between the monoculture +agrin and the co-culture -agrin (p=0.04), and the 
monoculture +agrin and the co-culture +agrin (p=0.016). 
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Figure 3.13. MyoD (development) mRNA expression in C2C12 cultured in different 
conditions. Control conditions (control, C2C12 monoculture without agrin), C2C12 
monoculture with agrin (C2C12+agrin), C2C12/SH-SY5Y co-culture without agrin (co-culture 
-agrin) and C2C12/SH-SY5Y co-culture with agrin (co-culture +agrin). Student’s t-Test did 
not reveal statistical difference across mean values. Results are shown as average ± SD, n=6. 
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Figure 3.14. MyoG (development) mRNA expression in C2C12 cultured in different 
conditions. Control conditions (control, C2C12 monoculture without agrin), C2C12 
monoculture with agrin (C2C12 +agrin), C2C12/SH-SY5Y co-culture without agrin (co-
culture -agrin) and C2C12/SH-SY5Y co-culture with agrin (co-culture +agrin). Asterisks show 
significant difference between samples: * = p ≤ 0.05. The statistical analysis was done using 
Student’s t-Test. Results are shown as average ± SD, n=6. 
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Figure 3.15. MyHC3 (embryonic) mRNA expression in C2C12 cultured in different conditions. 
Control conditions (control, C2C12 monoculture without agrin), C2C12 monoculture with 
agrin (C2C12 +agrin), C2C12/SH-SY5Y co-culture without agrin (co-culture -agrin) and 
C2C12/SH-SY5Y co-culture with agrin (co-culture +agrin). Asterisks show significant 
difference between samples: * = p ≤ 0.05. The statistical analysis was done using Student’s t-
Test. Results are shown as average ± SD, n=6.  
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Figure 3.16. MyHC8 (neonatal) mRNA expression in C2C12 cultured in different conditions. 
Control conditions (control, C2C12 monoculture without agrin), C2C12 monoculture with 
agrin (C2C12 +agrin), C2C12/SH-SY5Y co-culture without agrin (co-culture -agrin) and 
C2C12/SH-SY5Y co-culture with agrin (co-culture +agrin). Asterisks show significant 
difference between samples: * = p ≤ 0.05. The statistical analysis was done using Student’s t-
Test. Results are shown as average ± SD, n=6. 
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Figure 3.17. MyHC7 (slow) mRNA expression in in C2C12 cultured in different conditions. 
Control conditions (control, C2C12 monoculture without agrin), C2C12 monoculture with 
agrin (C2C12 +agrin), C2C12/SH-SY5Y co-culture without agrin (co-culture -agrin) and 
C2C12/SH-SY5Y co-culture with agrin (co-culture +agrin). Student’s t-Test did not reveal 
statistical difference across mean values. Results are shown as average ± SD, n=6. 
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Figure 3.18. MyHC1 (fast) mRNA expression in in C2C12 cultured in different conditions. 
Control conditions (control, C2C12 monoculture without agrin), C2C12 monoculture with 
agrin (C2C12 +agrin), C2C12/SH-SY5Y co-culture without agrin (co-culture -agrin) and 
C2C12/SH-SY5Y co-culture with agrin (co-culture +agrin). Student’s t-Test did not reveal 
statistical difference across mean values. Results are shown as average ± SD, n=6. 
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Figure 3.19. MyHC2 (fast) mRNA expression in C2C12 cultured in different conditions. 
Control conditions (control, C2C12 monoculture without agrin), C2C12 monoculture with 
agrin (C2C12 +agrin), C2C12/SH-SY5Y co-culture without agrin (co-culture -agrin) and 
C2C12/SH-SY5Y co-culture with agrin (co-culture +agrin). Asterisks show significant 
difference between samples: * = p ≤ 0.05. Student’s t-Test did not reveal statistical difference 
across mean values. Results are shown as average ± SD, n=6.
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3.5 Discussion  
Establishing the conditions to co-culture different cell types is essential and represents a 
bottom-up approach whereby a tissue is gradually developed in vitro (Goers et al., 2014). 
Muscle-nerve co-cultures can provide scientists with information regarding the behavior of 
cells in a more complex environment, as well as laying the grounds for further analysis. 
Utilising cell lines to achieve this is a faster, cheaper and more reproducible fashion to perform 
preliminary studies, compared to primary cells. Limitations which are typical of primary cells, 
such as variability and cell number do not represent an issue when using cell lines. Furthermore, 
the use of a chimeric co-culture whereby murine muscle is cultured with human neurons 
represents a progression versus animal only co-cultures, implementing the ‘reduction, 
refinement and replacement’ approach that is vastly being embraced in nowadays’ research 
(https://www.nc3rs.org.uk/the-3rs).  
3.5.1 A concentration of 1 µM RA ensures both C2C12 and SH-SY5Y differentiation 
C2C12 and SH-SY5Y cells require different culture conditions when cultured independently 
from one-another. Therefore, the medium compatibility results presented in this chapter 
determined a suitable differentiation protocol for both C2C12 and SH-SY5Y. In particular, 
C2C12 fuse into multinucleated myotubes when the serum concentration is reduced or totally 
removed (Burattini et al., 2004; Sharples et al., 2012), and/or when the species from which the 
serum is derived, changes (Manabe et al., 2012). On the other side, to promote neurite extension 
and induce a cholinergic phenotype in SH-SY5Y, the use of RA is required (Clagett-dame et 
al., 2006; Encinas et al., 2000; Hong-rong et al., 2010). Since the effect of RA on myogenesis 
is unclear (Xiao et al., 1995b; Zhu et al., 2010), testing different concentrations was used as an 
approach to determine what amount of RA promoted differentiation in both cell types, without 
causing muscle atrophy or hindering neuronal extension. Three doses of RA were investigated 
in this work, 1, 5 and 10 µM, based on previous work where 1 µM (Korecka et al., 2013) and 
10 µM (Påhlman et al., 1995; Presgraves et al., 2004) were used to induce a cholinergic 
phenotype. However, this data has not been compared within a single study. The results 
indicated that C2C12 monocultures differentiated in all conditions, without showing a 
statistical difference between the control (gold standard muscle differentiation medium) and 
the neuronal differentiation medium supplemented with RA. The presence of SH-SY5Y in 
culture did not significantly impact the width of the myotubes, although an increase in mean 
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value was observed at 1 and 10 µM. The measurement of SH-SY5Y neurite length was on cells 
which were monocultured and co-cultured both with undifferentiated C2C12 (myoblasts) and 
differentiated C2C12 (myotubes). A lower seeding density was used to prevent C2C12 from 
fusing into myotubes, therefore providing us with additional information. A trend in decreasing 
neurite length was observed when the concentration of RA was enhanced. The concentration  
reported in the literature to induce cholinergic differentiation of SH-SY5Y is 10 µM (Påhlman 
et al., 1984) and was therefore used as an initial control. In this work, neurite extension was 
obtained at all concentrations, but the neurite length was higher when the RA concentration 
was lower. Neurite extension is a determining factor for the contact between MNs and SkM 
fibres. Although it was not reported what the “standard” neurite length of differentiated SH-
SY5Y should be, it was interesting to observe that the presence of myotubes in culture had an 
increasing effect on neurite length, compared to the neuronal monoculture. The longest neurites 
were observed in C2C12/SH-SY5Y co-cultures differentiated in 1 µM RA. This suggests that 
this concentration not only does not affect the size of the myotubes compared to the standard 
control, but allows projection of neurites which are essential for the cells to interact with one 
another. In conclusion, neuronal differentiation medium (NDM) supplemented with 1 µM RA 
was used for further C2C12/SH-SY5Y co-cultures. 
3.5.2 NMJ formation between C2C12 and SH-SY5Y: finding a needle in a haystack 
Immunostaining observations of C2C12 and SH-SY5Y co-cultures revealed that neurites 
typically extended in proximity of myotubes. This may indicate that the maturation of the 
muscle attracted neuronal extensions towards them. In order to determine whether the cells 
express pre- and post-synaptic proteins, specific co-localisation staining was performed. 
AChR’s on the surface of C2C12 cells were found after 3, 5 and 7 days of differentiation in 
standard MDM. Following the co-culture protocol optimised in the first part of this chapter, 
C2C12 and SH-SY5Y were co-cultured for 5 days in NDM supplemented with 1 µM RA. As 
a result, C2C12 in co-culture with SH-SY5Y were also positive to AChR’s-specific 
immunostaining (BTX). In addition, the neurons were positively stained by a marker for SV-
2, the vesicles responsible for the release of ACh. Thin SV-2-positive neuronal projections 
were seen running alongside and projecting towards cultured myotubes, and are believed to 
indicate neurite growth in close proximity of AChR-expressing SkM cells (Figure 3.8 and 
Figure 3.9). This outcome is comparable to what was previously observed (Smith, 2012). 
Although it was frequently observed that pre- and post-synaptic markers were in promixity of 
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one-another, the incidence of the co-localisation of AChR’s and SV-2 was rare. A 3D culture, 
although more complex, could provide both cell types with a more physiologically-relevant 
niche. This could enhance the frequency at which these co-localisations appear, as reported in 
a similar work (Smith, 2012). The lack of directionality that is intrinsic in monolayer cultures 
did not promote organization of two cell types, which can be achieved by using patterened 
surfaces or 3D constructs (Pardo-Figueres, 2017; Tong et al., 2014). 
3.5.3 Agrin enhanced muscle maturity in co-cultures, and decreased it in 
monoculutures  
Treatment of muscle cells with agrin has been previously shown to improve levels of post-
synaptic patterning, characterised by a significant increase in clusters of AChR’s on myotube 
membranes (Henriquez et al., 2008). The localisation of AChR clusters on the myotubes’ 
surface requires the expression of agrin, which maintains the molecular architecture of the post-
synaptic membrane (McConville and Vincent, 2002). The role of agrin is to stabilise the 
AChR’s, prevent them from dispersing across the myotubes, and initiating the cascade of 
events which lead to the formation of a NMJ (Witzemann, 2006). The effect of agrin on C2C12 
monocultures and C2C12/SH-SY5Y co-cultures was addressed in this work in order to 
determine whether this compound would have been necessary or not for the formation of a 
NMJ in 2D and, subsequently, in 3D. The addition of agrin did not appear to increase the 
interactions between C2C12 and SH-SY5Y, but it had some effect on the expressions of SkM-
related genes. MyoD and MyoG are expressed during SkM development and regeneration 
(Brown et al., 2012; Schiaffino et al., 2015). Their levels decreased in the monoculture, from 
the control to the addition of agrin. In the co-culture, the levels of mRNA increased upon the 
addition of agrin, but these changes were non-significant. A similar trend was observed for 
MyoG, where agrin decreased its expression in the monoculture and increased in the co-culture. 
This time, the difference between the monoculture with agrin and the co-culture with agrin, 
was significant, indicating that the presence of the neurons and the agrin treatment encouraged 
muscle maturation. MyHC’s expressed in mouse during the early stages of development are 
MyHC3 (embryonic), MyHC8 (neonatal) and MyHC7 (slow fibres) (Brown et al., 2012; 
Schiaffino et al., 2015). Although the addition of agrin did not significantly influence the 
expression of MyHC7, the co-culture did play a role in MyHC3 and MyHC8. The addition of 
agrin in the co-culture enhanced MyHC3 expression when compared to the monoculture +agrin. 
Since MyHC3 is the earliest heavy chain expressed during embryonic development and 
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regeneration (Brown et al., 2012), these results suggest that the treatment with agrin promoted 
development both in mono and in co-cultures. As for MyHC8, if compared to C2C12 
monocultures with or without agrin, an increase in gene expression was observed, although it 
was only significant if compared to the monoculture with agrin. Finally, post-natal MyHC1 
and MyHC2, which encode for fast fibres, were not influenced by the presence of agrin or the 
addition of SH-SY5Y to the culture. Although agrin is generally utilised in muscle-nerve co-
cultures (Flanagan-Steet et al., 2005; Guo et al., 2011), it did not represent a determining factor 
in the maturation of C2C12. Observations of BTX-stained myotubes did not lead to include 
agrin in future 3D co-cultures, particularly considering that these co-cultures were firstly 
established using the chimera C2C12/SH-SY5Y.  
Despite the observation of some changes in gene expression when adding agrin to the culture, 
an increase by 1 or 2 fold was not considered biologically relevant to justify the use of an 
additional compound in the culture in 3D. Indeed, the use of agrin was not perpetuated in the 
3D cultures reported in the following chapter. It was hypothesised that the 3D environment and 
the potential to stimulate the constructs (mechanically, electrically or using drugs), could 
enhance cell-cell interactions and facilitate NMJ formation, rather than the addition of agrin.  
3.6 Chapter summary 
The work conducted in this chapter established successful muscle-nerve co-cultures using cell 
lines. C2C12, a widely used murine myoblast line, were co-cultured with the human 
neuroblastoma line SH-SY5Y. Optimisation of the differentiation conditions lead to the 
definition of a medium which can be used for further cultures in 3D tissue engineered 
constructs. This chimeric co-culture is a step forward from the mouse-mouse co-cultures 
reported in the literature, as the source of neurons was human. Even though working with cell 
lines includes several advantages (i.e. low cost of cells and reagents, high availability, high 
reproducibility, non-necessity for surface coatings), some limitations can also be highlighted. 
First, there is a possibility that different species may have played a role in the low number of 
interactions observed in the co-cultures, when AChR’s and synaptic vesicles were 
immunostained. In addition, since SH-SY5Y may include different kinds of neurons, the 
cholinergic population will be lower than the one found in primary MNs. Despite that, these 
cells were previously found to be cholinergic if differentiated in the presence of RA, therefore 
representing a valid candidate for muscle-nerve human co-cultures, where no animal models 
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are used and a readily available source of human MNs is still not available. The addition of 
agrin to the culture was tested to investigate its role on the expression of muscle maturation 
markers and the clustering of AChR’s. Alttough some significant differenes were found, the 
increase in gene expression was no larger than two times the baseline value, thus not justifying 
the addition of another component to the co-culture medium.  
Muscle and neurons require a complex matrix to be physiologically relevant and functionally 
active. Therefore, the use of tissue engineered constructs may provide the cells with a more 
suitable environment for NMJ formation. The preliminary studies carried out in this chapter 
were essential to establish the co-culture conditions in terms of medium composition, seeding 
density and timing. Tissue engineered constructs were extensively used in our laboratory for 
SkM culture (collagen gels) and SkM/MNs co-culture (fibrin gels). Information on morphology, 
cell distribution, cell-cell interaction and functionality can be obtained and will a crucial aspect 
when establishing a primary human co-culture in 3D. Furthermore, training is required when 
using such constructs, which would be cheaper and more quickly completed with cell lines. 
The C2C12/SH-SY5Y co-culture will be briefly carried out in 3D in the following chapter.   
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4 C2C12 & SH-SY5Y CO-CULTURE: FROM 2D TO 3D 
4.1 Introduction 
Tissue engineering has been defined as “an interdisciplinary field that applies the principles of 
engineering and life sciences toward the development of biological substitutes that restore, 
maintain or improve function or a whole organ” (Nerem, 1992). Using tissue engineering as a 
tool for the development of an in vitro model would allow for the generation of a pre-clinical 
platform, alongside the use of animal models (or potentially, in the future, completely 
substituting them). Matrices of various types resemble the in vivo microenvironment more 
closely than monolayer cultures do (Edmondson et al., 2014), and therefore it is important to 
have a representative 3D (three dimensional) system which mimics human tissues. Within the 
field of tissue engineering, various tissues have been be cultured in closed systems that allow 
nutrient and waste exchange while providing the cells with a 3D environment to grow in 
(Langer and Vacanti, 1993). Skeletal muscle (SkM) is a highly organised tissue (Gillies and 
Lieber, 2012), which features aligned fibres that must be achieved in 3D cultures. Biomaterials 
of different kinds can be utilised to guide SkM reorganisation, acting as a matrix in which cells 
can grow three-dimensionally, and mediating the delivery of bioactive factors or therapeutics 
in a controlled fashion (Qazi et al., 2015). Constructs such as using porous scaffolds, hydrogels, 
fibrous meshes and patterned substrates were used to culture SkM (Qazi et al., 2015). Among 
hydrogels, widely used ones are collagen gels (Passey et al., 2011; Player et al., 2014; Sharples 
et al., 2012; Smith et al., 2016), fibrin gels (Martin, 2012; Martin et al., 2015, 2013), 
combinations of collagen and Matrigel® (Powell et al., 2002), and collagen and alginate (Bach 
et al., 2004). Each of these constructs is suitable for SkM tissue engineering due to their 
biocompatibility and support role for the growth and differentiation of SkM in vitro. Besides a 
3D environment and a construct which allows for the generation of aligned structures, the use 
of such gels can resemble in vivo tissues. Therefore, great importance is given to the suitability 
of 3D constructs for functional studies. External stimuli which enhance muscle maturation and 
contraction, such as mechanical (Goldspink et al., 1992; Noah et al., 2002; Tatsumi et al., 2001; 
Vandenburgh and Kaufman, 1979) and electrical stimulation (Dusterhoft and Pette, 1990; 
Wehrle et al., 1994) can be reproduced in tissue engineered constructs. These systems are 
important because SkM is an adaptable tissue which responds to conditions such as mechanical 
stress, physical activity, availability of nutrients and growth factors (Sandri, 2008). Thus, these 
85 
 
models could be used to understand the mechanisms behind the formation of the NMJ and how 
these are disrupted in pathological situations  
The 3D tissue engineering constructs (collagen and fibrin gels) used in our laboratory were 
described in sections 1.4 of this thesis. The advantage of using these types of hydrogels versus 
polymeric scaffolds, is that they are highly biocompatible, being made out of the same 
constituents of SkM’s extracellular matrix (ECM). Collagen is the main component in SkM 
(Alberts et al., 2002). In particular, collagen type I is mainly found in the perimysium, the ECM 
layer which surrounds groups of muscle cells (Gillies and Lieber, 2012); collagen type III is 
mainly found in epimysium (around the whole muscle) and endomysium (around single muscle 
cells). Other collagen subtypes are part of SkM’s ECM. Collagen type IV makes up the 
basement membrane with smaller amounts of type VI, XV and XVIII. Although other 
components are present (proteoglycans, glycosaminoglycans, glycoproteins and matrix 
remodelling enzymes) (Gillies and Lieber, 2012), the abundance of collagen in SkM’s ECM 
makes such constructs particularly suitable for supporting SkM growth and differentiation in 
vitro. The high collagen content required by muscle cells and intrinsic in the preparation of 
collagen constructs, together with the similar stiffness of fibrin gels to native muscle, make 
these constructs suitable for SkM tissue engineering. On the other hand, a suitable matrix for 
neuronal cultures should be made of other ECM proteins such as laminin or fibronectin.  
Another crucial aspect of 3D cultures is being able to simulate basic functions and the electrical 
impulse coming for peripheral motor neruons (MNs) in vitro. This represents a powerful tool 
for physiology and pathophysiology studies. For instance, mechanical loading replicates 
physiological contraction and exercise in vitro, and has been shown to enhance myotube width 
and force generation (Powell et al., 2002) and the co-culture of primary rat muscle and MNs 
significantly increased spontaneous muscle twitching compared to muscle alone (Martin et al., 
2015). Supporting both cell types within the construct is essential to enable matrix remodelling 
and cell-cell interactions. While collagen represents a valuable candidate for SkM culture, 
surfaces for neuronal 2D and 3D outgrowth can be based on collagen, fibrin and fibronectin 
(Alovskaya et al., 2007). Primary neurons require surface modifications or coatings such as 
poly-D-lysine/fibronectin or poly-D-lysine/laminin to adhere (Smith et al., 2013), as well as 
complex matrices (e.g. Matrigel®) (Yi et al., 2018). Therefore, establishing the 3D culture 
conditions for both SkM and MN differentiation is essential.  
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All in all, developing a stable 3D model of the NMJ is crucial to support the integration of 
multiple cell types in a more complex environment than the one found in 2D cultures, allowing 
for studies on cell-cell and cell-matrix interactions. 
4.2 Aims & objectives of the chapter 
Following the optimisation of the C2C12/SH-SY5Y co-culture in monolayer carried out in 
Chapter 3, this chapter focusses on the culture of these cell lines in 3D tissue engineered 
constructs. Utilising these cell lines provided important information on the cell-cell and cell-
matrix interations and also the set up the conditions used for the succesful co-habiting of both 
cell types. Engineering the co-culture in collagen- and fibrin-based matrices enables the 
characterisation of muscle-nerve cells in a complex environment and can be used for functional 
studies or as a platform for drug testing. Achieving this co-culture aims to underpin how both 
cell types coexist in different types of materials, providing us with essential information on 
how the presence of the neurons may or may not affect muscle maturity, matrix remodelling 
or spontaneuous muscle twitching. Finally, this chapter sets the grounds for engineering 3D 
cultures of human primary cells. 
The aims for this chapter were: 
 Culturing and differentiating C2C12 and SH-SY5Y cells in fibrin and collagen gels; 
 Increasing matrix remodelling when SH-SY5Ys are added to the gels; 
 Facilitating NMJ formation using tissue engineered constructs. 
The objecives for this chapter were: 
 To utilise immunofluorescent staining to observe the morphology and distribution of 
C2C12 and SH-SY5Y cells in collagen and fibrin constructs; 
 To measure the gels width as an indication of the matrix remodelling performed by the 
cells and identify a difference when neurons are added; 
 To measure C2C12 myotube width in the absence of presence of neurons 
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4.3 Materials & Methods  
4.3.1 Co-culture in fibrin gels 
The co-culture of SH-SY5Y and C2C12 in fibrin gels was carried out following the procedure 
described in 2.2.2. C2C12 myoblasts were expanded for 4 days in muscle growth medium 
(MGM), then SH-SY5Y cells were seeded on top of the gel in neuronal growth medium (NGM) 
and left to adhere for 15 minutes, before filling up the culture chamber with NGM. The 
following day, the medium was switched to neuronal differentiation medium (NDM) for a 
further 7 days. The gels which were used for the co-culture were chosen at the very beginning 
of the culture, in order to obtain unbiased results. 
4.3.2 Co-culture in 500 µL collagen gels  
The co-culture in 500 µL collagen gels was carried out following the procedure described in 
2.2.3. C2C12 myoblasts were expanded for 4 days in MGM, then SH-SY5Y cells were seeded 
on top of the gel in NGM and left to adhere for 15 minutes, before filling up the culture chamber 
with NGM. The following day, the medium was switched to NDM for a further 7 days. The 
gels which were used for the co-culture were chosen at the very beginning of the culture, in 
order to obtain unbiased results. 
4.3.3 Morphological staining of 3D constructs: phalloidin and β-III Tubulin 
The morphological staining using rhodamine phalloidin for actin filaments and β-III Tubulin 
for the neuronal structure, was performed as described in 2.3.1.4 and 2.3.1.5. The only 
differences are the fixing process (2.3.1.2) and the fact that the antibodies were incubated for 
3 hours instead of 2.  
4.3.4 Statistical analysis 
The data from the myotube width analysis was presented as average ± SD. Statistical analysis 
was performed using the GraphPad Prism 6.0 software. An F-Test was used to determine if the 
variances of the two populations were equal. Then, the statistical difference between control 
and co-culture gel deformation, and the myotube width in control and co-culture gels were 
verified using an unpaired t-Test. 
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4.4 Results 
4.4.1 C2C12 & SH-SY5Y co-culture in fibrin gels 
Fibrin gels were used to co-culture C2C12 and SH-SY5Y cells in 3D. To do this, C2C12 were 
seeded within the fibrin matrix at day 0, and expanded in MGM until day 4. Then, SH-SY5Y 
were seeded in NGM on top of the gel, and the day after the medium was changed to NDM, 
based on the media optimisation carried out in Chapter 3.  
C2C12 myoblasts were successfully monocultured in fibrin-based constructs. The cells 
differentiated into aligned myotubes, which can be seen in Figure 4.1. Over time, the gels 
width decreased in size as C2C12 remodeled the matrix, both in absence and presence of SH-
SY5Y (Figure 4.2).   
 
Figure 4.1. C2C12 myoblasts differentiate into myotubes in fibrin gel constructs. The gels 
were fixed and immunostained with morphological markers: actin filaments were stained with 
rhodamine phalloidin (red) and nuclei were counterstained with DAPI (blue). The arrow shows 
the alignment of the cells. Scale bars: 50 µm.  
Quantitative analysis of the width of the gels revealed that this decreased at day 5, when the 
control gels were exposed to MDM for 24h and SH-SY5Y were seeded on co-culture gels. 
Control gels contracted more than co-culture gels, but the difference was not found to be 
significant. Further deformation was observed at the end of the culture (day 14), showing 
comparable values between control and co-culture gels (Figure 4.3). 
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Figure 4.2. Fibrin gels deformation over time in control conditions (C2C12 monoculture) and 
C2C12/SH-SY5Y co-culture. Scale bar: 1 cm.  
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Figure 4.3. Fibrin gels deformation. Each gel was measured in the middle three times, and then 
averaged. Such values were then averaged to the other gels to obtain a final value. No difference 
was observed between control and co-culture gels using the Student’s t-Test. Results are shown 
as average ± SD, n=3. 
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From a cell distribution point of view, it was interesting to observe that SH-SY5Y seeded at 
day 4 differentiated extending neurites along the same direction as the myotubes, as highlighted 
by the arrows in Figure 4.4. The alignment was quantified and is reported in the supplementary 
section (Table S9.1). Both cell types coexisted until the end of the culture period (14 days) and 
in all co-culture gels certain features were observed. Firstly, although the seeding density was 
the same for C2C12 and SH-SY5Y, the neurons did not appear to be adhering to the matrix, or 
proliferate, as the amount found upon immunostaining the gels was limited. In fact, the neurons 
were seeded on top of the gel, whereas C2C12 were embebbed in the matrix from day 0, as 
myoblasts require physical interactions to fuse into myotubes, and it was hypothesised that the 
presence of SH-SY5Y could have impaired this process. This resulted in a lower number of 
neurons at the end of the culture, although not quantified, possibly due to the lower amount of 
days that the neurons spent in growth medium (4 days for C2C12, 1 day for SH-SY5Y). The 
growth period was not prolonged because SH-SY5Y continue to proliferate in NDM and the 
remaining days in culture were necessary for the muscle to differentiate too. In addition, SH-
SY5Y neurites formed into bundles, rather than extending in isolation on the gel (Figure 4.5). 
The measurement of the width of myotubes in the gels revealed no difference between control 
and co-culture conditions (Figure 4.6). While in 2D the presence of the neurons influenced 
myotube width by increasing it (Chapter 3), in fibrin gels this was not observed. However, it is 
important to highlight that besides being in a 3D matrix which differs from 2D cultures, fibrin 
gels also require an additional compound. Aminocaproic acid (AA) must be added to the 
growth and differentiation stage to retain muscle cells from degrading the matrix, and this may 
have influenced the myotube width in 3D. Further work may be carried out to understand the 
effect of SH-SY5Y on C2C12 within a 3D tissue engineered construct. Gene expression 
analysis and functional work were not carried out on these gels, but interesting information 
may arise from these investigations. 
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Figure 4.4. C2C12 and SH-SY5Y co-culture in fibrin gel constructs. The gels were fixed and 
immunostained with morphological markers: actin filaments were stained with rhodamine 
phalloidin (red), SH-SY5Y cytoskeleton was stained with β-III Tubulin (green) and nuclei were 
counterstained with DAPI (blue). The arrow shows the alignment of the cells.  
 
 
Figure 4.5. Bundles of SH-SY5Y on fibrin gel constructs. The gels were fixed and 
immunostained with morphological markers: actin filaments were stained with rhodamine 
phalloidin (red), SH-SY5Y cytoskeleton was stained with β-III Tubulin (green) and nuclei were 
counterstained with DAPI (blue). Scale bars: 50 µm.  
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Figure 4.6. Myotube width of C2C12 cells monocultured in fibrin gels (control), and co-
cultured with SH-SY5Y cells (co-culture). No significant differences were found between 
control and co-culture conditions using the Student’s t-Test. Results are shown as average ± 
SD, n=3.  
 
4.4.2 C2C12 & SH-SY5Y co-culture in 500 µL collagen gels 
C2C12 myoblasts seeded in collagen gels differentiated into aligned myotubes, as shown in 
Figure 4.7. The presence of muscle cells within the matrix caused it to decrease in width over 
time (Figure 4.8) both in C2C12 monocultures and in C2C12/SH-SY5Y co-cultures. The co-
culture did not have an effect on the gel width, as shown in Figure 4.9.   
For the setup of the co-culture, the same experimental setup as fibrin gels was utilised. SH-
SY5Y seeded on the surface of the constructs extended neurites along the axis of the anchor 
points, suggesting that they either followed the alignment of C2C12 embebbed in the gel, or 
the tension generated by the two fixed points (Figure 4.10). Also for these constructs, the 
alignment was quantified and is reported in the supplementary section (Table S9.1). 
Quantitification of the number of neurites on the gels, and the neurite extension was not carried 
out because of imaging limitations. In fact, the neurites present were bundled up similarly to 
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what was observed in the fibrin gels (Figure 4.5), therefore making it challenging to discern 
how many cells adhered on the gels and how to analyse neurite length.  
Like in fibrin gels, the measurement of myotube width revealed no difference between the 
C2C12 monoculture and the co-culture with SH-SY5Y (Figure 4.11).  
 
 
Figure 4.7. C2C12 myoblasts differentiate into myotubes in collagen gel constructs. The gels 
were fixed and immunostained with morphological markers: actin filaments were stained with 
rhodamine phalloidin (red) and nuclei were counterstained with DAPI (blue). The arrow shows 
the alignment of the cells. The gels were fixed and stained for morphological markers: 
rhodamine phalloidin (red) and DAPI (blue). Scale bars: 100 µm.
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Figure 4.8. Collagen gels deformation over time in control conditions (C2C12 monoculture) 
and C2C12/SH-SY5Y co-culture. Scale bar: 1 cm.  
 
Figure 4.9. Collagen gels deformation. Each gel was measured in the middle three times, and 
then averaged. Such values were then averaged to the other gels to obtain a final value. No 
difference was observed between control and co-culture gels using the Student’s t-Test. Results 
are shown as average ± SD, n=4. 
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Figure 4.10. C2C12 and SH-SY5Y co-culture in 500 µL collagen gel constructs. The gels were 
fixed and immunostained with morphological markers: actin filaments were stained with 
rhodamine phalloidin (red), SH-SY5Y cytoskeleton was stained with β-III Tubulin (green) and 
nuclei were counterstained with DAPI (blue). The arrow shows the alignment of the cells.  
 
 
Figure 4.11. Myotube width of C2C12 cells monocultured in 500 µL collagen gels (control), 
and co-cultured with SH-SY5Y cells (co-culture). No significant differences were found 
between control and co-culture conditions when using the Student’s t-Test. Results are shown 
as average ± SD, n=4.  
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4.5 Discussion  
The generation of 3D tissues in vitro which are physiologically relevant for biomedical studies 
is increasing. This approach is a promising tool to investigate development, as well as 
physiological and pathophysiological processes, whilst resembling the in vivo architecture 
(Dixon et al., 2018; Ostrovidov et al., 2014). The native cellular microenvironment comprises 
cell-cell and cell-matrix interactions which are not closely reproduced in 2D models (Griffith 
and Swartz, 2006; Kalman et al., 2015; Lund et al., 2009), therefore making 3D tissue 
engineered constructs a valuable platform for the development of in vitro models, which can 
be utilised for disease modelling, drug testing and functional studies (Dixon et al., 2018).  
4.5.1 C2C12 & SH-SY5Y differentiate and align in fibrin gel constructs 
Muscle-nerve co-cultures were previously reported in 3D constructs (Morimoto et al., 2013). In 
this work, the presence of two fixed points at each end of the gel created tension that allowed 
myotube formation,  uniaxial alignment and gel deformation (Figure 4.1, Figure 4.2, Figure 4.3). 
This is in agreement with previous C2C12 cultures in fibrin gels (Khodabukus et al., 2007; 
Khodabukus and Baar, 2014, 2009) and acts as a fundamental muscle control when establishing 
co-cultures. Other types of fibrin constructs were reported for the 3D culture of human induced 
pluripotent stem cell-derived (hiPSC) SkM (Maffioletti et al., 2018), therefore showing that fibrin 
is a suitable matrix for primary human SkM as well as for the murine cell line used for this work. 
Fibrin gels were also used as a 3D matrix for the generation of a primary rat NMJ (Martin et al., 
2015), but has never been reported with human MNs and human SkM cells.  
The abrupt decrease in gel width at day 5 can be attributed to the decrease in serum concentration, 
both in the control differentiation medium and in the co-culture one. In fact, the cells were exposed 
to 20% fetal bovine serum (FBS) during the growth phase (day 0 to day 4) and then control gels 
were immersed in 2% horse serum (HS). The decrease in serum percentage, and the different 
species (from bovine to horse) is well known to be responsible for C2C12 differentiation (Burattini 
et al., 2004; Manabe et al., 2012), which may have caused greater gel deformation at the beginning 
of the differentiation window. Co-culture gels in NGM for 24h showed a lower deformation at day 
5, perhaps due to a serum concentration equal to 10% (NFBS). This amount is half of what was 
used in the growth phase, but higher than the 2% used in the control. In fact, when the medium 
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was switched to NDM at day 5, the gels width was found to be comparable between control and 
co-cultures. 
Preliminary co-culture work reported in this thesis showed that the human neuroblastoma line 
SH-SY5Y adhered to the constructs and aligned to the direction of the muscle fibres (Figure 
4.4). Although single neurites were observed (Figure 4.4), it is unsure whether SH-SY5Y 
spread within the gel or not. The formation of bundles (Figure 4.5) on the surface of the 
construct may suggest that the neurons occupied the available space left by the muscle fibres, 
or adhered to one-another because they found the environment suboptimal for further neuronal 
extension. This did not permit the measurement of neurite length allowing comparison with 2D 
cultures or collagen constructs. In addition, it appeared to be challenging to be compared to the 
literature, as no co-cultures with these cell types in fibrin-based constructs have been 
previously reported. The measurement of myotube width represents a method to quantify 
muscle maturity morphologically, and ensure that the myofibres are not atrophic. SH-SY5Y 
did not significantly influence this parameter (Figure 4.6 and Figure 4.11). The difference in 
species may have played a role in hindering the contact between C2C12 and SH-SY5Y since 
most MNs co-cultures with C2C12 were performed with a murine source of neurons (Morimoto 
et al., 2013; Tong et al., 2014). It is however interesting to observe that even in primary rat 
muscle-nerve co-culture carried out in these constructs, MNs did not affect myotube width 
(Martin et al., 2015). What was affected, was the percentage of striated myotubes, the generated 
force and the expression of myosin heavy chains 3 and 8 (MyH3, MyH8). These measurements 
were not acquired for this work due to the fibrinogen batch-to-batch variability, which caused 
subsequent results to be inconsistent and to an increased amount of gels which failed to set at 
the very start. Difficulties in using these constructs brought our laboratory to increasingly focus 
on collagen-based constructs, and to eventually use these for human muscle-nerve co-cultures 
(see Chapter 6).  
4.5.2 C2C12 & SH-SY5Y differentiate and align in 500 µL collagen gel constructs 
Musculoskeletal tissues have been widely generated utilising collagen as a matrix, due to its 
abundance in SkM (Gillies and Lieber, 2012) in various isoforms. Collagen’s high 
biocompatibility and low immunogenicity, as well as conservation across species, allows for 
its use for tissue engineering applications (Abou Neel et al., 2006). Previous work with collagen 
gels was carried out in our laboratory using larger gel volumes (2 mL) and cell numbers (8x106 
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cells/gel) (Player, 2013; Sharples et al., 2012). The setup was different and less reproducible 
than the more recent 500 µL gels used in this work, and the greater amount of consumables 
and cells required represented a disadvantage compared to the smaller gels used for this work. 
However, the principle remains the same: the presence of anchor points creates tension and 
causes the myoblasts to differentiate into aligned myotubes (Sakar et al., 2012). The precursors 
of the tissue engineered constructs used for this work (A. S. T. Smith et al., 2012) were recently 
investigated in comparison with commercially available polyether ether ketone (PEEK) 
chambers (Jones et al., 2018). The manuscript revealed that C2C12 morphology and gene 
expression were comparable between the manufactured model and the custom-built system 
previously used in our laboratory. However, the matrix remodeling found in PEEK chambers 
was more consistent. The design of the 500 µL collagen-based constructs used for this muscle-
nerve co-culture resembles the PEEK chambers, therefore representing a much more 
reproducible system if compared to the old custom-built systems, or fibrin-based gels described 
above, also less consistent.  
C2C12 myoblasts seeded in a type I collagen-based matrix formed aligned myotubes (Figure 
4.7). Myotube formation was observed upon differentiation in MDM, similarly to what was 
found within the fibrin constructs (Figure 4.1) and previous work (Sharples et al., 2012; Smith, 
2012).  
Collagen-only based tissue engineered constructs for muscle-nerve co-cultures are not 
commonly used as they do not facilitate neuronal adherence. Collagen-laminin-coated 
microfluidic chambers were used to generate a NMJ in vitro (Southam et al., 2013), but do not 
represent a truly 3D model and cannot be compared to the collagen constructs utilised in this 
work.  
When C2C12 and SH-SY5Y were co-cultured in 500 µL collagen gels, it was challenging to 
find neurites on the surface of the gel, suggesting poor neuronal adhesion and/or proliferation 
(Figure 4.10). Gel remodeling occurred both in control and co-culture conditions (Figure 4.8 
and Figure 4.9), suggesting that this process was mainly dependant on the presence of C2C12 
in the gels, rather than C2C12 and SH-SY5Y combined. The presence of the neurons in the 
gels and the use of a different kind of differentiation medium did not affect myotube width 
(Figure 4.11). Gel deformation (Figure 4.9) was observed mainly at the beginning of the 
culture (from day 0 to day 4) and can be appointed to the matrix remodeling done by C2C12. 
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At day 4 the neurons were seeded on top of the gels, and greater deformation was observed 
compared to control gels, although non-significant. Similarly to fibrin-based constructs, the 
decrease in serum concentration (Manabe et al., 2012) within the differentiation medium used 
for the co-cultures, may have affected the matrix remodelling process, which was more evident 
in co-culture conditions. However, this greater remodelling started earlier in the culture as it 
was already observable at day 4. No significant difference was observed between control and 
co-culture gels, and at the end of the culture period, these were comparable. Quantification of 
the neurite length was not performed due to the little amount of neurites observed on the surface 
of the gel, as seen in Figure 4.10. The limited adhesion of SH-SY5Y on the collagen matrix 
may be related to the nature of the matrix itself. Further optimisation of the collagen system 
carried out after these experiments were completed, led to the use of a mixture of matrices for 
the outgrowth of neurites, which could allow for higher adhesion and greater neurite extension 
in all directions, as previously shown (Sun et al., 2012). The use of laminin or Matrigel® is 
well reported in the literature to enhance neuronal adhesion in culture (Kleinman and Martin, 
2005; Ma et al., 2008; Sun et al., 2012). Matrigel® was also found to increase muscle 
differentiation, if compared to collagen type I (Grefte et al., 2012). 
In conclusion, carrying out the co-culture of C2C12 and SH-SY5Y in collagen gels highlighted 
some limitations that may be overcome by changing the composition of the gel itself, 
particularly by adding a percentage of Matrigel® to it. The use of collagen/Matrigel® hybrid 
gels was reported for muscle-only cultures (Dixon et al., 2018; Powell et al., 2002) and muscle-
nerve co-cultures (Dixon et al., 2018). Matrigel®-based gels were also used to generate a 
mouse NMJ in a 3D model (Morimoto et al., 2013), even though these models are always based 
on mouse-derived cells, rather than on a chimeric mouse/human model that we proposed. 
4.6 Chapter summary 
Optimisation of co-culture conditions in 2D carried out in the previous chapter allowed for 
progression to 3D culture analysis. To the best of the author’s knowledge, no C2C12/SH-SY5Y 
co-cultures were reported in the literature, although muscle-nerve co-cultures using C2C12 are 
common. Using C2C12 and SH-SY5Y cell lines ensured higher reproducibility to improve the 
co-culture conditions and observe muscle and nerve behavior in culture in a less expensive 
manner than when using primary cells. In this chapter, the co-culture was carried out using two 
different types of 3D tissue engineered constructs: fibrin- and type I collagen-based hydrogels. 
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The use of the same differentiation medium for the co-culture in 2D and 3D successfully led 
to myotube formation and neurite extension. With regards to the neuronal distribution on either 
gel types, preliminary results indicated that additional molecules to the collagen matrix may be 
key for SH-SY5Y cells to adhere and differentiate. Due to the neurons laying in a different 
focal plan than C2C12, it was hypothesised that there was no interaction between the two cell 
types. The fact that the nature of the collagen matrix hindered cell-cell interaction, indicated 
that further optimisation of this 3D model was required for primary human co-cultures. As for 
the fibrin-based constructs, the lack of successful gels due to fibrinogen batch-to-batch 
variability did not allow for extensive studies and thus, this approach was discarded. No 
significant difference in myotube width was observed when C2C12 were co-cultured with SH-
SY5Y in either constructs. The different species may play a role in this lack of influence, even 
though the same outcome was previously observed in primary rat co-cultures (Martin et al., 
2015).  
The aim of this work was to set the conditions for muscle/nerve co-cultures in 3D gels, rather 
than to verify the effect of the neurons on the muscle population. Nevertheless, the encouraging 
coexistence of C2C12 and SH-SY5Y in 3D tissue engineering constructs is a promising first 
step towards the optimisation of a more complex muscle-nerve model. Due to time limitations, 
subsequent work did not focus on human co-cultures using primary SkM and SH-SY5Y cells. 
As iPSC-derived MNs became available, this neuronal source was tested to more closely mimic 
a human NMJ in vitro. Therefore, the following chapter will show the characterisation of such 
MNs. 
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5 IPSC-DERIVED MOTOR NEURON PROGENITORS 
CHARACTERISATION 
5.1 Introduction 
The advancements in stem cell biology led to the generation of an alternative source of human 
pluripotent stem cells than embryonic stem cells. Neurons generated via the process of de-
differentiation and re-differentiation were characterised to assess their morphology and 
cholinergic features, in order to be used as substitues of SH-SY5Ys.  
5.1.1 Sources of human motor neurons 
To develop a human in vitro model of the neuromuscular junction (NMJ), the search for human 
motor neurons (MNs) represents a challenge. Animal-derived and human embryonic stem cells 
(ESCs) have been the gold standard for several years (Lu et al., 2015; Hynek Wichterle et al., 
2002). In addition, animals in research can be expensive to keep and take care of, besides being 
strongly affected by ethical issues, as well as ESCs do. However, the rapidly growing use of 
induced pluripotent stem cells (iPSCs) in research appears to be a promising alternative to 
generate human MNs. Since their innovative discovery just over a decade ago (Takahashi and 
Yamanaka, 2006; Yamanaka et al., 2007), iPSCs opened new avenues and applications for 
which the cells could be used (Dolmetsch and Geschwind, 2013). These range from the 
development of disease models (Lee et al., 2010) and cell therapies (Imberti et al., 2015), to 
drug screening platforms (Wheeler et al., 2015). Although some believe that the similarities 
between ESCs and iPSCs are still debatable (Yamanaka, 2012), others are confident that the 
cells have equal differentiation potential and the same protocols can be used for either 
(Chambers et al., 2009; Karumbayaram et al., 2009; Qu et al., 2014).  Using iPSCs would 
provide researchers with an alternative method to generate human MNs. This approach 
primarily overcomes the availability and ethical issues which are typical of both animal-derived 
and ESCs. In addition, using iPSC-derived MNs represents a human source of highly 
specialised cells which can be used to generate a model for in vitro drug screening, personalised 
therapeutics testing and to study physiology and pathophysiology of the peripheral nervous 
system. 
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5.1.2 Induced pluripotent stem cells for the generation of motor neurons 
The literature reports several recent works about the generation of human MNs from iPSCs. 
Despite the advantages listed above, there are still limitations to overcome, such as the long 
period of time required to generate MNs (Hu and Zhang, 2009), the low percentage of MNs in 
the cell population (Ebert et al., 2009) and the inconsistency of the process which can be 
influenced by various factors. In fact, there is often a substanital batch-to-batch variability 
(Zeng et al., 2010) and it is challenging to identify which aspects play an essential role in the 
success of the differentiation process (i.e. how long do the cells have to be exposed to a certain 
medium formulation, what factors or substrates can be used and at what concentration). As 
summarised in Table 5.1, the induction/differentiation protocols differ substantially between 
published examples. Some common methods can be identified across different protocol. For 
instance, the use of mouse embryonic fibroblasts (MEFs) (Dimos et al., 2008; Ebert et al., 2009; 
Karumbayaram et al., 2010) or Matrigel® (Du et al., 2015; Qu et al., 2014; Su et al., 2013)  as 
substrates to sustain neuronal adhesion is reported in several publications. Similarly, the 
protocols to induce a neuronal phenotype include similar compounds (e.g. RA and N2 
supplement). As for other media components, Rho kinase (ROCK) inhibitors (here reported as 
Y-27632) are generally used in critical steps such as thawing and plating. ROCKs are targets 
of the protein Rho, and the binding of the two is involved in several cell functions, such as 
motility, secretion, proliferation and gene expression (Liao et al., 2009). In stem cell cultures, 
ROCK inhibitors are routinely used to prevent  dissociation-induced apoptosis when generating 
single-cell cultures from ESCs (Martin-Ibañez et al., 2008). They were shown to improve 
embyoid body formation (Ungrin et al., 2008) and increase the survival of cryopreserved ESCs 
after thawing (Li et al., 2009). Retinoic acid (RA), described in Chapters 1 and 3 of this thesis, 
is also a key factor during neuronal induction, and was shown to induce differentiation in the 
neuronal cell lines SH-SY5Y (Xun et al., 2012) and NT2 (Lee and Andrews, 1986). During the 
differentiation stage, the use of neutrophic factors such as brain-derived neutrophic factor 
(BDNF) and ciliary neutrophic factor (CNTF) is also common. BDNF is a key neutrophin 
during neurogenesis and differentiation of stem cells into MNs (Huang and Reichardt, 2009), 
and it has been seen to support neuronal survival (Acheson et al., 1995). Thus, it was used to 
generate MNs from iPSCs, often in combination with CNTF (Du et al., 2015; Su et al., 2013). 
CNTF is also involved in neuronal differentiation and survival, and was shown to help nerve 
recovery after injury (Sleeman et al., 2000). 
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A recent protocol based on the use of small molecules to generate an adherent neuronal culture, 
allowed for the production of functional MNs which express the expected markers (β-III 
Tubulin, HB9, MAP2 and neurofilament) and do not express pluripotent markers which were 
observed in the early stages of the differentiation (Olig2, Pax6 and Sox1) (Bianchi et al., 2018). 
This protocol required 21 days for synapses between neurons and functional Ca2+ activity to 
be detected, and 5 weeks for the cells to be electrophysiologically active. The MNs were 
thoroughly characterised, but it is unclear whether they could be used for long-term studies 
such as in vitro modelling, thus highlighting how even the most recent works require 
optimisation.  
Even though similar features can be identified, methods to derive iPS from differentiated cells, 
substrates for iPS adhesion, media compositions for the neuronal induction and differentiation 
stages all differ. Thus, understanding what condition allows for the generation of a specific 
phenotype, at a certain timepoint, remains a challenge when attempting to define a reproducible 
protocol.  
5.1.3 ChAT and Islet 1 as markers of mature MNs 
Among the numerous markers that can be used to identify mature MNs, two are commonly 
utilised for iPSC-derived MNs in the literature, choline acetyltransferase (ChAT) (Dimos et al., 
2008; Du et al., 2015; Ebert et al., 2009; Egawa et al., 2012) and Islet 1 (Chambers et al., 2009; 
Dimos et al., 2008). These are used alongside an antibody that marks the structure of the neuron, 
such as MAP-2 or β-III Tubulin. ChAT is the enzyme responsible for the synthesis of the 
cholinergic neurotransmitter acetylcholine (ACh) (Kasa et al., 1991; Necker, 2004). Neurons 
that are positively stained by anti-ChAT antibodies are considered spinal and cholinergic, thus 
suitable for co-cultures which aim to form a NMJ in vitro. Islet 1 is required for the formation 
of mature and functional MNs (Dimos et al., 2008; Qu et al., 2014) and expressed by all classes 
of MNs (Pfaff et al., 1996), therefore representing a valuable marker of MN generation. 
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Table 5.1. Summary of recent protocols used for the differentiation of hES and iPSCs into MNs. 
Abbreviations: AA = ascorbic acid; BDNF = brain-derived neutrophic factors; bFGF = basic fibroblast growth factor; cAMP = cyclic adenosine monophosphate; ChAT = choline acetyltransferase; cpdC = 
compound C; CTNF = ciliary neutrophic factors; FGF2 = fibroblasts growth factor; GDNF = glial-derived neutrophic factors; IGF1 = insulin-like growth factor 1; KOSR = knockout serum replacement; 
MAP2 = microtubule-associated protein 2; MEF = Mouse Embryonic Fibroblasts; MSCs = mesenchymal stem cells; NEAA = non-essential amino acids; Pur = Purmorphamin; RA = Retinoic Acid; SHH = 
Sonic hedgehog; SV-2 = synaptic vesicle 2; Syn = synapsin; Tuj1 = β-III Tubulin.                          = Neuronal induction;                           = MN differentiation. 
 
   Protocol (days) 
    
Reference Substrate Characterisation  
(Dimos et al., 2008) MEF Tuj1, HB9, Islet 
 
 
(Ebert et al., 2009) MEF 
Nestin, Tuj1, HOXB4, Olig2, 
Islet1, HB9, ChAT, SMI-32 
 
(Karumbayaram et 
al., 2009) 
MEF 
Brn2, Sox3, Pax6, Nkx6.1, 
Olig2, Tuj1, 
electrophysiology 
 
(Hu et al., 2010) MEF 
Olig2, HB9, Tuj1, HOXC8, 
biotin, ChAT, Syn, Btx, 
electrophysiology 
 
(Hester et al., 2011) 
MEF 
 
HOX, HB9, ChAT, 
electrophysiology 
 
(Egawa et al., 2012) 
SNL feeder 
layer / 
Matrigel 
Nanog, SSEA-4, Sox-17, 
Tuj1, Islet1, HB9, ChAT, 
synapsin, MAP2 
 
(Reinhardt et al., 
2013) 
MEF / 
Gelatin / 
Matrigel 
Islet1, HB9, ChAT, SMI-32, 
electrophysiology 
 
(Su et al., 2013) 
MEF 
Matrigel 
 
Pax6, Olig2, Tuj1, HOXB4, 
HB9, Islet1, Lhx3, ChAT, 
eletrophysiology 
 
(Qu et al., 2014) 
Matrigel / 
Vitronectin-
laminin-
fibronectin 
Pax6, Sox1, Zic1, Oct4, 
Nanog, HB9, Tuj1, ChAT, 
MAP2, Btx, Syn1, SV-2, 
electrophysiology 
 
(Du et al., 2015) 
MEF 
Matrigel 
 
Sox1, Otx2, HOXA3, 
Nkx2.2, Olig2, Btx, ChAT, 
Map2, Islet1 
 
(Hu et al., 2015) 
Vitronectin 
 
Nanog, Oct4, SSEA4, Sox1, 
Sox2, Tra-1-60, Tra-1-81, 
Nanog, Pax6, Olig2, HB9, 
Tuj1, ChAT 
 
N2, NEAA, l-
glutamate, 
SB431542, 
CHIR. 
RA, Pur, SB431542, LDNM193189, CHIR, 
BDNF, GDNF, IGF-1, AA, cAMP 
0      2      4      6      8      10      12      14      16      18      20      22      24      26      28      30      32       34      36      38      40     44     50    
55 
KOSR, N2 N2, BDNF, RA, SHH, GDNF, Noggin 
B27, bFGF, EGF, 
heparin 
RA, SHH, cAMP, AA, GDNF, BDNF 
   RA, Pur RA, SHH, CTNF, 
BDNF, GDNF 
N2, NEAA, FGF2 or Noggin, SB43152 N2, cAMP, BDNF, GDNF, IGF-1 
N2, KOSR RA, SHH, B27, Ngn2, Isl-1, Lhx-3  
KSR, NEAA, L-glutamine, 2-
mercaptoethanol, 
dorsomorphin, SB431542 
B27, RA, SHH, FGF-2, BDNF, GDNF, NT-3. 
SB431542, dorsomorphin, CHIR, PMA, N2, B27, 
AA 
N2, B27, PMA, RA, BDNF, GDNF, dbcAMP. 
KOSR, NEAA, L-glutamine, β-
mercaptoethanol, bFGF 
RA, SHH, BDNF, GDNF, 
CTNF, IGF-1, cAMP 
N2, glutamine, 
heparin, cpdC 
N2, glutamin, heparin, cpd C, RA, SHH, 
BDNF, GDNF, IGF-1, cAMP 
N2, B27, AA, SB431542, 
DMH1, CHIR, RA, Pur, VPA 
RA, Pur, CpdE, IGF-1, BDNF, CTNF 
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5.2 Aims & objectives of the chapter 
Recently, companies have focused their attention on developing a stable protocol to derive 
MNs from human iPSCs. The main objective of this chapter is to characterise human iPSC-
derived motor neuron progenitors (MNPs) which were kindly provided by Axol Bioscience 
(Cambridge, UK), as part of a beta testing collaboration. Determining the cholinergic potential 
of these cells is essential to substitute the previously used human neuroblastoma line SH-SY5Y 
to form a NMJ with human skeletal muscle (SkM). Finally, the substrates and media used to 
culture MNPs were used for SH-SY5Y to compare their effects on the two neuronal cell type 
used for the realisation of this thesis. 
The aims of this chapter were: 
 Culturing and differentiating MNPs into MNs for 35 days; 
 Assessing cholinergic characteristics of iPSC-derived MNs 
 Verifying the potential use of MNPs after multiple passages 
The objectives of this chapter were: 
 To thaw, plate and grow MNPs until ready for differentiation using a specific medium 
supplemented with neutrophic factors, in order to use them for co-culture with human 
SkM; 
 To use immunofluorescent stainng to observe the positivity to the cholinergic markers 
ChAT and Islet 1; 
 To freeze MNPs P1, re-thaw them and plate them as P2 in order to use them for 
differentiation and co-culture with human SkM. 
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5.3 Materials & Methods  
Human MNPs from a healthy 74 years old male donor, their substrates and culture medium 
were kindly provided by Axol Bioscience (Cambridge, UK), and cultured according to the 
manufacturer’s protocol as described in section 2.1.7. A copy of the protol used for these cells 
can be found at the end of the Supplementary section, while updated versions of the protocols 
will be available at the following webpage: https://www.axolbio.com/shop/product/human-
ipsc-derived-motor-neuron-progenitors-5172.  
MNPs were cultured in monolayer to characterise their phenotype, both upon receiving the 
cells from Axol Bioscience (passage 1, P1), and after the cells were frozen down after the first 
expansion (P2). Finally, the cells at P1 were also differentiated and characterised for the 
positivity to cholinergic markers until day 35.  
5.3.1 MNPs: expansion and differentiation at P1 
The P1 cells were both cultured on their recommended substrate (SureBond™+ReadySet, Axol 
Bioscience, UK), as described in 2.1.7.2. 
5.3.1.1 MNPs: positivity to cholinergic markers 
Upon thawing, the cells were expanded on a layer of SureBond™ (2.1.7.1) until they reached 
70% confluency (5-7 days). Then, they were detached according to the manufacturer’s 
guidelines and seeded on SureBond™+ReadySet-coated glass. The cells were cultured up to 
35 days, and fixed/immunostained at the following timepoints: 5, 7, 14, 21, 28 and 35 days. 
Bright-field images were taken after each medium change, and the cells were stained for 
cholinergic markers (ChAT and Islet1) as described in sections 2.3.1.6 and 2.3.1.7, respectively.  
5.3.2 MNPs characterisation: expansion and differentiation at P2 
The P1 batch of cells that was utilised for the full characterisation were frozen down to be used 
for further tests. The cells were cultured as above. Daily micrographs were taken to compare 
the morphology during the expansion stage with the P1 cells. Then, differentiation was induced 
upon seeding the progenitors on SureBond™+ReadySet-coated glass coverslips, in preparation 
for immunofluorescent staining.  
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5.4 Results 
5.4.1 MNPs characterisation: expansion and differentiation at P1 
The first batch of iPSC-derived MNPs P1 used for the characterisation were seeded on 
SureBond™-coated T25 flasks after thawing, and showed a viability of 77.8% prior to seeding 
for expansion.  
 
Figure 5.1. MNPs P1 proliferation after thawing. The cells were imaged at 24 (A), 48 (B) and 
72 (C) hours after plating. Scale bars: 100 µm.  
The cells proliferated in clusters which increased in size gradually from day 1 (24h after 
seeding, Figure 5.1A) to day 2 (48h after seeding, Figure 5.1B) and day 3 (72h after seeding, 
Figure 5.1C). Cells seeded on gelatin, the substrate used for primary human SkM culture, did 
not survive after 24 hours (Figure 5.2), confirming that SureBond™ is a suitable substrate for 
the cells to adhere in culture. 
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Figure 5.2. MNPs P1 did not adhere on gelatin upon thawing. Scale bar: 100 µm.  
When the cells were 70% confluent, they were passaged and re-plated on 
SureBond™+ReadySet-coated glass coverslips. Bright-field images showed rapid generation 
of protrusions and neuronal extensions, enhancing the complexity of the neuronal network over 
time and suggesting that the differentiation process occurred rapidly and efficiently. As 
observed in Figure 5.3, within 48 hours from the beginning of the differentiation process, the 
cells proliferated and extended neurites in different directions. The amount of neurites visibly 
increased until day 10-12, after which the cells clumped in aggregates and seemed to form 
neurospheres (Figure 5.4). These spheres appeared greater in size and number until the neurons 
began to die in culture. The formation of aggregates may indicate that the substrate on which 
the cells were seeded was suboptimal. The culture was carried out until day 35 as the 
manufacturer suggested, despite the poor viability of the cells at that stage, and the change in 
morphology compared to earlier days (Figure 5.5). 
110 
 
 
Figure 5.3. MNPs P1 differentiation in monolayer from day 0 to day 10. Scale bars: 100 µm.  
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Figure 5.4. MNPs P1 differentiation in monolayer from day 12 to day 22. Scale bars: 100 µm.  
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Figure 5.5. MNPs P1 differentiation in monolayer from day 24 to day 34. Scale bars: 100 µm.
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5.4.1.1 MNPs characterisation: MN markers immunostaining 
MNPs P1 that were expanded up to 35 days were also immunostained for the cholinergic 
markers ChAT and Islet 1. The cells appeared positive to both ChAT (Figure 5.6) and Islet 1 
(Figure 5.7) at all timepoints, even though the observation of considerable cell death made 
imaging challenging after day 14. The staining appeared to be localised within the soma of the 
neurons, which was more and more clear as days passed and neurospheres formed. To confirm 
that, higher magnification images were taken and showed that both ChAT and Islet 1 are 
localised in the soma (Figure 5.8 and Figure 5.9).   
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Figure 5.6. MNPs are positive to ChAT immunostaining from day 5 to day 35. The cells were immunostained for ChAT to identify the enzyme 
(green), β-III Tubulin for the cytoskeleton (red) and DAPI to counterstain the nuclei (blue). Scale bars: 50 µm.  
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Figure 5.7. MNPs are positive to Islet 1 immunostaining at day 5, 7 and 14. The cells were immunostained for Islet 1 to identify the cholinergic 
marker (red), β-III Tubulin for the cytoskeleton (green) and DAPI to counterstain the nuclei (blue). Scale bars: 50 µm.
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Figure 5.8. MNPs express the cholinergic marker ChAT in the nuclei after 5 days in MM. The 
cells were immunostained for ChAT to identify the enzyme (green), β-III Tubulin for the 
cytoskeleton (red) and DAPI to counterstain the nuclei (blue). Scale bars: 50 µm.  
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Figure 5.9. MNPs express the cholinergic marker Islet 1 in the nuclei after 5 days in MM. The 
cells were immunostained for Islet 1 (red), β-III Tubulin for the cytoskeleton (green) and DAPI 
to counterstain the nuclei (blue). Scale bars: 50 µm.
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5.4.2 MNPs characterisation: expansion and differentiation at P2 
A comparison between MNPs at P1 (upon receiving from the supplier) and P2 (after they had 
been cultured, passaged and frozen down once) was briefly performed. After thawing, 36.8% 
of MNPs P1 were viable, and the viability of MNPs P2 was 50%. This may not be necessarily 
linked to the passage, since 77.8% of the previously used P1’s were viable (see 5.3.1). The 
cells were expanded for 5 days, and proliferation as well as morphology were monitored daily. 
Images of the cells throughout the 5 days are shown in Figure 5.10. The morphology did not 
appear to vary across passage, indicating that the cells can be cultured after a first expansion 
and cryopreservation. Further marker characterisation would be necessary to ensure that the 
positivity to the previously investigated ChAT and Islet 1 is retained at passage 2.  
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Figure 5.10. MNPs at passage P1 and P2 expansion upon thawing, from day 1 to day 5. Scale bars: 100 µm.  
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When the cells were plated for differentiation, they did not adhere to the substrate and died 
after 24h (Figure 5.11). This suggests that the multiple cryopreservation and passage steps 
influenced the ability of these cells to adhere, although this only represented one attempt to 
further expand and differentiate previously cultured MNPs. 
 
 
Figure 5.11. MNPs P2 did not adhere to SureBond™+ReadySet-coated glass after passage. 
Scale bar: 100 µm.
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5.5 Discussion  
The use of iPSCs recently allowed for the generation of human MNs (Demestre et al., 2015; 
Du et al., 2015). Several protocols were described in the literature, many of which require 
extensive times to produce MNs. Optimising the differentiation stage to minimise time-
consuming and expensive procedures is still a priority in order to obtain a cholinergic 
population of MNs which is able to form a NMJ with human primary SkM cells in vitro. This 
chapter focused on the characterisation of commercially available MNPs, to assess their 
morphology in culture, their positivity to cholinergic markers, morphology upon re-freezing 
and re-thawing, and the effect of medium and substrate used for MNPs on SH-SY5Y.   
5.5.1 MNPs can be cultured and differentiated into MN-like cells 
Here we reported the differentiation of commercially available MNPs into MNs in 5 days. This 
protocol generated cells which presented a MN-like morphology in a timescale comparable to 
previous works (Hester et al., 2011; Karumbayaram et al., 2010). The cells were cultured for 
35 days, although considerable cell death was noticeable after 14 days. Formation of 
neurospheres was also observed within the first 14 days, and such spheres appeared larger and 
more numerous as time in culture proceeded. Aggregates of neurons routinely form during the 
neuronal induction phase, where embryoid bodies are generated and selected to preserve a 
population of pluripotent cells (Su et al., 2013). Explants from an adult mouse brain were 
cultured in vitro in the absence of adhesion factors to create spheres of floating cells from which 
differentiated cells spread (Reynolds and Weiss, 1992). The neurospheres observed in this 
thesis were adherent rather than in suspension. In addition, neuronal projections extended from 
the spheres instead of undifferentiated cells, advises that the cell population constituting the 
aggregate was neuronal. However, the presence of such aggregates suggests that the 
differentiation conditions may still be suboptimal for these MNPs. MNs require other cell types 
to sustain their growth and function in vivo (Bear et al., 2001), thus highlighting the need to 
add other neuronal cell types (i.e. Schwann cells) to the culture. 
5.5.2 MNPs cannot be differentiated at P2 
Upon receiving MNPs from Axol Bioscience, the cells were plated for expansion and passaged 
so that they could be plated for experimental work. These cells were used at P1 for the 
characterisation up until day 35 and the co-culture with hSkM in 2D and in 3D (see Chapter 6). 
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To this date and the best of the author’s knowledge, there are currently three commercially 
available types of human iPSC-derived MNs. The cost of a single vial is not negligible and the 
manufacturers recommend a single use. Thus, testing viability after re-freezing/re-thawing and 
the ability of the cells to adhere to SureBond™+ReadySet after a second passage is important. 
One attempt has been done in this work to re-use the cells at P2. During the expansion stage, 
the cells spacial organisation and morphology appeared similar to the same batch at P1 (Figure 
5.10). However, after the second passage, MNPs P2 did not adhere on the coating used for final 
plating and differentiation (SureBond™+ReadySet), as shown in Figure 5.11. Whether this is 
dependant on the substrate itself or on the cells ability to adhere after a second passage, it 
remains unclear. More attempts should be performed to verify that the cells can or cannot be 
used after a second round of expansion. Since the manufacturer’s protocol for the generation 
of these cells is unknown, it is challenging to identify stages at which the cells could be adapted 
for multiple uses. This would certainly be easier if the cells were generated in house, rather 
than purchased from a commercial provider, and it could be considered for future approaches. 
5.5.3 MNPs express cholinergic markers ChAT and Islet 1 
In order to use MNPs for the generation of an in vitro NMJ, such cells must have a cholinergic 
phenotype. Since the previously used SH-SY5Y cholinergic potential was highly debated in 
the literature (Korecka et al., 2013; Påhlman et al., 1984), it was hypothesised that an iPSC-
derived source of MNPs could be differentiated into MNs expressing cholinergic markers. In 
particular, the enzyme ChAT was used as it is responsible for the synthesis of ACh, the 
neurotransmitter released by MNs, that initiates contraction of SkM fibres (Guyton and Hall, 
2005). ChAT was extensively utilised as a cholinergic marker (Du et al., 2015; Ebert et al., 
2009; Egawa et al., 2012; Hu et al., 2010; Qu et al., 2014), and therefore considered a reliable 
approach to characterise MNPs. Upon differentiation in MM, the cells expressed ChAT in their 
nuclei at all timepoints, despite the cell death observed after 14 days. Images taken at the same 
exposure time showed increasing fluorescence intensity as the culture proceeded. The other 
marker utilised for the characterisation was Islet 1, involved in neuronal development (Li et al., 
2014; Waclaw et al., 2017) and also previously used to identify cholinergic neurons (Dimos et 
al., 2008; Du et al., 2015; Ebert et al., 2009; Egawa et al., 2012; Reinhardt et al., 2013). The 
cells nuclei appeared positive to Islet 1 at all timepoints, most importantly after 5 days of 
differentiation. This is generally the time required for SkM to differentiate in vitro, therefore 
making these neurons suitable for a co-culture with SkM cells.  
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5.6 Chapter summary 
In this chapter, the characterisation of iPSC-derived MNPs was carried out. The cells were 
expanded until they reached 70% confluence, before undergoing differentiation for a total of 
35 days. Considerable cell death was observed after 14 days, and the formation of neurospheres 
was also evident within the first days in culture. The presence of aggregates may suggest that 
the developing MNs require additional cell populations to sustain their adhesion and 
differentiation, or that the substrate and differentiation medium (MM) still needs optimisation. 
Positivity to the cholinergic markers ChAT and Islet 1 was an encouraging result, showing that 
iPSC-derived MNPs can be differentiated into cholinergic MNs in as little as 5 days. Finally, 
using MNPs at P2 was not possible due to cell death after passage. This represents a 
disadvantage typical of iPSC cultures, whereby it is rarely possible to use cells after multiple 
freezing-thawing cycles or passages, thus increasing the cost and time required for these 
cultures. 
Overall, the search for a suitable source of human MNs led to the characterisation of promising 
MNPs which can readily differentiate to neuronal cells which are positive to the neuronal 
morphological marker β-III Tubulin and the cholinergic markers ChAT and Islet 1. Therefore, 
these were considered valuable cells for primary co-cultures with human SkM, in order to fulfil 
the aim of this thesis and generate a human NMJ in vitro. 
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6 ESTABLISHING HUMAN MUSCLE-NERVE CO-
CULTURES 
6.1 Introduction 
After establishing a chimeric co-culture using murine skeletal muscle (SkM) cells and a human 
neuroblastoma line, moving to primary human SkM and induced pluripotent stem cell-derived 
motor neurons (iPSC-derived MNs) has great potential for the generation of a human 
neuromuscular junction (NMJ) model. A human model would provide researchers with a 
system whereby primary cells could be used. 
6.1.1 iPSC-derived MNs and human primary SkM co-cultures 
Primary human muscle can be obtained by Bergstrom biopsy, both from healthy and diseased 
donors (Bergstrom, 1975). As for MNs, although a primary source is not available, the use of 
stem cells represents a great advantage and it allows to obtain such cells from a variety of 
donors, while not being derived from embryos or animals. Combining these two cell types 
would enable the generation of a model the biomimetics of which is closely representative of 
the in vivo environment. To do so, it is essential to determine the co-culture conditions. The 
substrates used for cellular adhesion, as well as the media utilised for growth and 
differentiation are essential criteria which are intrinsic to heterotypic cultures (Goers et al., 
2014). Subsequently, a bidimensional (2D) co-culture must be successfully replicated in a 
three dimensional (3D) tissue engineered system, to closely replicate the in vivo 
microenvironment in which the cells physiologically interact. Finally, 3D models which are 
suitable for functional studies represent an ideal system in which muscle-nerve interactions 
can be investigated. 
The literature mainly reported iPSC-derived MNs co-cultures using the murine myoblast line 
C2C12 (Du et al., 2015; Hester et al., 2011; Qu et al., 2014), rather than human-human systems. 
Human-based NMJ cultures were reported using fetal spinal stem cells and SkM stem cells 
(Guo et al., 2011) or ESC-derived MNs and primary SkM (Bakooshli et al., 2018). To the best 
of the authors knowledge, at this time there is only one work that reported NMJ formation 
between human iPSC-derived MNs and primary SkM, whereby the muscle counterpart was 
125 
 
also derived from iPSCs (Demestre et al., 2015). In addition, iPSC-derived MNs were co-
cultured with immortalised primary SkM cells (Shimojo et al., 2015), although this was done 
in bidimensional conditions and not in a tissue engineering construct, as this work aimed to 
do. Establishing a human-human co-culture in a 3D environment is, indeed, a key aspect 
which would provide researchers with a representative model to investigate physiological and 
non-physiological aspects of the NMJ. Tissue engineered constructs such as collagen gels 
were previously utilised for SkM 3D cultures to allow for its maturation, differentiation and 
alignment (A. S. T. Smith et al., 2012). The same constructs were then utilised for muscle-
nerve co-cultures, and allowed for the generation of a NMJ using rat primary cells (Smith et 
al., 2016). A recent work also reported a nerve-muscle co-culture in collagen-based constructs 
was were used for functional studies looking at force generation within the gel (Morimoto et 
al., 2013). Similarly, fibrin gels were used both for SkM monocultures and functional studies, 
and as a platform to generate a primary rat NMJ (Martin et al., 2015).  
6.2 Aims & objectives of the chapter 
The main objective of this chapter is to co-culture human iPSC-derived motor neuron 
progenitors (MNPs) and human primary SkM. The aims are to optimise media, substrates and 
timing of the co-culture in monolayer, and thus establish a robust methodology for NMJ 
formation. Finally this monolayer model will be utilised to develop a 3D tissue engineered 
model of neuromuscular interaction. 
The aims for this chapter were: 
 Identifying co-culture conditions for hSkM and MNs; 
 Co-culturing and differentiating hSkM and MNs in 2D; 
 Assessing the positivity to pre- and post-synaptic proteins; 
 Enhancing the expression of SkM markers by adding MNs to the culture; 
 Co-culturing and differentiating hSkM and MNs in tissue engineered constructs; 
 Increasing force generation in tissue engineered constructs by adding MNs to the 
culture. 
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The objectives for this chapter were: 
 To culture hSkM on different substrates and differentiate using muscle and neuronal 
medium; 
 To use immunofluorescent staining and myotube width measurement as indications of 
the differentiative stage and AChR expression of hSkM cultured in different 
conditions, and in the presence or absence of MNs; 
 To  use gene expression analysis as a measurements of  SkM development and 
maturation when using different media for the differentiation, as well as MNs in co-
culture; 
 To co-culture hSkM and MNs in tissue engineered constructs and verify differentiation 
using immunofluorescent staining, observe cell distribution using confocal 
microscopy and cross sectional images, and to measure functional activity of SkM 
with electrical stimulation. 
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6.3 Materials & Methods  
6.3.1 Human MNPs and human SkM co-culture 
Human SkM cells were cultured, trypsinised and counted as previously described (2.1.4). SkM 
cells were seeded at a density of 10,000/cm2, and expanded on gelatin and/or 
SureBond™+ReadySet-coated glass coverslips until 100% confluent in MGM. Then, the 
controls were differentiated in standard MDM, or in MN Maintenance Medium (MM, Axol 
Bioscience). For the co-culture, MNPs were seeded on the layer of SkM cells in MN Recovery 
Medium (RM, Axol Bioscience, supplemented with 10 µM Y-27632) and left to adhere for 4-
6 hours. Then, the medium was changed to MM. Human MNPs, their substrates and culture 
medium were kindly provided by Axol Bioscience (Cambridge, UK), and expanded prior to the 
experiment according to the manufacturer’s protocol (2.1.7). The co-culture was carried out for 
5 days (hu028_1) and 4 days (hu020, hu027 and hu028_2) to ensure myotube formation and 
MN differentiation (identified by the presence of neurite projections). At the end of the 
experiment, the cells were fixed and stained for morphological markers (rhodamine phalloidin, 
β-III Tubulin and DAPI) and interaction (BTX and SV-2) immunostaining of the co-cultures 
were performed as previously described in Chapter 3. 
The media formulations are summarised below in Table 6.1  for clarity.  
Table 6.1. Media abbreviations and compositions used for the MNPs & human primary SkM co-
culture. 
Medium name Cells Composition 
Muscle Growth Medium (MGM) hSKM DMEM, 20% FBS, 1% P/S 
Muscle Differentiation Medium (MDM) hSKM DMEM, 2% HS, 1% P/S 
Recovery Medium (RM) MNPs RM, 10 µM Y-27632 
Maintenance Medium (MM) MNPs/Co-culture MM, 0.5 µM RA, 5 ng/mL BDNF 
and 10 ng/mL CNTF 
 
Since the co-cultures conditions were unique for different biopsy samples, a summary of the 
experimental setup is provided below in Table 6.2. 
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Table 6.2. Experimental setup for the MNPs/hu028_1 co-culture in monolayer. All samples were seeded both on SureBond™+ReadySet and 
gelatin. 
 
Abbreviations: hSkM = human skeletal muscle; DMEM = Dulbecco’s Modified Eagle’s medium; FBS = fetal bovine serum; P/S = 
penicillin/streptomycin; HS = horse serum; MM = motor neuron maintenance medium; MN = motor neurons; RM = recovery medium; MNPs 
= motor neuron progenitors. 
Plate ID Sample name Expansion 
MNPs 
seeding 
Differentiation 
  Hu028 MNPs  Hu028 MNPs Co-culture 
A hSkM control 
DMEM + 20% 
FBS + 1% P/S 
/ / 
DMEM + 2% 
HS + 1% P/S 
(5 days) 
/ / 
B hSkM MM 
DMEM + 20% 
FBS + 1% P/S 
/ / MM (5 days) / / 
C Co-culture MM 
DMEM + 20% 
FBS + 1% P/S 
RM + 10 µM Y-
27632 (24h), 
then RM for up 
to 6 days. 
RM + 10 µM 
Y-27632 (24h) 
/ / MM (5 days) 
D 
Co-culture 
(pre-
differentiation) 
DMEM + 20% 
FBS + 1% P/S 
RM + 10 µM Y-
27632 (24h), 
then RM for up 
to 6 days. 
RM + 10 µM 
Y-27632 (24h) 
DMEM + 2% 
HS + 1% P/S 
(24h) 
/ MM (5 days) 
E MNPs control / 
RM + 10 µM Y-
27632 (24h), 
then RM for up 
to 6 days. 
RM + 10 µM 
Y-27632 (24h) 
/ MM (5 days) / 
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For the co-culture using hu020, hu027 and hu028_2, the setup was simplified and it is 
represented in Figure 6.1.  
  
 
Figure 6.1. Co-culture protocol using hu020, hu027 and hu028_2 SkM cells. The muscle was 
seeded in MGM and expanded until confluent (3 days), then the MNPs were seeded on the 
layer of muscle in MN RM until adhesion was complete (4-6 hours). Finally, the cells were 
exposed to MM for 4-5 days to allow differentiation.  
6.3.2 Human co-cultures in collagen/Matrigel® gels 
Collagen constructs were generated using C2C12 myoblasts, with the method based around 
previous work from our group (Smith et al., 2016). Collagen hydrogels were formed by the 
addition of 85 % v/v type I rat tail collagen (First Link, UK; dissolved in 0.1 M acetic acid, 
protein at 2.035 mg/mL), with 10 % v/v of 10X minimal essential medium (MEM) (Gibco, 
UK). This solution was subsequently neutralised by the addition of 5 M and 1 M sodium 
hydroxide (NaOH) dropwise, until a colour change to cirrus pink was observed. The cells were 
added at a seeding density of 4x106 cells/mL in a 5 % v/v muscle growth medium (MGM) 
solution, before being transferred to the pre-sterilised inserts to set for 10-15 minutes at 37 °C. 
A scalpel blade was used to detach the constructs from the edges of the scaffolds, to ensure the 
only points of attachment were the posts. MGM was added for four days and changed daily, 
before being changed to muscle differentiation medium (MDM, DMEM, 2 % Horse Serum 
(HS), 1 % P/S) for a further 10 days in culture. Collagen/Matrigel® constructs were generated 
using human donor hu028_2 in removable 50 μL scaffolds 3D printed via fused deposition 
modelling (FDM, see 2.2.3.2 for details). Gels were formed by the addition of 65 % v/v type I 
rat tail collagen, with 10 % v/v of 10X minimal essential medium (MEM) (Gibco, UK). This 
solution was subsequently neutralised by the addition of 5M and 1M sodium hydroxide (NaOH) 
dropwise, until a colour change to cirrus pink was observed. This was followed by the addition 
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of 20% v/v Corning® Matrigel® Matrix (Corning™ Matrigel™ Membrane Matrix). The cells 
were added at a seeding density of 4x106 cells/mL in a 5 % v/v MGM solution, before being 
transferred to the pre-sterilised inserts to set for 10-15 minutes in an incubator. MGM was 
added for four days and changed daily, before being changed to MDM for a further 10 days in 
culture. For co-culture gels, on the fourth day a new 50 µL gel was prepared using the same 
protocol, but seeding MNPs into it at a density of 12x106 cells/mL. Upon removing MGM from 
the mould, and washing twice with sterile PBS, the gel was pipetted in the mould, ensuring 
total coverage around the previously set muscle gel. This was left in the incubator for 10-15 
minutes to ensure setting, before adding MN RM (supplemented with 0.1 µM RA and 10 µM 
Y-27632)  for 24h. On the fifth day, the medium was changed to MM (supplemented with 0.5 
µM RA, 5 ng/mL BDNF and 10 ng/mL CNTF) for a further 9 days to ensure differentiation. 
6.3.3 Force measurement  
To enable force measurement, constructs were prepared as follows. After being washed twice 
in PBS, one end of the construct was detached from the mould. The loose end of the construct 
was then attached to the force transducer (403A Aurora force transducer, Aurora Scientific, 
UK) using the eyelet present in the construct. The construct was covered (3 mL) with Krebs-
Ringer-HEPES buffer solution (KRH; 10 mM HEPES, 138  mM NaCl, 4.7 mM KCl, 1.25 mM 
CaCl2, 1.25 mM MgSO, 5 mM Glucose, 0.05% Bovine Serum Albumin in dH20, Merk, UK). 
Wire electrodes were positioned either side of the construct to allow for electric field 
stimulation. Impulses were generated using LabVIEW software (National Instruments, 
Berkshire, United Kingdom) connected to a custom-built amplifier. Maximal twitch force was 
determined using a single 3.6 v/mm, 1.2 ms impulse and maximal tetanic force was measured 
using a 1 second pulse train at 100 Hz and 3.6 v/mm, generated using LabVIEW 2012 software 
(National Instruments, UK). Data was acquired using a Powerlab system (ver. 8/35) and 
associated software (Labchart 8, AD Instruments, UK). 
6.3.4 Confocal imaging  
Confocal images were acquired using  a Leiss LSM 880 microscope.  All images were taken 
at 40x using an oil immersion objective. For tile scan images, a sequence of images of either 
7x2 or 15x2 images were taken and then stitched together to create a single image. Z-stack 
images were taken longitudinally across the gel at 1.07 µm thickness. Image analysis was 
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performed using the software Fiji (Java 1.6.0_24, available to download at 
https://imagej.net/Fiji/Downloads).  
6.3.5 Cross sections preparation 
The collagen/Matrigel® constructs were sectioned to perform morphological immunostaining. 
To do so, the gels were dehydrated over night in a 20% sucrose (Thermo Fisher Scientific, UK) 
solution in TBS 1x. The following day, the gels were layered on a glass slide (Superfrost® plus, 
Fisher, UK) covered in optimum cutting temperature medium (OCT, Thermo Fisher Scientific, 
UK) for adhesion. Then, isopentane (Merk, UK) which was previously coolen down with liquid 
N2 was used to dip the glass slide and freeze the OCT and the embebbed gels. A scalpel was 
used to cut the gel out of the OCT/isopentane matrix and place it on the microtome stage for 
sectioning. The sections were cut using a Shandon Cryotome SME (Thermo Fisher Scientific). 
The chamber temperature was set to -25ºC and the sample temperature at -20ºC. Sections 12 
µm thick were placed on a new glass slide for immunostaining and imaging. Morphological 
staining was conducted as previously described (see sections 2.3.1.441 and 2.3.1.5).  
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6.4 Results 
6.4.1 MNPs & human primary SkM co-culture in monolayer 
The human MNP/SkM co-culture in monolayer was repeated four times, using three donors 
(hu020, hu027, and two different batches of hu028). Due to the variability in results, the outputs 
from these cultures are reported in two parts. In the first part, hu028 (batch_1) SkM cells were 
co-cultured with MNPs, both on the standard muscle substrate gelatin, and on the MNPs 
substrate SureBond™+ReadySet. Following the acquisition of these results, three co-cultures 
were performed on gelatin only (hu020, hu027 and hu028 (batch_2), as fewer myotubes were 
observed on SureBond™+ReadySet (see Figure 6.4). 
6.4.2 Hu028_1 & MNPs co-culture in monolayer: preliminary cues on substrate and 
media compatibility 
Co-culturing MNs with human primary SkM required extreme attention while expanding the 
two cell types in mono- and co-culture. First, different culture conditions were tested to identify 
what medium would allow more myotube formation, comparing the standard MDM and the 
MM used to induce MN maturation from MNPs. 
Although MNPs did not adhere to gelatin (see Figure 5.2), the co-culture was performed on 
gelatin as well as SureBond™+ReadySet. As a result, MNPs adhered on the layer of hu028_1 
myoblasts, indicating that the presence of a “neuronal-friendly” substrate is not a necessary 
requirement for co-cultures. Despite using standard MDM in Plate A, no myotube formation 
occured on either substrate. However, when MM was used, a few myotubes formed (Figure 
6.2), more abundant on gelatin than on SureBond™+ReadySet (Figure 6.4). Gelatin is 
commonly used to culture primary SkM, and the exact composition of SureBond™+ReadySet 
is unknown, thus suggesting that gelatin is a more suitable substrate than 
SureBond™+ReadySet. 
In the co-culture Figure 6.3 there was a notable increase in myotube number when the cells 
were either co-cultured or differentiated in MM as opposed to standard MDM (Figure 6.4).  
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Figure 6.2. Human primary SkM cells hu028_1 cultured on gelatin and SureBond™+ReadySet. 
Plate A are muscle monocultures cultured in control conditions; plate B are muscle 
monocultures differentiated in MM. The cells were immunostained for morphological markers: 
rhodamine phalloidin was used to identify actin filaments in SkM cells (red) and the nuclei 
were counterstained with DAPI (blue). Scale bars: 100 µm. 
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Figure 6.3. Human primary SkM cells hu028_1 and MNPs were co-cultured on gelatin and 
SureBond™+ReadySet. The SkM cells in plate C were pre-differentiated in MDM for 24h 
before adding MM to the co-culture. In plate D, the co-culture was differentiated with MM 
only. The cells were immunostained for morphological markers: rhodamine phalloidin was 
used to identify actin filaments in SkM cells (red), β-III Tubulin was used to highlight the 
cytoskeleton of the neurons (green), and the nuclei were counterstained with DAPI (blue). 
Scale bars: 100 µm.  
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Figure 6.4. Number of hu028_1 myotubes per frame. The cells were differentiated in both 
standard and MM medium, on gelatin and SureBond™+ReadySet. The asterisk shows 
significant difference between samples: * = p ≤ 0.05. This was found performing ANOVA and 
the Bonferroni post-hoc test. Results are shown as average ± SD, n=3.
136 
 
Despite the lack of differentiation in the muscle control, this experiment represented a valuable 
piece of information for future human primary co-cultures. In fact, it was interesting to observe 
the distribution of the MNPs around SkM fibres. At higher magnification, it was possible to 
notice how the neuritic extensions projected along the muscle fibres, as well as wrapped around 
them (Figure 6.5). This behavior was observed in all co-culture conditions. 
 
 
Figure 6.5. MNPs extend along and around hu028_1 myofibres (plate C). The cells were 
immunostained for morphological markers: rhodamine phalloidin was used to identify actin 
filaments in SkM cells (red), β-III Tubulin was used to highlight the cytoskeleton of the neurons 
(green), and the nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. 
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6.4.2.1 Hu020, hu027 and hu028_2 & MNPs co-culture: how do MNs affect SkM? 
The second, third and fourth biological repeats of the co-culture were done using hu020, hu027 
and hu028_2. This time, SkM cells were only seeded on gelatin as it was previously observed 
that MNPs adhere on the layer of SkM and therefore the presence of SureBond™+ReadySet 
as a substrate previously did not represent a crucial factor for the cells to proliferate in co-
culture. 
Morphological staining is shown in Figure 6.6. Donor hu020 did not differentiate in control 
conditions, just like the first repeat carried out with hu028_1 (Figure 6.2). This shows the 
unpredictable myogenic potential of primary cells. On the other hand, both hu027 and hu028_2 
did differentiate in control conditions. When exposed to MM, hu020 formed myotubes which 
were comparable in number to the ones observed in the co-culture with MNs. The myotube 
width was quantified across all conditions and donors, and it is reported in Figure 6.7. The 
images show the difference in neuronal morphology when comparing between donors. The 
morphology of the MNs co-cultured with hu020 appeared comparable to what was previously 
observed (see Chapter 5). MNs on hu027 appeared to be peeling off during the mounting stage 
of the immunostaining, hence the spread morphology shown in Figure 6.6. Despite that, 
neurites can be observed extending along the direction of the muscle fibres. When MNs 
differentiated on hu028_2, they formed into cell aggregates from which neurites extended.  
The 3 donors in monoculture (control), monoculture in MM and the co-cultures were also 
immunostained for pre- (SV-2) and post-synaptic (AChR) markers. All muscle donors 
expressed AChR’s on their surface, both with or without neurons (Figure 6.8). The clusters 
appeared more sparse in control and MM conditions, and localised in the co-culture, as 
highlighted by the arrows in Figure 6.8. The MNs were stained by the anti-SV-2 antibody, but 
this also highlighted the cell body of the muscle fibres, indicating that aspecific binding 
occurred, and therefore suggesting the necessity to repeat this analysis in the future. However, 
MNs were clearly observed in close proximity to all SkM donors, but no overlap of the two 
markers was identified in this work. 
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Figure 6.6. Human muscle-nerve co-cultures using hu020, hu027 and hu028_2 SkM cells and 
MNPs. The cells were immunostained for morphological markers: rhodamine phalloidin was 
used to identify actin filaments in SkM cells (red), β-III Tubulin was used to highlight the 
cytoskeleton of the neurons (green), and the nuclei were counterstained with DAPI (blue). 
Scale bars: 50 µm.  
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Figure 6.7. Myotube width (µm) of hu020, hu027 and hu028_2 in control, MM and co-culture 
conditions. The cells were cultured in control conditions (control), in Axol MM (MM) and in 
co-culture with MNPs in MM (co-culture). No statistical difference was observed within the 
same biopsy in different culture conditions when using 1 by 3 ANOVA. Results are shown as 
average ± SD, n=3.  
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Figure 6.8. Interaction immunostaining of pre- and post-synaptic markers in human co-cultures. 
The cells were immunostained with pre- and post-synaptic markers: texas red-conjugated α-
Bungarotoxin (BTX, red) was used for AChR clusters in all samples, synaptic vesicle 2 (SV-
2) was used for ACh-releasing vesicles in iPSC-derived MNs (green) in the co-culture, and 
nuclei were counterstained with DAPI (blue). The arrows indicate AChR clusters on SkM 
fibres in co-culture. Scale bars: 25 µm.  
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Gene expression analysis was carried out to investigate changes in MyHC8 (neonatal, Figure 
6.9), MyHC7 (slow, Figure 6.10) and MyHC1 (fast, Figure 6.11) in both hu027 and hu028_2. 
Significant differences were observed in both biopsies and all genes, apart from MyHC1 
expression in hu028_2. Generally, the cells expressed higher levels of the three genes when 
monocultured in MM. However, in the co-cultures with MNs, these levels of expression were 
depleted if compared to control or MM monocultures.  
MyHC8 expression (Figure 6.9) in hu027 was 6-fold greater in MM cultures, than in control 
(p < 0.001). the decrease in expression from MM to the co-culture was also significant (p < 
0.0001). Likewise, donor hu028_2 expressed 6 times more MyHC8 when cultured in MM, than 
in the control (p < 0.0001), and the decrease in co-culture was comparable to the one observed 
in hu027 cells (p < 0.0001). MyHC7 expression (Figure 6.10) showed a similar trend: the 
expression of MyHC7 in hu0274 doubled in MM (p < 0.0001) and was totally depleted in the 
co-culture (p < 0.0001 when compared to MM, p = 0.0009 when compared to the control). 
Hu028_2 cells showed comparable levels of expression in all samples, with a 2-fold increase 
from control to MM (p < 0.0001), a decrease from MM to co-culture (p < 0.0001) and from 
control to co-culture (p = 0.001). MyHC1 expression (Figure 6.11), which encodes for fast-
twitching fibres, is affected in hu027, but not in hu028_2 cells. The increase in MyHC1 
expression in hu027 cultured in MM, compared to the control, was 19 times higher (p < 0.0001), 
and then decreased when MNs were present in the culture (p = 0.0142 if compared to the control 
and p < 0.0001 if compared to MM). Interestingly, this great increase in MyHC1 expression 
was not observed in hu028_2, which maintained comparable levels of expression across all 
samples. 
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Figure 6.9. MyHC8 (neonatal) mRNA expression in human SkM hu027 and hu028_2. 
Asterisks show significant difference between samples: * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 
0.001, **** = p ≤ 0.00001 when using 1 by 3 ANOVA and the Bonferroni post-hoc analysis. 
Results are shown as average ± SD, n=3.  
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Figure 6.10. MyHC7 (fast) mRNA expression in human SkM hu027 and hu028_2. Asterisks 
show significant difference between samples: * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001, 
**** = p ≤ 0.00001 when using 1 by 3 ANOVA and the Bonferroni post-hoc analysis. Results 
are shown as average ± SD, n=3.  
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Figure 6.11. MyHC1 (fast) mRNA expression in human SkM hu027 and hu028_2. Asterisks 
show significant difference between samples: * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001, 
**** = p ≤ 0.00001 when using 1 by 3 ANOVA and the Bonferroni post-hoc analysis.  Results 
are shown as average ± SD, n=3. 
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6.4.3 The first attempt of a human muscle-nerve 3D co-culture 
Upon co-culturing human-derived SkM cells and iPSC-derived MNs in monolayer, 3D tissue 
engineered constructs were used to attempt the establishment of a co-culture in a more complex, 
in vivo-like environment. Collagen gels based on previously shown constructs (see chapter 4.1) 
were scaled down from 500 to 50 µL in volume, and 20% Matrigel® was added to the mixture 
to enhance neuronal adhesion and extension. The neurons, instead of being seeded on top of 
the muscle gel as previously shown (Chapter 4), were seeded in a second gel which surrounded 
the first gel at day 4.  
All gels gradually deformed throughout the 14-day period (Figure 6.12), and this was 
quantified as reported in Figure 6.13.  
Morphological immunostaining showed differentiation of both hu028_2 and MNs within the 
gels. The use of both standard MDM and MM induced myotube formation in monoculture 
hu0285_2 gels (Figure 6.14A and Figure 6.14B). A gel with MNs only was also prepared to 
observe cell morphology and distribution within the matrix. The neurons extended neurites 
both in monoculture (Figure 6.14C) and in co-culture with hu028_2 (Figure 6.14D). 
The myotube width of the cells in control conditions, or when the cells were differentiated in 
MM both in monoculture and co-culture is shown in Figure 6.15. 
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Figure 6.12. Collagen gels (50 µL) with hu028_2 and MNs. Scale bars: 1 cm. 
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Figure 6.13. Collagen/Matrigel® gels deformation. Each gel was measured in the middle three 
times, and then averaged. Such values were then averaged to the other gels to obtain a final 
value. No difference was observed across the conditions at each timepoint when using the 
Student’s t-Test. Results are shown as average ± SD, n=2.  
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Figure 6.14. 3D culture of hu028_2 and MNs. The cells were immunostained for 
morphological markers: rhodamine phalloidin was used to identify actin filaments in SkM cells 
(red), β-III Tubulin was used to highlight the cytoskeleton of the neurons (green), and the nuclei 
were counterstained with DAPI (blue). Scale bars: 50 µm.  
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Figure 6.15. Myotube width (µm) of hu028_2 cultured in 50 µL collagen/Matrigel® gels. The 
myotube width was measured when the cells were cultured in control conditions (control), in 
MM (MM) and in co-culture with MNs (co-culture). No statistical differences were found 
across the conditions. Results are shown as average ± SD, n=1. 
 
The force traces generated from the electrical stimulation analysis are reported in Figure 6.16. 
One gel per condition was used to determine the force generated by the muscle within a control 
gel (hu028_2 monoculture), a MM gel (hu028_2 differentiated in MM) and a co-culture gel 
(hu028_2 and MNPs). During three tetanic stimuli, the maximum force generated by hu028_2 
in the MM gel was higher than the one generated by the control gel. The co-culture gel 
generated the lowest amount of force (Table 6.3). Similarly, the co-culture gel generated a 
limited amount of force, if compared to control and MM conditions. However, upon 
administering a single stimulus to the gels, hu028_2 cells in control conditions generated more 
force than what the same cells in MM conditions did. Indeed, also upon single twitch 
stimulation, the signal from SkM in co-culture was merged to the background noise recorded. 
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Table 6.3. Maximum force (µN) generated by hu028_2 cells in 50 µL collagen/Matrigel® 
constructs. Results of the tetanus signal are shown as average, n=3 measurements from 1 gel 
per condition. The single twitch was repeated once per gel. 
 Control MM Co-culture 
Tetanus (100 Hz) 67.86 ± 6.14 81.18 ± 5.88 16.21 ± 4.65 
Single twitch (1 Hz) 36.27 22.59 4.07 
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Figure 6.16. Contractility of hu028_2 cells in 50 µL collagen/Matrigel® gels. Maximal tetanic 
force (µN) was measured using a 1 second pulse train at 100 Hz and 3.6 v/mm (A) and maximal 
twitch force (µN) was determined using a single 3.6 v/mm, 1.2 ms impulse (B). The tetanus 
curves were generated by averaging the results from 3 stimuli on one gel. The single twitches 
were only repeated once per gel. 
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Subsequently, confocal imaging was utilised to determine the spacial organisation of the cells 
within the gel. Tile scans of all conditions are reported in Figure 6.17. Gels with hu028_2 
monocultures, both control and MM, showed the presence of differentiated myotubes. The gel 
with MNs in monoculture also showed differentiation as generation of protrusions and neurite 
extension within the matrix. In co-culture conditions, the upper area showed a higher density 
of MNs, in accordance with the setup of the gel. Indeed, a second 50 µL gel was set around the 
first SkM gel, thus showing the upper part of the tile scan predominantly made of neurons. The 
lower portion of the co-culture image shows myotubes and undifferentiated hu028_2 cells, 
suggesting that portion corresponds to the inner part of the gel. 
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Figure 6.17. Tile scans of human 50 µL collagen/Matrigel® constructs. The cells were 
immunostained for morphological markers: rhodamine phalloidin was used to identify actin 
filaments in SkM cells (red), β-III Tubulin was used to highlight the cytoskeleton of the neurons 
(green), and the nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. 
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A tile scan image of the co-culture gel shows the distribution of the cells at the interface 
between the outer neuronal gel and the inner muscle gel (Figure 6.18).  Here, the separation of 
the channels showed the individual cell types across the full width of the gel. Although  the β-
III Tubulin immunostaining showed aspecific binding to the muscle fibres, it can be observed 
that the upper part of the image (corresponding to the outer section of the gel) was mainly 
characterised by the presence of MNs. On the contrary, the lower part of the image 
(corresponding to the inner, muscular portion of the gel) has a higher abundance of SkM cells.  
The presence of both hu028_2 cells and MNs within the same snap shot of the tile scan also 
showed coexistence of the two cell types (Figure 6.18).  
To verify this coexistence, 1.07 µm thick sections of the gel were imaged (Figure 6.19). The 
Z stack began at the outer edge of the gel, within the neuronal gel region, whereby a high 
abundance of MNs was observed. The cells extended neurites within the matrix, suggesting 
differentiation (Figure 6.19A and Figure 6.19B). Image C  shows the first visible myotubes, 
which are also reached by neurites (D), not just at the periphery of the muscle gel, but also 
within (E and F). Finally, observations on images G and H suggest that the abundance of 
myotubes at the opposite edge of the neuronal gel decreased, thus representing the other end 
of the outer neuronal gel, whereby less myotubes were observed.   
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Figure 6.18. Morphological tile scan image of human co-culture gels. The cells were 
immunostained for morphological markers: rhodamine phalloidin was used to identify actin 
filaments in SkM cells (red), β-III Tubulin was used to highlight the cytoskeleton of the neurons 
(green), and the nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. 
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Figure 6.19. Z stack of co-culture gels acquired via confocal imaging. These 8 images were acquired running longitudinally across a 50 µL 
collagen/Matrigel® co-culture gel (hu028_2 and MNPs), from the outer neuronal portion of the gel (A) to the interface between neuronal and 
muscle gel (D, E and F) until the other side of the neuronal gel (H). The cells were immunostained for morphological markers: rhodamine phalloidin 
was used to identify actin filaments in SkM cells (red), β-III Tubulin was used to highlight the cytoskeleton of the neurons (green), and the nuclei 
were counterstained with DAPI (blue). Scale bar: 100 µm. 
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The distribution of the cells throughout the matrix was investigated by performing cross 
sections of the gels and immunostain them for morphological markers. As shown in Figure 
6.20, a low magnification image (A)  was taken to observe the general layout of the cells within 
the gel. Here, the neuronal, outer gel can be identified by the densely populated area at the edge 
of the gel. At higher magnification (image B), an empty inner area can be seen. A limited 
amount of muscle cells were visible within the muscle gel, however the edges of such gel were 
densily populated. Finally, an image of the edge between the two gels (C) shows a neuronal 
population confined within the outer gel and muscle cells, highlighted by white rectangles.  
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Figure 6.20.  Cross sectional images of hu028_2 and MNs co-culture constructs. The cells were immunostained for morphological markers to 
identify their location across the gel: rhodamine phalloidin was used to identify actin filaments in SkM cells (red), β-III Tubulin was used to 
highlight the cytoskeleton of the neurons (green), and the nuclei were counterstained with DAPI (blue). Scale bar: 100 µm. 
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6.5 Discussion  
Since the discovery of a cocktail of factors which induces pluripotency in human fully 
differentiated cells (Yamanaka et al., 2007), the use of iPSs to generate MNs increased. These 
cells were co-cultured in monolayer with the murine myoblast line C2C12 (Du et al., 2015) 
and a human myoblast cell line (Shimojo et al., 2015). However, the work carried out in this 
chapter highlights the optimisation of co-culture conditions for iPSC-derived MNs and human 
primary SkM cells. Despite the variability in SkM cells which is intrinsic in primary work, the 
progression of these co-cultures could lead to a better model for personalised medicine, 
whereby both SkM and skin are taken from the patient to generate an in vitro co-culture and 
test potential treatments before they are administered to the patient. First, the media and 
substrates used for the culture of MNPs were tested on human SkM cells. Then, 3 more donors 
were used to establish a 2D co-culture. Finally, the co-culture was performed in 3D tissue 
engineered constructs as part of preliminary work. 
6.5.1 Substrate and media compatibility for human SkM co-cultures with human MNs 
The co-culture optimisation carried out in Chapter 3 with C2C12 and SH-SY5Y showed that a 
layer of confluent myoblasts is crucial for the generation of myotubes. The principle behind 
this section is that the differentiation medium for iPSC-derived MNs (MM) will be used in the 
co-culture, and that the substrates on which neurons and SkM cells grow differ. While primary 
muscle grows on gelatin, MNPs require SureBond™+ReadySet to adhere and proliferate. Thus, 
it was necessary to establish the effects of the neuronal media and substrate on SkM cells, to 
optimise the co-culture conditions. Although the donor used in this section (hu028_1) did not 
differentiate in the control conditions, myotube formation was observed when the muscle was 
monocultured and co-culture with MNPs in MM. This indicates that the neutrophic factors 
which supplement MM were beneficial to the myogenicity of this particular donor, even though 
desmin positivity was not investigated. A study on mouse embryos found that BDNF and 
CNTF enhanced muscle survival in aneural SkM cultures (Kablar and Belliveau, 2005). The 
co-cultures in this section were established using 2 approaches: plate C, where a pre-
differentiation in MDM was carried out for 24h, before using MM, and plate D, where the cells 
were directly exposed to MM. This approach aimed to determine whether the exposure to gold 
standard MDM would affect myotube formation. Interestingly, when quantifying the number 
of myotubes per frame, no difference appeared across samples, indicating that the pre-
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differentiation step was not necessary. No myotubes formed in the control, but hu028_1 
exposed to MM in mono and co-cultures, showed some myotube formation. All samples were 
cultured on gelatin and on SureBond™+ReadySet. The trend across all samples showed that 
myotube formation was predominant in samples cultured on gelatin. Previous research 
indicated gelatin as a suitable susbtrate for primary SkM cultures (Brady et al., 2008). Even 
though the difference between the substrates was not significant, this information represented 
an important cue on how substrates can influence SkM differentiation. As a consequence, 
SureBond™+ReadySet was not used for subsequent co-cultures with MNs, as it was 
hypothesised that the neurons would have adhered on the layer of confluent myoblasts, rather 
than on the underneath substrate. In addition, previous work reported in the supplementary 
section, showed that long-term cultures of SkM on SureBond™ caused lower Desmin 
positivity and differentiation (Figure S9.9). 
6.5.2 Human muscle-nerve co-cultures in 2D: cues on SkM maturation and the 
influence of MNs 
The setup of iPSC-derived MNPs with three different SkM donors (hu020, hu027 and hu028_2) 
was established based on previous work (see supplementary Figure S9.6 and Figure S9.7) 
SureBond™+ReadySet, the substrate used to culture MNPs for differentiation into MNs, was 
not used for this work as it had previously shown to reduce myotube formation and hinder 
myogenicity (Figure S9.9). Therefore, all co-cultures established in this section were based on 
gelatin as a substrate for muscle growth and differentiation. We hypothesised that the confluent 
layer of myoblasts would have provided the neurons with a substrate to adhere to, since it was 
extensively reported that myoblasts require cell-cell contact in order to fuse into myotubes. 
Thus, the neurons would not be in direct contact with the underlying substrate, whether this is 
gelatin or SureBond™+ReadySet. Although donor hu020 did not differentiate in the control, 
the presence of myotubes when the cells were differentiated in MM suggests that this medium 
can be used for myotube formation and it is more effective than conventional MDM. This was 
not surprising, considering that neutrophic factors have been shown to be beneficial to SkM 
cells in terms of survival (Mousavi et al., 2002) and contraction (Matthews et al., 2009). 
In the co-cultures, low magnification images allowed for the observation of the distribution of 
MNs on myotubes. The variability in the cells distribution can be attributed to the different 
substrates (i.e. SkM donors) the cells are seeded onto. The specific factor that is crucial for 
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these changes remains unclear, but we hypothesised that a more or less myogenic myoblast 
population could affect neuronal adhesion. The ECM of MNs comprises fibronectin, laminin, 
vitronectin, collagens and proteoglycans (Letourneau et al., 1994). Therefore, when culturing 
embryonic- or iPSC-derived MNs, surface coatings are required. The literature reported the use 
of Matrigel® (Sun et al., 2012; H Wichterle et al., 2002),  mouse embryonic fibroblasts (MEFs) 
(Dimos et al., 2008; Ebert et al., 2009; Karumbayaram et al., 2010) or combinations of more 
substrates (Du et al., 2015; Reinhardt et al., 2013). These substrates are necessary for the 
neurons to adhere and interact with the underlying matrix. However, such substrates can be 
expensive, are animal-derived and vary in composition. The vast use of MEFs suggests that 
fibroblasts, which are responsible for the production of ECM components, favour neuronal 
adhesion. The distribution of MNs on donor hu020 appeared homogeneous and the neuronal 
network developed like in the monocultures previously established in Chapter 5. The low 
number of myotubes in hu020/MN co-cultures may suggest that the myogenic population in 
hu020 was lower, also confirmed by the lack of differentiation in control conditions. Fewer 
myogenic cells imply that a great portion of cells were non-myogenic cells, such as fibroblasts. 
Since these are the cells responsible for the production of ECM, having a less myogenic 
population compared to the other donors (hu027 and hu028_2) meant for the neurons that more 
ECM components were present in the culture and allowed them to adhere and extend neurites. 
In fact, where a higher number of myotubes was observed, MNs started to peel off the surface 
or rolled-up into neurospheres. These outcomes reinforce the need to continue to optimise co-
culture conditions to favour NMJ formation, potentially by adding Schwann cells, which can 
support and stabilise MNs in culture (Bear et al., 2001).  
The neuromuscular interaction immunostaining did not show any colocalisation of AChR and 
SV-2. This may be due to the necessity of improving the culture niche for both SkM and MNs 
so that a closer interaction can be identified. Colocalisation of pre- and post-synaptic markers 
was reported in mouse co-cultures (Toma et al., 2015; Umbach et al., 2012a) and in human 
MNs/murine SkM (C2C12) (Qu et al., 2014). In a human iPSC-derived MN co-culture with 
iPSC-derived SkM, the proximity between neurons and muscle was identified by β-III Tubulin 
and BTX staining (Demestre et al., 2015). Although this did not show pre- and post-synaptic 
interaction using BTX and SV-2, it highlighted how close the two cell types were, which is 
comparable to what was observed in this work. In addition, the observation of a more punctate 
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appearance of the BTX staining in co-culture, rather than in control or MM conditions, suggests 
that the presence of the neurons had an effect on the clustering of the receptors. 
Investigating gene expression of MyHC’s provides researchers with information on fibre 
composition, development and maturation, as specific isoforms coincide with specific sets of 
contractile and metabolic properties (Delbono, 2010). Adding MNs to a SkM culture aimed to 
enhance the expression of MyHC’s which are related to such conditions. This analysis revealed 
that the use of MM enhanced the expression of MyHC8, MyHC7 and MyHC1. These markers 
identify genes which are expressed during the embryonic/fetal phase or regeneration (MyHC8 
and MyHC7) and late fetal (MyHC1) in human (Schiaffino et al., 2015). The expression of 
MyHC8 in adult SkM is specific to specialised muscles, and MyHC7 encodes for type I fibres. 
The higher expression of these markers when the cells were cultured in MM indicates that the 
medium composition was ideal for muscle maturation in all 3 genes, with the exception of 
MyHC1 expression in hu028_2. Although the complete composition of MM is unknown to us, 
the supplementation with BDNF and CNTF may have influenced gene expression. The 
reduction in gene expression in the co-cultures was unexpected, and the reasons behind these 
results are poorly understood. However, it was reported that during regeneration, the switch 
from fast fibres (MyHC1) to slow fibres (MyHC7) can be controlled by neuronal activity, thus 
implying that when MNs are present, a higher production of slow fibres is expected instead of 
fast ones (Esser et al., 1993). Preliminary results conducted in this thesis showed a reduction 
of both fast and slow fibres gene expression, thus requiring further studies to investigate more 
markers and SkM donors. 
6.5.3 The first attempt to establish a human muscle-nerve co-culture in 3D 
Animal models of the NMJ have elucidated several aspects of it, such as its structure and 
function, or protein changes which cause pathological conditions. Mice have been particularly 
useful for their size and relatively manageable for handling and analysis (for an extensive 
review see Webster, 2018). However, it was recently shown that the NMJ in lower animals and 
in humans differs under many aspects. For instance, the morphology is different, human NMJ’s 
are stable throughout the adult lifespan, if compared to humans, and the proteome is not entirely 
conserved (Jones et al., 2017). Therefore, developing a human model of the NMJ represents a 
great advantage over animal models, not just because understanding the physiology of the same 
species is more accurate using that species’ tissues, but also because using patient-specific SkM 
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and MNs would closely mimic one’s particular pathology. Previous models were mainly 
generated in a 2D environment, whereby the cell-cell and cell-matrix interactions were limited, 
and the applicability for functional studies was also a challenge. Here, a single, but crucial 
attempt to generate a 3D model of the NMJ using human cells was carried out. First, a novel, 
biocompatible collagen construct was used, adapted from previous work which proved the 
suitability of this system for SkM tissue engineering (Smith et al., 2016) and NMJ studies 
(Smith, 2012). Immunofluorescent staining highlighting the morphology of the cells within the 
construct, showing differentiation of both hSkM and iPSC-derived MNs, in monoculture and 
in co-culture. In particular, SkM myoblasts fused into aligned myotubes both in standard MDM 
and in MM, conventionally used for the differentiation of MNPs into MNs. This confirmed the 
outcome previously obtained in 2D. Although there was no significant change in matrix 
remodeling or myotube width, the differentiation in MM did have an effect on the functionality 
of the muscle. The augmented force generation when the muscle was differentiated in MM, 
and reduced when in co-culture, reflect the 2D gene expression results which showed a net 
increase in gene expression when different donors were cultured in MM. This confirmed the 
maturation increase due to the medium composition, but did not explain why the addition of 
the neurons depleted force generation. This outcome may be due to the mechanics of the system. 
When adding a second gel around the first one, further deformation was impaired and the cells 
were not able to pull on either side of the construct as they could do in control or MM conditions. 
A previous model of the NMJ using primary rat cells showed an increase in force generation 
when MNs were co-cultured with SkM conditions (Martin et al., 2015), thus suggesting that 
seeding the cells on the surface of the gel may be a more suitable approach to maximise 
twitching. Subsequently, a combination of confocal microscopy and cross sections were used 
to gather information on the distribution of the cells within the gel. Confocal imaging appeared 
to be misleading when determining the location of the cells and their interaction within the 
matrix. Due to the sample preparation for this type of analysis, the gels were pressed between 
the glass slide and the coverglass, thus filling the necrotic gap in the middle of the gel and 
giving a non-realistic view of cell-cell proportion. In previous work, cross sections of collagen-
only constructs with primary rat cells, the distribution of the muscle cells appeared 
homogeneous, whereas the amount of MNs was limited and confined to the top edge of the gel 
(Smith, 2012). In this work, the same analysis revealed an empty area in the centre of the gel, 
distribution of muscle cells along the outer edges of both the inner, muscle gel, and the outer, 
neuron gel. Compared to previous work (Smith, 2012), these results, although not conducted 
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the same way, showed a totally different cell distribution, but a much greater portion of neurons 
and neuronal extension. Necrotic areas in the middle of the gel were previously observed (Juhas 
and Bursac, 2014) and a population of fibroblasts was identified among the cells which 
migrated towards the periphery of the construct. This distinction was not performed in this 
work, but immunostaining using specific markers could provide more information on the 
distribution of different cell types. This represents a promising starting point whereby the 
interactions between SkM and MNs are favoured, even though further optimisation and repeats 
are necessary.  
6.6 Chapter summary 
The co-culture work carried out in this chapter provided important information regarding media 
and substrate compatibility, and the influence of iPSC-derived MNs on human primary SkM 
cultures. Utilising 3 different donors, one of which was used in 2 batches, was crucial and 
highlighted how variable primary cultures can be. Here lays the challenge of this work, 
establishing a primary co-culture which allows for differentiation of 2 very diverse cell types 
in a well-defined environment. The first part of the chapter highlighted that the medium used 
for the differentiation of MNPs into MNs was beneficial to the differentiation of SkM. This 
was further confirmed  in the second part of the chapter. This difference was not only visible 
from a morphological point of view, but reflected on the expression pattern of 3 MyHC’s. 
These appear at different stages during SkM development and can be used to address the effects 
of the different culture conditions on muscle maturation. Although moving from cell lines to 
primary cells was a great progression, the lower variability observed in the morphology of MNs 
in co-cultures highlighted the necessity to further optimise the co-culture conditions. Future 
work may be focused on introducing a third cell types into the system, in order to support MNs 
and enhance muscle-nerve interactions. When translating the co-culture from 2D to a 3D 
system, the differentiation of both SkM and MNs was obtained, and neither the myotube width 
or the matrix remodeling were impaired by the use of neuronal medium or the presence of the 
neurons themselves, if compared to a standard muscle-only gel. Areas of proximity between 
the two cell types were identified, thus showing migration of the cells within the matrix. In fact, 
both aligned myotubes and extended neuronal projections formed in co-culture gels. The 
interface between SkM and MNs showed that both cell types coexisted in a 3D environment 
which is suitable for their differentiation. 
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7 GENERAL DISCUSSION 
The investigations conducted in this thesis allowed for the generation of muscle-nerve co-
cultures using different cell sources and culture conditions. Initial optimisation and proof of 
concept work was conducted using a murine myoblast cell line, C2C12, which is widely used 
for SkM studies, and a human neuronal cell line, SH-SY5Y. The ultimate aim of this work was 
to establish a human-human muscle-nerve co-culture. Thus, C2C12 were eventually replaced 
by primary human SkM, and SH-SY5Y by a human stem cell source of MNs. Culturing these 
cells both in monolayer and in 3D tissue engineered costructs, enabled for the development of 
a system which potentially promotes NMJ formation. This model could be used in vitro as a 
tool for drug screening studies, as well as to understand the mechanisms underpinning 
physiology and pathophysiology of the NMJ.  
To date, common NMJ models are either based on the use of animals, animal-derived cells, or 
human embryonic stem cells (Lu et al., 2015; H Wichterle et al., 2002). The initial chimeric 
co-culture using C2C12 and SH-SY5Y cells was essential to generate information and 
expertise in the culture of heterogeneous cell types in monolayer and in two different kinds of 
3D tissue engineered constructs. These constructs were shown to be suitable for SkM culture 
as they resemble the mechanical structure of the musculoskeletal tissue, allowing for the cells 
to mature and align in an in vivo-like matrix (Player et al., 2014). In addition, muscle-nerve co-
cultures were also performed within these constructs to generate a NMJ in vitro. However, 3D 
co-cultures using human SkM and human MNs were not reported, to the best of our knowledge. 
The generation of pluripotent stem cells from an adult cell source allowed for the differentiation 
of several cell types including cardiomyocytes (Burridge et al., 2015), SkM (Maffioletti et al., 
2015), endothelial cells (Patsch et al., 2016), hepatocytes (Si-Tayeb et al., 2010), pancreatic β 
cells (Zhang et al., 2009), lung epithelial cells (Huang et al., 2014) and different types of 
neurons (Chambers et al., 2009; Ma et al., 2011; Shi et al., 2012). This was achieved without 
requiring embryos and expensive, time-consuming procedures. Although some challenges still 
remain, protocols for the generation of MNs from iPSCs were reported (Du et al., 2015; 
Karumbayaram et al., 2010). Such protocols show common features (i.e. the use of neutrophic 
factors or similar coating solutions), but mostly differ in terms of the length of the neuronal 
induction/differentiation steps, and the concentrations of supplements and media composition. 
Therefore, the reproducible generation of MNs which are suitable for commercial use is still 
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limited. Establishing a collaboration with Axol Bioscience (Cambridge, UK) was a crucial 
aspect for the completion of this work. Axol provided us with iPSC-derived MNs in order to 
characterise the cells and co-culture them with human SkM. After determining that the cells 
can be cultured for extensive periods of time, and that they express two commonly tested 
cholinergic markers, they were co-cultured with primary human SkM in monolayer and in 
collagen/Matrigel® hydrogels.  
The final aim of this work was to establish a human 3D in vitro model of the NMJ. This was 
achieved partially by utilising human sources of SkM and MNs within a 3D environment. 
Future studies would be essential to further investigate the interactions between the cells and 
complete the model using an additional neuronal population which sustains MNs both in vivo 
and in vitro.  
7.1 Key findings 
The use of C2C12 for studies on SkM physiology and co-culture with neurons is extensively 
reported (Blau et al., 1985; Burattini et al., 2004). Also, SH-SY5Y were used as a cholinergic 
neuronal population which made them suitable for preliminary studies in this work (Adem et 
al., 1987; Påhlman et al., 1984). The differentiation of SH-SY5Y cells requires the use of RA 
in culture, which is linked to development and neuronal outgrowth within the nervous system 
(Rhinn and Dolle, 2012). However, the effect of RA on C2C12 appears to be controversial in 
the literature, as some reported that it promotes muscle differentiation (Albagli-Curiel et al., 
1993), others believed that it caused an atrophic phenotype (Pardo-Figueres, 2017) or reduced 
its maturation (El Haddad et al., 2017). Thus, the first aim of this thesis was to establish optimal 
conditions for the co-culture of C2C12 and SH-SY5Y in a 2D environment, by testing the 
mostly used concentration for SH-SY5Y differentiation (10 µM), and dilutions of it (5 and 1 
µM). Testing a medium to use in the co-culture, supplemented with different concentrations of 
RA, allowed for the definition of a medium which can be used to achieve both muscle and 
neuronal differentiation. The data collected in this work suggested that by lowering the 
concentration of RA, longer neurites and wider myotubes form in monoculture. Interestingly, 
when the cells were co-cultured, these values increased and were comparable to the control for 
C2C12, and higher than the control for SH-SY5Y. Thus, the concentration of RA used for both 
SH-SY5Y monoculture and the co-culture with C2C12 was 1 µM. Another crucial aspect that 
was observed was the distribution of the cells in culture. SkM is a highly aligned tissue in vivo, 
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where several fibres are bundled together to form a greater structure which contracts all 
together in the same direction. Monolayer cultures do not allow for control on cell alignment, 
although small areas of aligned myotubes were observed. When SH-SY5Y are monocultured, 
they spread across the culture well and extend neurites in all directions, whereas when seeded 
on a layer of C2C12 myoblasts, the process of differentiation induces the cells to align to the 
direction of the myotubes. The behaviour of the neurons suggests that the myofibres represent 
a topographical cue for them to follow, and this happened even in monolayer cultures. 
In terms of interaction between C2C12 and SH-SY5Y cells in monolayer, the immunostaining 
with BTX (to highlight AChR’s) and SV-2 (for the ACh-transporting vesicles) showed limited 
colocalisations areas of the two markers. Observing these colocalisations would have indicated 
a close interaction of the two cell types, via a link between the vesicles which are responsible 
for the release of the neurotransmitter on the pre-synaptic cells, and their own receptor on the 
post-synaptic membrane. It was then hypothesised that the use of a supplement could increase 
the incidence of these interactions and could be used when culturing the cells in 3D tissue 
engineered constructs. The addition of agrin to the differentiation stage was thought to be 
beneficial to C2C12 maturation, verified by looking at common developmental and 
differentiation gene expression. Agrin is a main component of the NMJ, where it promotes the 
aggregation of AChR’s in the middle of the muscle fibre surface (Daniels, 2012). Aggregation 
of AChR’s is essential for NMJ formation, as these aggregates are the binding site for the 
neurotransmitter ACh, which is released by MNs to induce depolarisation of the post-synaptic 
membrane, release of intracellular Ca2+ and, eventually, muscle contraction (Wu et al., 2010). 
The addition of agrin in muscle-nerve co-cultures was reported (Martin et al., 2015), but a 
comparison between the presence and absence of the compound appeared to be an important 
piece of information while developing optimal co-culture conditions. The results obtained in 
this work showed that adding agrin to a C2C12/SH-SY5Y co-culture increased the expression 
of MyoG, if compared to a C2C12 monoculture with agrin. The same effect was observed in 
MyHC3 and MyHC8, where the sole addition of SH-SY5Y to the culture increased MyHC8 
expression compared to a monoculture with agrin, and was comparable to the co-culture with 
agrin. This suggests that agrin promoted the expression of development-related genes, 
particularly in the co-culture. No significant changes in MyHC7 (slow fibres), MyHC1 (fast) 
and MyHC2 (faster) were found, indicating that the addition of agrin had an impact on the early 
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stages of muscle maturation, but not on the postnatal definition of the type of muscle fibre 
which were generated.  
Monolayer cultures are a simple way to gather information on the cells behaviour within a 
simple environment. However, cells naturally develop in 3D matrices which are rich in growth 
factors and ECM structures. Culturing cells in 3D is crucial to develop and in vitro model, as 
this allows researchers to study cell-cell and cell-matrix interactions in a microenviroment 
which closely mimics the in vivo conditions (Edmondson et al., 2014). Multiple constructs can 
serve this purpose, but in order to chose which ones are suitable for muscle-nerve co-cultures, 
it is necessary to address a few key points. First, the 3D constructs must allow the cells to align 
to resemble the native architecture of the muscle. This can be achieved by having a gel which 
is attached to two anchor points, creating tension in the gel which results in cell alignment 
(Khodabukus and Baar, 2009). This can be achieved by using previously described collagen- 
and fibrin-based gels. Second, the type of matrix that constitutes the gel is crucial as it should 
represent what the native environment is like. Collagen is a suitable material as it represents 
the most abundant protein in the muscle ECM, and is also present in the setting where neurons 
outgrow (Gillies and Lieber, 2012). Fibrin is also a good candidate as it has been previously 
shown to allow muscle maturation and differentiation (Martin et al., 2015), and was used for 
muscle-nerve co-cultures to establish an in vitro NMJ. Finally, these constructs can also be 
used to perform functional studies (Martin et al., 2015), which is particularly important when 
trying to reproduce such a complex interaction as the NMJ is. The co-culture of C2C12 and 
SH-SY5Y cells in 500 µL collagen gels and in fibrin gels was achieved in this work. C2C12 
matured into aligned myotubes both in the monoculture and in the co-culture with the neurons. 
Similarly to what was observed in monolayer, SH-SY5Y also aligned, suggesting that the 
anchor points were also beneficial to neuronal alignment as they were for the muscle. The 3D 
nature of the gels hindered imaging with a traditional fluorescent microscope, therefore the 
only cue about cell-cell interaction was achieved by observing how the cells sit on different 
focal plans. This implies that there is no close interaction between C2C12 and SH-SY5Y within 
collagen or fibrin gels. During the culture, remodelling of the matrix was observed in both 
systems, with a peak of bigger deformation at the point of adding the neurons to the culture. 
This may suggest that the decrease in serum concentration which is intrinsic in the use of 
differentiation medium triggered a bigger response in muscle differentiation, therefore 
resulting in higher matrix remodelling. However, at the end of the culture, both control and co-
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culture gels appeared comparable in terms of gel width and also myotube width. Thus, the 
addition of the neurons did not appear to be significant for muscle differentiation within these 
matrices. Further optimisation brought to the use of additional compounds within collagen gels, 
particularly Matrigel®, which was considered for subsequent experiments involving 3D tissue 
engineered constructs. This product is commonly used to culture primary neurons and its rich 
composition encourages adhesion and differentiation, therefore making it suitable for the aim 
of this work. 
Following the optimisation of C2C12/SH-SY5Y co-cultures, the availability of a human source 
of MNs allowed for characterisation of such neurons and their use in muscle-nerve co-cultures. 
While replacing C2C12 with human primary SkM is fairly easy and available, finding a source 
of human MNs was much more challenging. The culture conditions and characteristics of 
C2C12 and SH-SY5Y are known, whereas newly developed cells still require investigation to 
determine their phenotype, positivity to certain markers and behaviour in co-cultures. IPSC-
derived MNPs were acquired by Axol Bioscience as part of a β-testing collaboration. The cells 
were expanded following the manufacturer’s protocols for up to 5-7 days, showing variable 
viability after thawing (77.8% the first batch, 36.8% the second batch). The cells adhered and 
proliferated in culture, forming agglomerates of cells which expanded until they reached 70% 
confluency and were ready to be plated for differentiation. The progenitors which underwent 
only one passage (P1) were cultured for 35 days, whereas the ones which were frozen down 
and re-thawed (P2), died after the second passage and could not be further differentiated. 
Although this was only attempted once, it may indicate that these cells are not yet optimised to 
undergo several passages and be used for multiple experiments. This represents a limitation to 
this date, but colony selection and immortalisation of the cells may result in the use of these 
cells for a prolongued period of time. MNs P1 were immunostained for cholinergic markers 
which are commonly used to identify acetylcholine-releasing neurons, ChAT (Hu et al., 2010) 
and Islet 1 (Kablar and Rudnicki, 1999). These were expressed by the cells at all timepoints (5, 
7, 14, 21, 28 and 35 days). However, cell death was increasingly observed during the culture, 
and the formation of neurospheres around day 7 led to belief that the substrate on which the 
cells are routinely cultured (SureBond™+ReadySet) may not be optimal. Alternatively, the 
seeding density could be adjusted to achieve both neuronal proliferation/differentiation and 
prevent cell-cell aggregation, which suggests that the cells are not fully adhering to the 
substrate.  
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Preliminary work was performed to test adherence and differentiation of human SkM to the 
substrate used for MN cultures, in the presence of neuronal differentiation medium (MM). The 
culture of hu028_1 was achieved both on gelatin and SureBond™+ReadySet, even though a 
higher number of myotubes was observed on gelatin. Different conditions in mono and co-
culture led to base future co-cultures on gelatin only, in order to enhance myotube formation. 
Since the confluent layer of myoblasts will not allow MNs to adhere to the underneath substrate, 
the presence of SureBond™+ReadySet underneath the muscle layer was a secondary aspect to 
consider. Also, previous work had shown that SureBond™+ReadySet hindered desmin 
positivity and led to progressive muscle death, if compared to gelatin (for supplementary work, 
see appendix). Thus, subsequent repeats were conducted using gelatin only as a substrate. 
Keeping MNs in culture for more than 5 days was not necessary when establishing co-cultures 
with human primary SkM. The timing of primary co-cultures is challenging, as the rate at which 
these MNs grow is known, but muscle donors are variable in that aspect. In order to achieve 
muscle differentiation, a fully confluent layer of myoblasts must form. Since the growth rates 
of different biopsies are different, and MNPs must be seeded on the myoblast layer on the same 
day, some biopsies may have not been 100% confluent before the neurons were seeded on them. 
This may be the reason why hu028_1 and hu020 did not differentiate in control conditions. 
However, the fact that both these donors did differentiate when cultured in MM suggests that 
the components within this medium had a pro-myogenic effect on a less myogenic population 
than hu027 and hu028_2. In fact, gene expression analysis showed that the MyHC8, MyHC7 
and MyHC8 were highly expressed when hu027 and hu028_2 were differentiated in MM, if 
compared to the control, with the exeption of hu028_2’s MyHC1 expression, which was 
unvaried. These results suggest that the composition of MM, which is unknown to us, was 
beneficial to the muscle and enhanced its developmental marker, as well as markers for fast 
and slow-twitching fibres. Potentially, the addition of certain neutrophic factors to MM played 
a role in this increase in gene expression, although the same medium was used for the co-
culture with MNs and this significantly decreased MyHC8, MyHC7 and MyHC1 levels. 
Unexpectedly, the co-culture with the neurons depleted completely MyHC8 and MyHC7 if 
compared to the control, even though MyHC1 expression in hu027 increased. When in co-
culture with the different donors, the neurons adhered differently. The phenotype observed 
when in co-culture with hu028_1 and hu020 was comparable to the previously established 
monocultures. However, the cells on donor hu027 appeared to be densily proliferating in 
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separated areas and peeling off during the immunostaining process. In addition, all neurons on 
donor hu028_2 formed into neurospheres, similarly to what was partially observed in long-
term neuronal monocultures. These results indicate that the donor to donor variability is, at this 
stage, a determining factor when establishing human muscle-nerve co-cultures. Although 
variability is intrinsic in primary cultures, further optimisation of such cultures may reduce the 
impact on cell-cell interactions. As for the interaction between pre- and post-synaptic proteins 
(SV-2 and AChR, respectively), clusters of AChR’s were found in hu020, hu027 and hu028_2, 
across all conditions. However, the presence of MNs appeared to enhance clustering, which 
was visible as highly stained areas on the muscle fibre, if compared to the sparse punctate 
staining that was observed in control conditions. On the neuronal side, the SV-2 antibody 
positively stained the MNs, but aspecific staining was also noticeable where myotubes 
appeared green (yellow in the merged images). Repeating this immunostaining would be 
important to determine whether the SV-2 antibody is suitable for such analysis, or other 
markers can be used for the same purpose (e.g. synapsyn).  
When moving from a 2D to a 3D human muscle-nerve co-culture, more challenges were faced. 
Despite conducting preliminary studies with C2C12 and SH-SY5Y cell lines at the beginning 
of this thesis, the different cell types and engineering of the constructs utilised required further 
investigation. Encouraging results came from the morphological immunostaining, which 
showed the generation of aligned myotubes and extended neuronal projections within 
collagen/Matrigel® constructs. This showed the suitability of the gel for such cultures, and the 
coexistence of the two cell types in a complex environment. A great amount of information 
was also obtained by performing cross sections of the gels and observe the distribution of them 
within the matrix. This represented a unique attempt to co-culture primary hSkM and iPSC-
derived MNs, however multiple slices across the middle of the gel showed that the cells are 
distributed in promiximity of one-another, leaving an empty area in the middle of the construct. 
The repetition of such experiments by varying the neuronal seeding procedures or the timing 
at which these are seeded (for instance, after myotubes are already formed), would provide 
more information on the best approach to obtain a homogeneous distribution of cells and 
optimal conditions for them to interact. The novelty of this work is reflected on the functional 
data which was acquired from the 3D human co-cultures. These results did not show an increase 
in force generation when MNs were present, which reflects what was previously observed in 
monolayer, where the gene expression of muscle development and maturity markers was 
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depleted in the co-culture. However, this depletion was evident when comparing co-culture 
conditions with a muscle monoculture in MM, and less strong if compared to the control. 
Similarly, a higher degree of force was generated by muscle differentiated in MM. However, 
the single twitch showed higher force in the control, if compared to MM conditions.  
All in all, this isolated attempt represented the first system in which human primary SkM and 
iPSC-derived MNs were co-cultured in 3D, allowing for the acquisition of functional data. 
Future work may focus on the optimisation of the model and the investigation of potential 
interactions between the two cell types, identified as NMJ. 
7.2 Future directions 
The work conducted in this thesis shows muscle-nerve co-cultures which aimed to ‘humanise’ 
previously reported models. The use of a mouse-human chimera was firstly achieved to 
optimise co-culture conditions and observe the engineering aspect which relates to the use of 
3D constructs. The subsequent use of primary human SkM and MNs further improved the 
system by utilising more suitable cell sources than cell lines. Despite the few attempts to 
establish a NMJ both in 2D and in 3D, interactions between SkM and MNs still appear to be 
challenging. Adding Matrigel® to the collagen gel matrix was a promising modification to the 
original protocol, as the numerous factors which are intrinsic to Matrigel® would be beneficial 
for neuronal outgrowth, which is why this coating is routinely used for primary neuronal 
cultures (Umbach et al., 2012b). Schwann cells are known to cover a support role for MNs in 
vivo, (Bear et al., 2001) thus representing an optimal candidate for future cultures. Providing 
MNs with an additional cell type which can sustain their growth and differentiation could be 
crucial for neuronal functionality within complex 3D matrices. In addition, humanising the 
system leads to the fulfilment of the 3R’s (reduce, refine, replace), for which much more can 
be done. These cultures are still based on the use of animal-derived serum, but promising MNs 
were previously generated in serum-free conditions (Egawa et al., 2012), and the addition of 
certain growth factors may sustain the muscle when doing the same. Similarly, the gelatin used 
for the expansion of primary SkM, and the collagen that constitutes the 3D matrix of the gels 
are also animal-derived. Future work may focus on completely substitute these compounds 
with synthetic counterparts or human recombinant ones. Likewise, the growth factors and ECM 
components found in Matrigel® are variable and could be replaced by defined, synthetic 
products.  
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The real potential of this model, once fully optimised, lies in the generation of a platform which 
can be of interest for pharmaceutical companies which are developing new treatments. There 
is great interest in replacing animal models with human alternatives for preliminary studies, 
thus making the work conducted in this thesis a key progression in the process of generating 
such models. To do so, the constructs preparation would need some further optimisation to 
ensure that the protocols are kept consistent (e.g. specific amount of NaOH for neutralisation) 
and the gels can be prepared using high throughput methods. Although this co-culture does not 
represent a fully formed organism as an animal model would, this NMJ model has more 
potential for future applications. For instance, they could represent personalised co-cultures for 
patients who are affected by neurodegenerative diseases for which, to this date, no treatment is 
available (Figure 7.1). These patients often undergo ineffective treatments which have major 
consequences on their wellbeing. However, by deriving MNs from the patient’s skin or blood, 
their neurons could be closely studied and therapies could be tested to predict their 
effectiveness. Furthermore, SkM could also be derived using the same technology, thus 
avoiding biopsies which may be detrimental in patients affected by neurodegenerative or 
muscular diseases. It has been recently shown (Demestre et al., 2015) that it is possible to 
generate both SkM and MNs from healthy and affected individuals, however the following step 
would be to transfer this to a 3D culture system. Stem cell researchers are also in the process 
of optimising transdifferentiation protocols through which the fully differentiated cells used as 
donors, can be directly differentiated into the final cell type without undergoing a de-
differentiation process. This would significantly decrease the amount of time required for the 
generation of either MNs or SkM, while simplifying protocols and reducing the use of reagents.  
Overall, the models proposed in this thesis are suitable for neuromuscular co-cultures and may 
be the key to a personalised in vitro model of the NMJ. 
174 
 
 
Figure 7.1. Process to develop a personalised 3D muscle-nerve in vitro model. Skin or blood 
could be taken from the patient to derive both SkM and MNs (via de-differentiation and 
differentiation, or transdifferentiation). The cells would then be co-cultured in the 3D tissue 
engineered construct to test novel therapeutics or treatments which the patients could start. 
175 
 
7.3 Conclusions 
This thesis focussed on the development of a human model of the NMJ using tissue engineered 
constructs. The importance of creating this model lies on its being a representative system for 
in vitro testing and personalised drug screening. Avoiding the use of cell lines, animal cells or 
ESCs would not only help reduce, refine and replace the use of animals in research, but also 
provide researchers with a complex system which would help underpinning the physiological 
features of this fascinating tissue interface. A chimeric co-culture was an important step to take 
to determine cell behaviour and tissue engineering challenges when working with SkM and 
MNs. Although the primary 3D co-cultures presented the author with several challenges, the 
preliminary results presented in the second part of this work set the grounds for more 
optimisation to be carried out in the future. Growing interest from the scientific community, 
particularly from drug developing companies, makes this model’s optimisation a necessary 
leap to take in future studies. 
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9 SUPPLEMENTARY INFORMATION 
9.1 APPENDIX A: SH-SY5Y neurites alignment to C2C12 myotubes 
In C2C12/SH-SY5Y co-cultures in 3D tissue engineered constructs, SH-SY5Y were shown to 
extend neurites along the same direction as C2C12 myofibres. This alignment was quantified 
and is reported in Table S9.1 below. 
Table S9.1. Angle difference between the orientation of C2C12 muscle fibres and SH-
SY5Y neurites. 
 Angle difference 
Fibrin gels 5.18 ± 1.16 
Collagen gels 13.68 ± 8.28 
 
9.2 APPENDIX B: Human skeletal muscle & SH-SY5Y co-culture 
As an intermediate step between the chimeric C2C12/SH-SY5Y co-culture and the human 
primary one, human donor hu035 was co-cultured with SH-SY5Y in monolayer. Myotube 
formation was observed in all conditions. However, a higher number of myotubes was present 
when hu035 were monocultured in NDM or in the co-culture with the same medium. SH-SY5Y 
extended neurites in all conditions, but it was not possible to quantify their length due to 
imaging limitations. However, the neurites in co-culture, differentiated in MN MM, did not 
show the typical SH-SY5Y morphology that was previously reported in Chapter 3, nor 
compared to the monoculture or the co-culture with C2C12 cells.  
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Figure S9.1. hu035 and SH-SY5Y co-culture in monolayer. The cells were immunostained for 
morphological markers: rhodamine phalloidin was used to identify actin filaments in SkM cells 
(red) and the nuclei were counterstained with DAPI (blue). Scale bars: 100 µm.  
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Figure S9.2. Number of hu035 myotubes per frame (n). Results are shown as average ± SD, 
n=3.
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9.3 APPENDIX C: SH-SY5Y vs iPSC-derived MNs comparison 
To perform a comparison between the previously utilised neuroblastoma line SH-SY5Y and 
the hereby characterised MNPs, ChAT immunostaining and culture of SH-SY5Y in the 
conditions which are ideal for MNPs were performed. The cells were immunostained for the 
cholinergic marker ChAT as previously described (2.3.1.6). The MNPs characterised in this 
Chapter were cultured according to the manufacturer’s recommendations. These conditions 
differ from the culture and differentiation of SH-SY5Y neuroblastoma cells. A summary of the 
media compositions for either cell types can be found in Table S9.2. SH-SY5Y were expanded 
in standard conditions and seeded for the experiment in the respective experimental conditions.  
The differentiation was induced the day after plating, and was carried out for 5 days as required 
for standard differentiation conditions in NDM. 
Table S9.2. Culture conditions for SH-SY5Y cells and MNPs. 
Cells Substrate Growth Medium 
Differentiation 
Medium 
SH-SY5Y Tissue culture plastic/glass 
NGM: 
Glutamax 
10% NFBS 
1% P/S 
NDM: 
Glutamax 
2% NFBS 
1 µM RA 
1% P/S 
MNPs 
SureBond™ for growth 
stage, 
SureBond™+ReadySet for 
differentiation stage 
MN RM: 
Axol RM 
supplemented with 
0.1 µM RA and 10 
µM Y-27632 for 
adhesion, then RM 
with 0.1 µM RA only 
MM: 
Axol MM 
supplemented with 0.5 
µM  RA, 5 ng/mL 
BDNF, 10 ng/mL 
CNTF 
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Figure S9.3. Positivity to ChAT immunostaining in SH-SY5Y and MNs. SH-SY5Y (A) and 
MNPs (B) were cultured and differentiated in their respective standard conditions. The cells 
were immunostained for ChAT (green) and the nuclei were counterstained with DAPI (blue). 
Scale bars: 100 µm.  
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Figure S9.4. Morphological difference between SH-SY5Y and iPSC-derived MNs. SH-SY5Y 
cells cultured in standard conditions (A) and in iPSC-derived MNPs conditions (B). The cells 
where then immunostained orr morphological markers: β-III Tubulin was used for the 
cytoskeleton (green) and DAPI was used to counterstain the nuclei (blue). Scale bars: 50 µm.  
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Figure S9.5. SH-SY5Y neurite length (µm) in different culture conditions. The neurite length 
was quantified in control culture and differentiation conditions (control), and in the conditions 
in which MNPs were cultured and differentiated (Axol). Results are shown as average ± SD, 
n=3.
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9.4 APPENDIX D: Media and substrate for human MNs: compatibility for hSkM 
A preliminary experiment was carried out to investigate the effect of the neuronal substrate 
SureBond™+ReadySet on primary hSkM. This was compared to control condition being 
gelatin, as this is normally used as a coating solution for primary muscle cultures. Furthermore, 
differentiation was carried out using conventional MDM for cells expanded on gelatin, and 
neuronal differentiation medium (MM) for both gelatin and SureBond™+ReadySet. The 
formulation of the MM used for this experiment differed from the one used in Chapters 5 and 
6. However, important information was gathered regarding media compatibility and how the 
substrate affects proliferation, differentiation and desmin positivity of hSkM cells. 
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Figure S9.6. hu029 proliferation on gelatin and SureBond™+ReadySet over a period of 4 days. Scale bars: 100 µm. 
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Figure S9.7. hu029 differentiation on gelatin (in control conditions, MDM and neuronal 
medium, MM) and SureBond™+ReadySet (in neuronal MM). Scale bars: 100 µm. 
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Figure S9.8.  Number of hu029 cells per frame (n) during proliferation on gelatin or 
SureBond™+ReadySet. Human primary SkM cells hu029 were cultured on both gelatin- and 
SureBond™+ReadySet-coated glass coverslips. The cells were seeded in MGM and expanded 
until they were confluent (day 4). The number of cells/frame was quantified daily and averaged 
across 3 wells in the same conditions. The asteriks show significant differences between the 
two substrates (*** = p ≤ 0.001). Results are shown as average ± SD, n=3.  
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Figure S9.9. Desmin positivity of hu029 cells cultured on gelatin or SureBond™+ReadySet, 
and differentiated in either MDM or MM. Myogenic cells were immunostained with desmin 
(green) and the nuclei with DAPI (blue). Scale bars: 100 µm. 
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9.5 APPENDIX E: Culture of Human iPSC-Derived Motor Neuron Progenitors  
Product Information  
Catalog. 
No.  
Product  
Name  
Format  
Stock 
Conc.  
Storage 
on Arrival  
Thawing  
Instruction
s  
Storage 
Once  
Thawed  
ax0070  
Human iPSC- 
Derived Motor  
Neuron 
Progenitors  
TBC  
cells/vial  
N/A  
Liquid 
Nitrogen  
Follow 
protocol  
N/A  
ax0071  
Motor Neuron 
Recovery 
Medium  
30 mL  1x  -80oC  
Overnight at 
4oC  
Once 
thawed 
store 
aliquot  
at 4oC for 
up to 1 
week  
ax0072  
Motor Neuron  
Maintenance 
Medium  
200 mL  1x  -80oC  
Overnight at 
4oC  
Once 
thawed 
store 
aliquot  
at 4oC for 
up to 1 
week  
ax0041+  
SureBond+Ready
Set  
SureBond  
3 x 120 µL  
ReadySet  
2 x 10 mL  
  
SureBond  
50x  
ReadySet  
1x  
  
SureBond  
-80oC  
ReadySet  
4oC  
  
SureBond  
Overnight at  
4oC  
ReadySet N/A  
  
SureBond  
Store at 
4oC for up 
to 2 weeks  
ReadySet  
Store at 
4oC for up 
to 1 month  
ax0041XF  SureBond-XF  1 mL  200x  4oC  N/A  
Store at 
4oC for up 
to 1 month  
ax0041  SureBond  3 x 120 µL  50x  -80oC  
Overnight at 
4oC  
Store at 
4oC for up 
to 2 weeks  
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ax0044  Unlock   25 mL  1x  
Aliquot & 
store at  
-80oC for   
5 months  
Overnight at 
4oC  
Once 
thawed 
store 
aliquot  
at 4oC for 
up to 1 
week  
  
  
   
 Additional Reagents   
Product Name  Provider  Catalog No.  
Retinoic acid  Sigma-Aldrich  R2625  
Brain-Derived Neurotrophic 
Factor (BDNF)  
Peprotech  450-02  
Cilliary Neurotrophic Factor 
(CNTF)  
Peprotech  450-13  
Rock Inhibitor ( Y27632 
hydrochloride)  
Selleck Chemicals  S1049  
  
These reagents must be added fresh for each use to each aliquot of medium.  
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Important!  
Axol Neural Cell Culture Media  
DOES NOT contain antibiotics or antifungal agents. Axol Bioscience does not recommend 
the use of antimicrobial agents such as penicillin, streptomycin and amphotericin. 
Antimicrobial agents should not be necessary if proper aseptic technique is adopted  
Preparation of Reagents   
 Preparation of Motor Neuron Recovery Medium  
 
• Upon receipt aliquot and store Motor Neuron Recovery Medium at or below -
80°C protected from light.   
• When ready to use, thaw an aliquot of Motor Neuron Recovery Medium 
overnight at 4°C in the dark.  
• Motor Neuron Recovery Medium requires supplement with retinoic acid before 
use.  
• Prepare Motor Neuron Recovery Medium by adding the following 
concentration of retinoic acid:  
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Growth Factor  
Stock 
Concentration   
Final 
Concentration  
50 mL Medium  
Retinoic acid  1 mM  0.1 μM  5 μL  
  
During thawing and passaging Motor Neuron Recovery Medium should be 
supplemented with rock inhibitor (Y27632 hydrochloride) to a final concentration of 10µM. 
  
Preparation of Motor Neuron Maintenance Medium  
• Upon receipt aliquot and store Motor Neuron Maintenance Medium at or 
below -80°C protected from light.   
• When ready to use, thaw an aliquot of Motor Neuron Maintenance Medium 
overnight at 4°C in the dark.  
• Motor Neuron Maintenance Medium requires supplement with 3 compounds 
before use.  
• Prepare Motor Neuron Maintenance Medium by adding the following factors 
fresh each time:  
 
Growth Factor  
Stock 
Concentration   
Final 
Concentration  
50 mL  
Medium  
Retinoic acid  1 mM  0.5 μM  25 μL  
Brain-Derived Neurotrophic Factor  
(BDNF)  
10 μg/mL  5 ng/mL  25 μL  
Cilliary Neurotrophic Factor (CNTF)  10 μg/mL  10 ng/mL  50 μL  
  
  
SureBond Coating Solution (required for plating during recovery)   
• Upon receipt store SureBond at -80°C.  
• Thaw the SureBond coating solution overnight at 4°C.   
• Calculate the total surface area that requires coating.  
• Dilute the SureBond stock solution (50x) in D-PBS (1x) (without calcium or 
magnesium) to make 1x working solution e.g. 120 μL in 6 mL.  
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• Coat the surface of your culture vessel with the SureBond 1x working solution. 
We recommend coating at a volume of 200 μL per cm2. •  Incubate your culture 
vessel overnight at 37oC.  
  
SureBond-XF Coating Solution (required for final plating on plastic)   
• Upon receipt store SureBond-XF at 4°C.  
• Calculate the total surface area that requires coating.   
• Dilute the SureBond-XF stock solution (200x) in Dulbecco’s-PBS (1x) (D-PBS 
without calcium or magnesium) to make 1x working solution e.g. 30 μL in 6 mL.  
• Coat the surface of your culture vessel with the SureBond-XF 1x working 
solution. We recommend coating at a volume of 200 μL per cm2 however, please 
optimize for your experiments.   
  
SureBond+ReadySet Coating Solution (required for final plating on glass)  
• Upon receipt store SureBond at or below -80°C and store ReadySet at 4°C.  
• Thaw the SureBond coating solution overnight at 4°C.   
• Calculate the total surface area that requires coating.   
• Pre-coat your culture vessel with ReadySet at a volume of 250 μL per cm2.  
• Incubate at 37ºC for 45 minutes.  
• Wash the plate thoroughly four times using an equal volume of sterile ddH2O (e.g. 
if 250 µL of  ReadySet, use 250 µL sterile ddH2O). During each wash rock the 
dish to ensure thorough washing.   
• Do not let the ReadySet dry out following washing, proceed straight to coating 
with SureBond.  
• Dilute the SureBond stock solution (50x) in D-PBS (1x) (without calcium or 
magnesium) to make 1x working solution e.g. 120 μL in 6 mL.  
• Coat the surface of your culture vessel with the SureBond 1x working solution. 
We recommend coating at a volume of 200 μL per cm2.  
• Incubate for 1 hour at 37oC.  
  
Important!  
Make sure that the coating does not evaporate.  
Do not let the SureBond or SureBond-XF coating dry out before seeding the cells.  
DO NOT wash the vessel after coating with SureBond or SureBond-XF.  
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Unlock (required for passaging)  
•  Upon receipt aliquot and store Unlock at or below -80°C protected from light. 
Stored at            -80°C, the reagent is stable for 6 months from date of manufacture.  
  
Culture of Human iPSC-Derived Motor Neuron Progenitors   
Thawing and Plating  
The day before thawing iPSC-Derived Motor Neuron Progenitors  
• Thaw an aliquot of Motor Neuron Recovery Medium overnight at 4oC.  
• Prepare culture vessels by coating with SureBond overnight, MatrigelTM or 
Geltrex (prepared before seeding in accordance with manufacturer’s instructions) 
prior to thawing cells.  
• T-25 flasks or 60 mm dishes are recommended for initial plating of iPSC-Derived 
Motor Neurons after thawing.  
On the day of thawing Human iPSC-Derived Motor Neuron Progenitors.  
• Prepare Motor Neuron Recovery Medium by adding rock inhibitor (Y27632 
hydrochloride) to a final concentration of 10µM and retinoic acid to a final 
concentration of 0.1 µM.  
• Pre-warm all media and culture vessels to 37oC before use.  
• Add 4 mL of Motor Neuron Recovery Medium into a 15 mL sterile conical 
tube  
• To thaw the cells – transfer the vial of cells from storage by transporting the vial 
buried in dry ice. Remove the vial from dry ice and transfer it to a 37oC water bath.  
• Quickly thaw the vial of cells in a 37oC water bath. Do not completely submerge 
the vial (only up to 2/3rd of the vial). Remove the vial before the last bit of ice has 
melted, after 2-3 minutes.  
• Do not shake the vial during thawing.  
• Take the vial of cells to a biological safety cabinet, spraying the vial and hood 
thoroughly with 70% ethanol and wiping with an autoclaved paper towel before 
placing the vial in the hood.  
• Using a P1000 pipette, gently, drop-wise add the cell suspension into the 15 mL 
sterile conical tube containing Motor Neuron Recovery Medium. Gently wash 
the cryogenic vial with 1 mL of warm Motor Neuron Recovery Medium and 
transfer this to the 15 mL sterile conical tube.   
• Centrifuge cells at 200 x g for 5 minutes at room temperature.  
• Carefully aspirate and discard the supernatant with a pipette.  
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• Using a P1000 pipette, gently resuspend the cell pellet in 1 mL of Motor Neuron 
Recovery Medium until they are in a single cell suspension.   
• Perform a cell count to ensure optimal seeding density.  
• Remove the coating solution and add an appropriate volume of medium to the 
culture vessel. Do not let the culture vessel dry out.  
• Plate the resuspended cells drop-wise and evenly at a density ranging from 100,000 
- 150,000 cells/cm2.  
• Gently rock the culture vessel back and forth to ensure and even seeding density.  
• Incubate the cells at 37oC, 5% CO2.  
• The day after plating, replace all of the medium with fresh pre-warmed, 37oC, 
Motor Neuron Recovery Medium without rock inhibitor (Y27632 
hydrochloride).  
• Every 2 days replace all of the medium with fresh pre-warmed, 37oC, Motor 
Neuron Recovery Medium (without rock inhibitor (Y27632 hydrochloride)). 
Passage the iPSCDerived Motor Neuron Progenitors at day 5 or day 7, 
depending on confluency.  
  
  
Passaging and Maintenance of Human iPSC-Derived Motor Neuron 
Progenitors   
• When the culture is 70 % confluent, it is ready to undergo passaging.  
The day before passaging iPSC-Derived Motor Neuron Progenitors  
• Thaw an aliquot of Unlock and Motor Neuron Maintenance Medium 
overnight at 4oC before use and store at 4oC.   
• Pre-Coat Culture Vessels: Make sure to pre-coat the surface of your culture 
vessel that the cells will be passaged into. If continuing to expand iPSC-Derived 
Motor Neuron Progenitors, pre-coat culture vessels with SureBond-XF (for 
plastic culture vessels), SureBond+ReadySet (for glass culture vessels) or 
MatrigelTM (prepared before seeding in accordance with manufacturer’s 
instructions).  
On the day of passaging Human iPSC-Derived Motor Neuron Progenitors  
• Prepare Motor Neuron Maintenance Medium by adding rock inhibitor 
(Y27632 hydrochloride) to a final concentration of 10µM and retinoic acid to a final 
concentration of  
0.5 µM, BDNF to a final concentration of 5 ng/mL and CNTF to a final concentration 
of        10 ng/mL.  
• Pre-warm all media and culture vessels to 37oC before use.  
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• Remove all spent medium from cell culture vessels.   
• Gently rinse the surface of the cell layer once with the Dulbecco’s-PBS (1x) (D-
PBS, without calcium or magnesium, 2 mL D-PBS (1x) per 10 cm2 culture 
surface area).  
• Discard the D-PBS.  
• To detach the cells from a coating of SureBond use Unlock.  
• Add 1 mL per 10cm2 of culture surface area of cold/room temperature Unlock. 
Evenly distribute it over the entire cell layer. Incubate the cells for 5 minutes at 
37°C.  
• Use a P1000 pipette to transfer the cells drop-wise into a 15 mL sterile conical tube 
add gently four volumes of pre-warmed, 37°C, Motor Neuron Maintenance 
Medium. (For example if 1 mL of Unlock is used, then add 4 mL of the medium 
to stop the reaction). Gently pipette up and down a few times to disperse the 
medium.  
• Centrifuge cells at 200 x g for 5 minutes at room temperature.  
• Carefully aspirate and discard the supernatant with a pipette.  
• Using a P1000 pipette, gently resuspend the cell pellet in 1 mL of Motor Neuron 
Maintenance Medium until they are in a single cell suspension.   
• Perform a cell count to ensure optimal seeding density.  
• Remove the coating solution and add an appropriate volume of medium to the 
culture vessel. Do not let the culture vessel dry out.  
• Plate the resuspended cells drop-wise and evenly at a density of 100,000 
cells/cm2.  
• The day after plating, replace all of the medium with fresh pre-warmed, 37oC, 
Motor Neuron Maintenance Medium without rock inhibitor (Y27632 
hydrochloride).  
• Every 2 days remove and replace all of the medium with fresh pre-warmed, 37oC, 
Motor Neuron Maintenance Medium (without rock inhibitor (Y27632 
hydrochloride)).  
 
• iPSC-Derived Motor Neurons should be culture for a minimum of 19-35 days.  
  
  
  
  
 
Note   
Terminally differentiated  iPSC - Derived Motor Neurons can be cultured for up to 35 days   
  
